Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.146707584167217,0.00311853262844534,0.140595260215464,0.15281990811897,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,41843,-0.534598499745275,0.0116978211194864,-0.557526229139468,-0.511670770351082,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,42137,-0.221971917915905,0.0041720674972957,-0.230149170210605,-0.213794665621206,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.242699316287846,0.00608614991899945,-0.254628170129085,-0.230770462446607,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.13384664892452,0.0030453272258252,0.127877807561902,0.139815490287137,0
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,42296,-0.18511461330773,0.00497998532260797,-0.194875384540042,-0.175353842075419,3.16428414376019e-288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.135707052314532,0.00377132551512313,-0.143098850324173,-0.12831525430489,1.23678827356178e-268
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,42080,-0.137375164276676,0.00405807322120248,-0.145328987790233,-0.129421340763119,3.60916309823127e-241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYY,Peptide YY,39575,-0.324426848602789,0.00971877099829695,-0.343475639759451,-0.305378057446127,8.67212014088039e-233
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.27993461124253,0.00857589468738402,-0.296743364829802,-0.263125857655257,5.35458083120203e-225
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9,Complement component C9,39990,0.183371771555138,0.00562103471175992,0.172354543520088,0.194388999590187,3.03294359587118e-223
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.268748315218774,0.00839839545073175,-0.285209170302208,-0.25228746013534,3.28060265268748e-215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.373109957946447,0.0124338909990815,0.348739531588247,0.397480384304646,1.17708560653722e-191
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.084898784135442,0.00288014712149874,0.0792536957773045,0.0905438724935796,3.57321436058349e-185
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.141096869524155,0.00502231284306551,-0.150940602696563,-0.131253136351746,7.50979081600864e-169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,42089,-0.278656996136202,0.0101348631204311,-0.298521327852247,-0.258792664420157,5.65339821182057e-162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.15197487966437,0.00559647538853978,-0.162943971425908,-0.141005787902832,2.25278195350549e-157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,41913,-0.217462669079772,0.00815358858224745,-0.233443702700977,-0.201481635458567,1.01916141568602e-152
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,42145,0.124989960766603,0.00475377517950673,0.115672561414769,0.134307360118436,1.20624083084091e-148
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.218617330973331,0.00838435712405725,-0.235050670936483,-0.202183991010179,2.77693906938236e-146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,42123,-0.145107358534142,0.00557275453873205,-0.156029957430057,-0.134184759638228,6.90661947179711e-146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,39990,0.0669309074065353,0.00256709290435771,0.0618994053139942,0.0719624094990764,1.32398711104412e-145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,42296,-0.0732999809452053,0.00288413908766529,-0.0789528935570292,-0.0676470683333813,2.84743671377703e-139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.126730356436461,0.00501839998757018,-0.136566420412099,-0.116894292460824,7.66287702414086e-137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.161583867631985,0.00644349286450038,-0.174213113646406,-0.148954621617565,1.22194820012269e-135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,42145,-0.155497579853528,0.00622886422341463,-0.16770615373142,-0.143289005975635,1.61341457753144e-134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,42047,-0.177217106666472,0.00710567854194587,-0.191144236608685,-0.163289976724258,2.9945524414222e-134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0864890213970357,0.0034768321347793,-0.0933036123812031,-0.0796744304128683,1.30155014973789e-133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0737201067094889,0.0030002999630942,-0.0796006946371535,-0.0678395187818242,1.93310815590845e-130
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.221450259464389,0.00899564530029666,-0.23908172425297,-0.203818794675807,2.07061530914613e-130
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.0782227481959167,0.00320362768146529,-0.0845018584515887,-0.0719436379402448,6.42233257764909e-129
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.15082089740146,0.0061966996526973,-0.162966428720747,-0.138675366082174,4.20192475156145e-128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.196373783548876,0.00808740349041464,-0.212225094390089,-0.180522472707663,1.79656328002825e-127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.129504844709436,0.00540445628850864,-0.140097579034913,-0.118912110383959,2.88426774436794e-124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.125635817682171,0.0052603025682569,-0.135946010715955,-0.115325624648388,1.60656587125068e-123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,39649,-0.197579235162662,0.00828145676956722,-0.213810890431014,-0.18134757989431,1.02683171056708e-122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0675306992143735,0.00288131269193402,-0.0731780720905642,-0.0618833263381829,4.17353653175354e-119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,41839,-0.121508197744206,0.00522861572179701,-0.131756284558928,-0.111260110929484,3.99029574084054e-117
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.110191820124665,0.00479991902700276,-0.119599661417591,-0.10078397883174,1.83485468897196e-114
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.328771987843841,0.0145302645978695,-0.357251306455665,-0.300292669232017,2.92028125808479e-111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,42193,-0.0738884808401791,0.00328220155106284,-0.0803215958802622,-0.0674553658000959,3.24836604236252e-110
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,41225,-0.092584122512061,0.00411908237137607,-0.100657523959958,-0.0845107210641639,9.79548287277433e-110
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MME,Neprilysin,42070,-0.173869003861869,0.0077470595158858,-0.189053240513005,-0.158684767210733,1.50202592010535e-109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,39979,0.154235757897266,0.00686169620884986,0.14078683332792,0.167684682466612,1.62508128789783e-109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.0880918581880486,0.00395030715087664,-0.0958344602037669,-0.0803492561723304,3.24784482959597e-108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.190465679519383,0.0086394507182323,-0.207399002927118,-0.173532356111647,1.70600591998158e-105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,42310,-0.111876315414443,0.00510002801329179,-0.121872370320495,-0.101880260508391,7.35776159882367e-105
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.142199321459411,0.00649201929447345,-0.154923679276579,-0.129474963642243,1.697185568135e-104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.101504360927493,0.00468431788691497,0.0923230978691395,0.110685623985846,4.56308403147493e-102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.147811793618333,0.00684151520211315,-0.161221163414475,-0.134402423822191,8.51604809854128e-102
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0695683290167952,0.00322417731279795,-0.0758877165498792,-0.0632489414837112,3.81821005670387e-101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.303820933715466,0.0144262780081697,-0.332096438611478,-0.275545428819453,6.36872273011067e-97
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0701187882296858,0.0033728054393669,-0.0767294868908449,-0.0635080895685267,1.65442543456659e-94
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FURIN,Furin,42181,-0.0683860895925847,0.00329273181161818,-0.0748398439433563,-0.0619323352418131,2.41004310308914e-94
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.171730841070012,0.00834714289054769,-0.188091241135485,-0.155370441004538,1.29802515943176e-92
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.246225134628278,0.0119722941279383,-0.269690831119037,-0.222759438137519,1.38712046792695e-92
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.172616701662263,0.00845887843084619,-0.189196103386722,-0.156037299937805,3.43752369389696e-91
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0477823780298101,0.00235863075612282,-0.0524052943118109,-0.0431594617478094,6.31828209957961e-90
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.133777150381879,0.0066300654959492,-0.14677207875394,-0.120782222009819,3.11312936518532e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,42199,0.0570657785710631,0.0028304517491306,0.0515180931427671,0.0626134639993591,4.26600012841982e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0678482437110576,0.00336542489592967,-0.0744444765070797,-0.0612520109150354,4.29105909183432e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0567810952891948,0.00282225446900645,-0.0623127140484474,-0.0512494765299421,9.64819215176775e-89
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.119419481505154,0.00598259318086463,-0.131145364139649,-0.107693598870659,2.29794413661299e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.100539519410365,0.00504789324986873,-0.110433390180107,-0.090645648640622,5.40535943025895e-87
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELN,Elastin,39958,-0.0691922422288601,0.00347849198402245,-0.0760100865175441,-0.0623743979401761,1.42459698769425e-86
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,42195,-0.066987574142118,0.00339130628495427,-0.0736345344606284,-0.0603406138236076,1.20196774427435e-85
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0605470950126751,0.00310113701685287,-0.0666253235657068,-0.0544688664596435,9.65248360291564e-84
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.0594883798325207,0.0030900631435008,0.0534318560712591,0.0655449035937823,2.84709659021761e-81
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.0606726634613852,0.00317072373040116,-0.0668872819729715,-0.0544580449497989,1.45533939612273e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.0929677224121168,0.00486500888616389,-0.102503139828998,-0.0834323049952356,2.36217556705742e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.145895348012696,0.00763558769009466,-0.160861099885282,-0.130929596140111,3.97203847368332e-80
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.150961161421153,0.00800090564275122,-0.166642936480945,-0.13527938636136,2.13678132868712e-78
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.0684474929121457,0.00367213393530932,0.0612501103989395,0.075644875425352,1.36062279991893e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,42070,-0.0655650939850895,0.00352123617854797,-0.0724667168950435,-0.0586634710751355,2.01201447977689e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0646259598104232,0.00347950888721519,-0.071445797229365,-0.0578061223914814,6.9796881245221e-76
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,42296,-0.0484445819866786,0.00261904632717449,-0.0535779127879406,-0.0433112511854166,1.80694070515201e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.106613738258406,0.0057635893466054,-0.117910373377753,-0.0953171031390596,1.86092231555842e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.0902832323679706,0.00489574913887211,-0.09987890068016,-0.0806875640557813,5.21913494717013e-75
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.098181410846868,0.00536688894401062,-0.108700513177129,-0.0876623085166072,1.12889333521108e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.146868047581213,0.00804572012710818,-0.162637659030345,-0.131098436132081,1.47331732555518e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0891417232426373,0.00489739630469257,-0.0987406199998348,-0.0795428264854399,3.72061580971935e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELE,E-selectin,42310,-0.0918142735159742,0.00504659420274054,-0.101705598153346,-0.0819229488786027,4.21498063914994e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.0958695584254017,0.00527061683289776,-0.106199967417881,-0.0855391494329221,4.66050884926732e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,42310,-0.079118213172312,0.00435274791768341,-0.0876495990909715,-0.0705868272536526,5.67515139799254e-73
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.0828839784368222,0.00457697799201993,-0.0918548553011813,-0.0739131015724631,1.89089980039111e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.153468819386207,0.00850380912301575,-0.170136285267318,-0.136801353505096,5.84462418328453e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0511072092327521,0.00282872461673223,-0.0566515094815473,-0.0455629089839569,5.84940857630569e-72
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.222896209248771,0.0123728681834631,-0.247147030888359,-0.198645387609183,1.00391642899459e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.0879170988824659,0.00487920171992584,-0.0974803342535206,-0.0783538635114113,1.43786903921834e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.0970972282111148,0.00540022672929587,0.0865127838216948,0.107681672600535,1.93825320608205e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0498677564924208,0.00277240312353928,-0.0553016666145578,-0.0444338463702838,2.49716908188783e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0667217028456277,0.00372750252702787,-0.0740276077986023,-0.0594157978926531,7.68979258606427e-71
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,39638,-0.113225294996758,0.00633598110270873,-0.125643817958068,-0.100806772035449,1.96829929343436e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.178732478539901,0.0100411541056836,-0.198413140587041,-0.159051816492762,4.68630975663946e-70
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0601170665048788,0.00339895982083124,-0.066779027753708,-0.0534551052560495,3.16963883839581e-69
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,39468,0.0750192351859325,0.00424325978427123,0.0667024460087609,0.0833360243631041,5.53910838638405e-69
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.147810033858384,0.00841314573022475,-0.164299799489624,-0.131320268227143,2.53324035030019e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,42070,-0.0990129560322447,0.00564003892286849,-0.110067432321067,-0.0879584797434225,3.10696456836215e-68
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.115998333067882,0.00663623609352671,-0.129005355811195,-0.10299131032457,1.5650272915785e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.160001294511601,0.00917058105415304,-0.177975633377741,-0.142026955645461,2.03174954812014e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,42199,-0.0319628721294172,0.0018362777477686,-0.0355619765150437,-0.0283637677437908,3.9389341453184e-67
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.0997475927888002,0.00575031344128757,-0.111018207133724,-0.0884769784438766,1.08714361835902e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.0984218166834243,0.00566967875740003,-0.109534387047928,-0.0873092463189202,1.21915891033677e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.133864837978547,0.00772817283704094,-0.149012056739147,-0.118717619217946,1.74175271213763e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0503581887153427,0.0029154555882251,0.0446438957624215,0.0560724816682639,3.82133005325699e-66
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.146784048790434,0.0085592751693356,-0.163560228122331,-0.130007869458536,3.1385808937902e-65
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,42239,-0.0346000849091622,0.00202026654951464,-0.0385598073462109,-0.0306403624721135,4.50499237809611e-65
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,42296,-0.0523033058751598,0.00306581988593629,-0.0583123128515949,-0.0462942988987247,1.36416888816269e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0549754235621425,0.00322965338615975,-0.0613055441990156,-0.0486453029252694,2.61843039867456e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.0929532072756224,0.00547591847655071,-0.103686007489662,-0.082220407061583,5.9207478326844e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.0879991508538503,0.00519058629543757,-0.098172699992908,-0.0778256017147927,8.25592095571937e-64
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.0662436057790568,0.00394663932294685,-0.0739790188520326,-0.058508192706081,1.8477114995953e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.0841119011534999,0.00503127215872931,-0.0939731945846093,-0.0742506077223904,5.52278268761905e-62
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.057680427352242,0.00347226978046513,-0.0644860761219536,-0.0508747785825303,2.29228703504407e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0548546840410229,0.00331114996653888,-0.0613445379754391,-0.0483648301066067,4.76165452090375e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.07010430999816,0.00423468853279575,-0.0784042995224396,-0.0618043204738803,5.84278537536406e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.0825935152745742,0.00498595107263591,0.0728210511722078,0.0923659793769406,6.43801179111682e-61
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.128103431154344,0.00775172392876108,-0.143296810054716,-0.112910052253973,1.22327892652435e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,42194,-0.0511433251686405,0.0031108399636441,-0.0572405714973829,-0.0450460788398981,3.73964212886101e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,42070,-0.064573777926848,0.00393051934698885,-0.0722775958469462,-0.0568699600067499,4.56211180845442e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0370284471350603,0.00225499556688971,-0.0414482384461642,-0.0326086558239565,5.15136478730296e-60
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0538504582130453,0.00329093647274142,-0.0603006936996185,-0.0474002227264721,1.31372773236576e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.174759225865992,0.0107151640259963,-0.195760947356945,-0.153757504375039,3.11712257276202e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REN,Renin,42145,-0.132847459056524,0.00815048780580163,-0.148822415155895,-0.116872502957153,3.64534903064571e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.134561896955993,0.00827174830494628,-0.150774523633688,-0.118349270278298,6.23509596218796e-59
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,39736,-0.105142493393658,0.00649842488559637,-0.117879406169427,-0.0924055806178892,3.22785192276184e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0670104590413581,0.00415555992001531,-0.0751553564845882,-0.0588655615981281,5.88679449764003e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,42137,-0.0457772211395651,0.0028403836573978,-0.0513443731080648,-0.0402100691710654,6.74248896087576e-58
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.0883662679998639,0.00549359933386555,-0.0991337226942404,-0.0775988133054874,1.14342670427312e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.0931637685768091,0.00579590705003567,-0.104523746394879,-0.0818037907587392,1.73871382709866e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,42123,0.07178365960675,0.00448589366247502,0.0629913080282989,0.080576011185201,4.12906997375875e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0340258001290989,0.0021270744858075,0.0298567341369162,0.0381948661212816,4.45816339474134e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.0809919420711352,0.00507323208827864,-0.0909354769641613,-0.0710484071781091,7.37400088097178e-57
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.0551781424930153,0.00346296316568863,-0.061965550297765,-0.0483907346882656,1.19141404069792e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.0589001694676081,0.00371756171306354,-0.0661865904252126,-0.0516137485100035,4.97401763708484e-56
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,42296,-0.0719969677194686,0.00456041762719288,-0.0809353862687667,-0.0630585491701706,1.1760334357887e-55
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.175820059969417,0.0112551823458038,-0.197880217367193,-0.153759902571642,1.92577842951414e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.0523539584005953,0.00335511102620284,-0.0589299760119529,-0.0457779407892377,2.00782025631322e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0579644466251136,0.00371536523237925,0.0506823307696503,0.0652465624805769,2.61682920740185e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0712061804000418,0.00457740120110596,-0.0801778867542095,-0.0622344740458741,4.32489158634019e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,42255,-0.0381637283837932,0.00245409502258808,-0.0429737546280658,-0.0333537021395206,4.55032220830112e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,39736,-0.060138952594249,0.00386645220905806,-0.0677171989240029,-0.0525607062644952,5.5139079422931e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,42119,-0.113645477733613,0.00731754116888212,-0.127987858424622,-0.0993030970426044,6.29554765137786e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0604068037841886,0.00389661733337919,-0.0680441737576118,-0.0527694338107654,9.56106463205054e-54
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH1,Somatotropin,42129,0.276535272122792,0.0178475963950423,0.241553983188509,0.311516561057075,1.09632672547062e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0872340991918091,0.0056411717677898,-0.0982907958566771,-0.0761774025269411,2.22183256448783e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.05833368596781,0.00377865206771317,-0.0657398440205278,-0.0509275279150922,3.2438428434219e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.0958812695712773,0.00622372099161843,-0.108079762714849,-0.0836827764277051,4.16748793961148e-53
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.064891677766137,0.00423681554437929,-0.0731958362331204,-0.0565875192991536,1.64318770406661e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0610543209372467,0.00398866185805689,-0.0688720981790382,-0.0532365436954551,1.86586089284057e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,42119,-0.080796367471478,0.00528149030741489,-0.0911480884740112,-0.0704446464689449,2.16357454072667e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTR,Transthyretin,39862,-0.0382097916000765,0.00250374783579658,-0.0431171373582378,-0.0333024458419152,4.60617594572749e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0555285407024361,0.00364778253665896,-0.0626781944742876,-0.0483788869305845,6.79646073727701e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,42184,-0.0437676739237434,0.00287741553378468,-0.0494074083699614,-0.0381279394775255,8.01506322388359e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,41697,-0.0614884364616805,0.00404445872796613,-0.0694155755684941,-0.0535612973548669,9.3176083668201e-52
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.0816626936932365,0.00537814198193079,-0.0922038519778209,-0.0711215354086522,1.44806582212082e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANG,Angiogenin,42152,-0.0495965256354743,0.00329256831810605,-0.0560499595389621,-0.0431430917319864,7.29652168006343e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFM,Afamin,39979,-0.0306963813412814,0.00203838690694476,-0.0346916196788931,-0.0267011430036697,9.25901409142225e-51
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,42217,-0.0861965798720344,0.005740042992016,-0.0974470641363858,-0.074946095607683,1.4487224763045e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0561239078059437,0.00374521511961771,0.048783286171493,0.0634645294403944,2.31355749108567e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.109600944073953,0.00732478162392395,-0.123957516056844,-0.0952443720910624,3.84242525924321e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0550621775435611,0.00369330457071524,-0.062301054502163,-0.0478233005849593,7.1389571241224e-50
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POSTN,Periostin,39966,0.0567653949104728,0.00381587889852716,0.0492862722693595,0.064244517551586,1.3778204063823e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,42145,-0.0523507813330424,0.00354798704467715,-0.0593048359406096,-0.0453967267254752,6.83664288962567e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,42145,-0.093472348115395,0.00634430767694046,-0.105907191162198,-0.0810375050685917,9.39458657508946e-49
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.0547226848940082,0.00372310081765467,-0.0620199624966113,-0.047425407291405,1.58174221764088e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.0393330288721805,0.00268119743222054,-0.0445881758393327,-0.0340778819050282,2.35829195694955e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,39638,-0.0932005487208189,0.00635202385300287,-0.105650515472705,-0.0807505819689333,2.74943148017725e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.113001796573694,0.00770694165841074,-0.128107402224179,-0.0978961909232085,3.15904762140716e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.0953800052746515,0.00651168561533004,-0.108142909080698,-0.0826171014686046,3.24583751252251e-48
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.074624931070003,0.00512340292020042,-0.0846668007935958,-0.0645830613464101,1.06764620961484e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.100842336787635,0.00691733392778056,-0.114400311286085,-0.087284362289185,1.07763845646611e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.100509851653307,0.00691227159097762,-0.114057903971623,-0.0869617993349909,1.51843539160138e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.112242152548832,0.00772192869427808,-0.127377132789617,-0.0971071723080466,1.64396691745446e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0624608469359963,0.00430385383808617,-0.0708964004586452,-0.0540252934133474,2.26940048288629e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.0380841133833089,0.00263054661871984,-0.0432399847559998,-0.032928242010618,3.74610138743653e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,42137,0.039248367153639,0.00271670176158623,0.03392363170093,0.044573102606348,5.84515435283678e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.0871288969811963,0.00603645631739488,-0.0989603513632902,-0.0752974425991023,7.0343614092353e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.08423109040922,0.0058384625965561,-0.09567447709847,-0.0727877037199701,7.84907240495064e-47
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,42249,-0.0537495243799014,0.00375582885362092,-0.0611109489329984,-0.0463880998268044,4.02914788316023e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0400533785055668,0.00280674394333166,-0.0455545966344968,-0.0345521603766367,8.53556713199575e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.062972941411586,0.00441696841509775,-0.0716301995051776,-0.0543156833179944,8.80110038346189e-46
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0419253758056153,0.00294326291221088,-0.0476941711135486,-0.036156580497682,1.19769155465477e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,39954,0.0510133193259385,0.00358492718773468,0.0439868620379785,0.0580397766138985,1.47061898099338e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0811733384089424,0.00571235509089518,0.0699771224307878,0.0923695543870969,1.99204488532821e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.0380937887214089,0.00269176609119092,-0.0433696502601431,-0.0328179271826747,3.78489577243962e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0272975762575523,0.00193126027429063,0.0235123061199426,0.0310828463951619,4.85381880358225e-45
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.108258451037693,0.00769539047916166,-0.12334141637685,-0.0931754856985364,1.41360533798224e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0371058526194149,0.00264729752553659,-0.0422945557694666,-0.0319171494693632,2.91730349501919e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAST,Gastrin,39929,-0.184561033458754,0.0132160583378657,-0.210464507800971,-0.158657559116538,5.90200036946704e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.027426948702223,0.00196803301260684,0.0235696039975136,0.0312842934069324,7.68891428511938e-44
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.117072623218259,0.00845068868970238,-0.133635973050075,-0.100509273386442,2.71934227207499e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.0822554987528397,0.00595452371682344,-0.0939263652378137,-0.0705846322678658,4.18181651470855e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OCLN,Occludin,39934,-0.0617848826499029,0.00447785213728424,-0.07056147283898,-0.0530082924608258,5.83465739654952e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0797978825120257,0.00578967724498389,-0.0911456499121941,-0.0684501151118573,7.15623460829902e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,42274,0.0744300652728382,0.00540948048100045,0.0638274835300773,0.0850326470155991,8.64462654559824e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0393332281676901,0.0028579269595073,-0.0449347650083244,-0.0337316913270558,9.40600193835809e-43
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,42171,0.0538957607538049,0.00392249041230655,0.0462076795456841,0.0615838419619258,1.12556918875355e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0535423363868995,0.00390528507391564,-0.0611966951317741,-0.0458879776420248,1.68324487638053e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,42137,-0.0765225643296754,0.00560034274937814,-0.0874992361184566,-0.0655458925408943,3.17808674450484e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0540001538142785,0.00397470682078428,0.0462097284455413,0.0617905791830157,9.1206207044657e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,42119,0.0462504698504597,0.00340487082683942,0.0395769230298544,0.0529240166710649,9.41109557229648e-42
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,39958,-0.0383107720332342,0.00282036586041492,-0.0438386891196475,-0.032782854946821,1.05975983358729e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0434917957481084,0.00322129513747894,0.0371780572786496,0.0498055342175671,2.82983486866176e-41
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0343033816694994,0.00256776190499608,0.0292705683357071,0.0393361950032917,1.87368302453882e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.0917367690667063,0.00687062961813644,-0.105203203118254,-0.0782703350151589,2.10338000274776e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.101286707080684,0.00759397865799993,-0.116170905250364,-0.0864025089110042,2.4908470719146e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0509681374916322,0.00382369376791625,-0.058462577276748,-0.0434736977065163,2.79768690831617e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0580578433057779,0.00436438727767375,-0.0666120423700185,-0.0495036442415374,3.98890492368324e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,42185,0.0548164758713185,0.00412850919472004,0.0467245978496672,0.0629083538929698,5.54437536304285e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.062178874532545,0.0046806986531625,-0.0713530438927435,-0.0530047051723465,5.79138332612521e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.0963048875383509,0.00725586170387009,-0.110526376477936,-0.0820833985987655,5.9572493823528e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MENT,Protein MENT,39736,0.0319068047920545,0.00240532912705393,0.0271923597030288,0.0366212498810802,7.40246678285006e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0541310086008501,0.00408392385081359,-0.0621354993484447,-0.0461265178532554,7.54862948101687e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0363880517829922,0.00274443362689388,0.0310089618742802,0.0417671416917043,7.90713102413891e-40
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXN,Paxillin,41839,-0.0681478403212628,0.00515823349929557,-0.0782579779798821,-0.0580377026626434,1.34132415106098e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,42262,0.0220899213473491,0.00167322032244169,0.0188104095153634,0.0253694331793348,1.49122780044177e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,39736,-0.0378040914337134,0.00286201926174437,-0.0434136491867323,-0.0321945336806944,1.5453096163662e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.151615631061744,0.0114935892522143,-0.174143065996084,-0.129088196127404,1.72963926440848e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0647489647548006,0.0049092076004115,-0.0743710116516072,-0.0551269178579941,1.79334670188761e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0440991049241419,0.00334268321921049,-0.0506507640337944,-0.0375474458144893,1.89919291512908e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,42129,-0.0410613171458407,0.00311547580473911,-0.0471676497231294,-0.0349549845685521,2.0066133837056e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0510489566724942,0.00388511471850539,-0.0586637815207647,-0.0434341318242236,3.39045345921408e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0920651014704858,0.00700756118926232,-0.10579992140144,-0.0783302815395316,3.91629774661712e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.0675459373139626,0.00514624547968561,-0.0776325784541464,-0.0574592961737788,4.06583970808916e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGRN,Agrin,42185,-0.0472832888994451,0.00360592110869476,-0.0543508942724868,-0.0402156835264033,4.80814266347011e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.0496696636218336,0.00379976414205653,0.0422221259034029,0.0571172013402644,8.15808503354517e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0263076069255248,0.00201407045598397,-0.0302551850192534,-0.0223600288317963,9.3336016289002e-39
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.0861431643528733,0.00661585183459499,-0.0991102339486795,-0.0731760947570672,1.59017280042617e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0438132064583289,0.00336689350169558,0.0372140951950056,0.0504123177216523,1.74546505931019e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0390099815101741,0.00299788716130498,-0.0448858403463319,-0.0331341226740164,1.76419764911821e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.165366572314096,0.0127084220548187,-0.190275079541541,-0.140458065086651,1.7751239077103e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0517756087307973,0.00397965321958536,-0.0595757290411846,-0.04397548842041,2.01605432430624e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,42262,-0.0712993975722839,0.00549170227147115,-0.0820631340243673,-0.0605356611202004,2.57055238462616e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0842017070449707,0.00650639514588296,-0.0969542415309013,-0.0714491725590402,4.39259719958214e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0793550379098686,0.00615992297244097,-0.0914284869358529,-0.0672815888838843,9.43766302857764e-38
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,42134,0.0505386929853423,0.00393779156477317,0.0428206215183869,0.0582567644522977,1.74308868970003e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,42129,-0.0393027987550663,0.00306285105540451,-0.0453059868236591,-0.0332996106864734,1.79250481121932e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0368200693311805,0.00287390228093103,-0.0424529178018053,-0.0311872208605556,2.30956388657644e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.143748999134591,0.0112401428326142,-0.165779679086515,-0.121718319182667,3.14036851843624e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.040078181002153,0.00313758789151633,0.033928508734781,0.046227853269525,3.77214821990301e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.0755813429119688,0.00591717457117791,-0.0871790050714775,-0.0639836807524601,3.79344908656895e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,42145,-0.0873896062139933,0.006876961822663,-0.100868451386413,-0.0739107610415738,8.70206173703461e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0355654646423146,0.00280033652174994,-0.0410541242249444,-0.0300768050596847,9.53501639316294e-37
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0389620234547816,0.00307049654357198,-0.0449801966801827,-0.0329438502293806,1.09488022452689e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.0679384347936535,0.0053562846552318,-0.0784367527179078,-0.0574401168693991,1.1742541684899e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0618956761498613,0.0048785934180153,-0.0714577192491713,-0.0523336330505514,1.23553724420249e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0516474305310702,0.00407438307319655,-0.0596332213545354,-0.043661639707605,1.29540960327714e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.0461381202958875,0.00364909140311362,-0.0532903394459902,-0.0389859011457848,1.95599595408574e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0862445665065121,0.00682547362248291,-0.0996224948065786,-0.0728666382064456,2.1569563758939e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.15998312198662,0.0126915214371614,-0.184858504003456,-0.135107739969784,3.49055025248542e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,39736,-0.0676623640595629,0.0053727243515884,-0.0781929037886762,-0.0571318243304496,4.03072356252012e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.0919980298442598,0.00734746193794218,-0.106399055242626,-0.0775970044458931,9.07341361750856e-36
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEP,Leptin,42145,-0.0874326264614229,0.00701142324337912,-0.101175016018446,-0.0736902369043998,1.70381132345058e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.0802644851560529,0.00643535486845767,-0.0928777806982299,-0.0676511896138759,1.80376467595569e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0343298081495984,0.00275544405237886,-0.039730478492261,-0.0289291378069358,1.95723581173055e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLN,Promotilin,42119,-0.111737561856902,0.00899206265041671,-0.129362004651719,-0.0941131190620857,2.9328732427184e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.041183289213406,0.00331682925050488,-0.0476842745443956,-0.0346823038824165,3.34760154354063e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.0372990475873604,0.0030115213720259,-0.0432016294765311,-0.0313964656981896,5.27025537943575e-35
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0463908717181373,0.00377054745541521,-0.0537811447307511,-0.0390005987055234,1.32845461942454e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0275019534896555,0.00223456038495055,-0.0318816918441585,-0.0231222151351524,1.38371469593204e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,39802,-0.0291566488874888,0.00237079183536472,-0.0338034008848037,-0.024509896890174,1.54499967717599e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.0813201278008555,0.00663573294728308,-0.0943261643775303,-0.0683140912241807,2.40994314414648e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.113077254719737,0.00923044610345184,-0.131168929082503,-0.0949855803569714,2.74832245016505e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0333106890659748,0.00272399664961668,0.0279716556327261,0.0386497224992235,3.31183385449626e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,39934,-0.0522142446298117,0.00426883227206547,-0.06058115588306,-0.0438473333765634,3.46460504864925e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD248,Endosialin,39966,0.0499565529653722,0.00409540651418732,0.0419295561975651,0.0579835497331793,5.1837131220903e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.0524417262950693,0.00431164831406377,-0.0608925569906343,-0.0439908955995043,7.34832910300051e-34
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,39657,-0.103270682905443,0.00850413109357435,-0.119938779848849,-0.0866025859620375,1.01675702763128e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.0873203214758301,0.00720450275816404,-0.101441146881832,-0.0731994960698286,1.33211980460511e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.039905713063505,0.00329477506364461,-0.0463634721882484,-0.0334479539387615,1.36626765271298e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,39736,-0.056778367116322,0.00468909432983446,-0.0659689920027975,-0.0475877422298464,1.54453132420833e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,41992,-0.0393172293791224,0.00324977898081933,-0.0456867961815283,-0.0329476625767165,1.60990886707336e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.0677955537236491,0.00560617180802138,-0.078783650467371,-0.0568074569799272,1.72307904791733e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0678351966586655,0.00562810002740471,-0.0788662727123787,-0.0568041206049522,2.77177435837487e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0304687524161979,0.00253112083580141,0.0255077555780271,0.0354297492543686,3.31217399992797e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0536784871913403,0.00446478681597786,-0.0624294693506569,-0.0449275050320237,3.99251659184678e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.0543224884546056,0.00451980004089971,-0.063181296534769,-0.0454636803744422,4.54883554291951e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0888494296294502,0.00739403698831594,0.074357117132351,0.103341742126549,4.62664791745069e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.0816244962599975,0.00680135910437452,-0.0949551601045715,-0.0682938324154234,5.15942488867454e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.117834646517786,0.00985093037915446,-0.137142470060929,-0.0985268229746435,8.26003881363455e-33
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.126504231133713,0.0106370297270243,-0.14735280939868,-0.105655652868745,1.87539527057206e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.132240318147812,0.0111369732522593,-0.15406878572224,-0.110411850573384,2.51317628605007e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.0282683579549702,0.0023860669529723,-0.0329450491827959,-0.0235916667271445,3.4381481834152e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0330645554635987,0.00280224010438151,-0.0385569460681865,-0.027572164859011,5.64155339276415e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.120293577348916,0.0101944500460341,-0.140274699439143,-0.100312455258689,6.01150540811702e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0341638495116032,0.00289918544491205,-0.0398462529836308,-0.0284814460395756,6.7799351329124e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0374382040752057,0.00317879670043001,-0.0436686456080485,-0.0312077625423629,7.29356962633164e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.0839859870882069,0.00713606171188278,-0.0979726680434971,-0.0699993061329166,8.08390471082094e-32
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,41900,-0.063209999069616,0.00538556880031236,-0.0737657139182282,-0.0526542842210038,1.18081164300007e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0487399493593499,0.00416004499416563,-0.0568936375479146,-0.0405862611707853,1.61145654253292e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0447399303276113,0.00382834033192033,-0.0522434773781752,-0.0372363832770475,2.28558150493329e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,42016,-0.103354058781581,0.00885351222383869,-0.120706942740305,-0.0860011748228571,2.45927035423646e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSN,Gelsolin,39943,0.0223819803714715,0.00192034763906426,0.0186180989989056,0.0261458617440375,3.252044499141e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0859698101077246,0.00738096504833694,-0.100436501602465,-0.0715031186129842,3.35356190137483e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.128431712526902,0.0110225476356865,-0.150035905892848,-0.106827519160957,3.38617851715084e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.112653921626461,0.00967283670361144,-0.13161268156554,-0.093695161687383,3.60106190541356e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0418215933772081,0.00359960776922239,-0.048876824604884,-0.0347663621495322,4.70148001178716e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0362577556000583,0.00312298133005003,-0.0423787990069564,-0.0301367121931603,5.14293956592827e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,42296,-0.043656196290071,0.00376581713644809,-0.0510371978775093,-0.0362751947026328,6.25309424513931e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0415519889550321,0.00358780204850572,-0.0485840809701033,-0.0345198969399609,7.13492179167755e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,39638,-0.0698415013780578,0.00602829811781703,-0.0816569656889792,-0.0580260370671364,7.35154404488018e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,42181,-0.0470277499486142,0.00406228593432447,-0.0549898303798902,-0.0390656695173383,7.55137227672857e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.060593913483818,0.00524070598253255,-0.0708656972095818,-0.0503221297580542,9.63061309147066e-31
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,42230,-0.0801981638625387,0.00696304123692838,-0.0938457246869183,-0.0665506030381591,1.48793338753453e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,42296,-0.0393019166239925,0.00341901463233605,-0.0460031853033712,-0.0326006479446139,1.92553384300848e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0762019562984245,0.00664653155838029,-0.0892291581528499,-0.0631747544439991,2.73209985596734e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,39966,-0.13192665104622,0.0115022309391402,-0.154471023686935,-0.109382278405505,2.74985841635649e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0487392311485273,0.00426252638368592,-0.0570937828605517,-0.0403846794365029,3.858223592771e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.0267732896793301,0.00234292425589558,-0.0313654212208855,-0.0221811581377748,4.49219821919148e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.0266888107415361,0.00234354469140301,-0.031282158336686,-0.0220954631463862,6.54830266199218e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,42211,-0.0699445714511813,0.0061494911463491,-0.0819975740980255,-0.0578915688043371,7.67990281035642e-30
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,42181,-0.0620200973981933,0.0054661856060301,-0.0727338211860123,-0.0513063736103744,1.05454196043153e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.0997630957391582,0.00880144613214573,-0.117013930158164,-0.0825122613201526,1.28444073758473e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.10443330004837,0.00922247041826821,-0.122509342068175,-0.086357258028564,1.35797507564251e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,39929,-0.0444623162101719,0.0039268200700405,-0.0521588835474513,-0.0367657488728925,1.45968538232378e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,42262,-0.072875170502892,0.00644086115503638,-0.0854992583667633,-0.0602510826390206,1.5054151929793e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,42016,0.0392664720050075,0.00347341539011916,0.0324585778403739,0.046074366169641,1.68792872484967e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0710875273679665,0.0062933595139309,-0.0834225120152711,-0.058752542720662,1.98137123563498e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.042134367939977,0.00373590210460387,-0.0494567360650006,-0.0348119998149535,2.27223190642551e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0411566061059305,0.00364763008102509,-0.0483059610647396,-0.0340072511471213,2.30711839272697e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,41839,-0.0756773691106905,0.00672836067131599,-0.0888649560264698,-0.0624897821949111,3.23155304068321e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EZR,Ezrin,42249,-0.0274726319729064,0.00244789428497357,-0.0322705047714546,-0.0226747591743582,4.21790006905295e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,41843,-0.0540984565187655,0.00482487645592812,-0.0635552143723846,-0.0446416986651464,4.79017263783566e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0446995993165535,0.00399718878415808,-0.0525340893335034,-0.0368651092996037,6.63152370645283e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.0689291568428931,0.0061610717896118,-0.0810048575505322,-0.0568534561352539,6.70155028715492e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.0733946478241163,0.00656441951255794,-0.0862609100687298,-0.0605283855795027,6.82931836796877e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.0317303505669929,0.0028408990047993,-0.0372985126163996,-0.0261621885175863,7.73041104823552e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,42262,0.0521082828476246,0.00467156712223035,0.0429520112880531,0.0612645544071961,9.07760362049724e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0764426416426483,0.00685080311347577,-0.0898702157450608,-0.0630150675402358,9.32293243299221e-29
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0329715333088544,0.00295877951149519,-0.038770741151385,-0.0271723254663239,1.03217124452675e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,42249,-0.0513403694889463,0.00461449381811048,-0.0603847773724428,-0.0422959616054498,1.24620805941132e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0399760154261704,0.00359597063412576,0.0329279129832839,0.0470241178690569,1.3810137510741e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0351353778370822,0.00316131793399085,-0.0413315609877043,-0.0289391946864601,1.42475179700773e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0581441631468969,0.00523174041049033,-0.068398374351458,-0.0478899519423359,1.52328870558173e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0502301805787374,0.00452544257298597,-0.0591000480217899,-0.0413603131356849,1.76900754859844e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0712205057542454,0.00642593513356285,-0.0838153386160285,-0.0586256728924622,2.01620040456409e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORT1,Sortilin,42129,-0.0425955609743235,0.00384691830995413,-0.0501355208618336,-0.0350556010868134,2.25460789635992e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.0967448588195741,0.00874627554306514,-0.113887558883982,-0.0796021587551664,2.55745624481352e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0587352584759277,0.00531309540185009,-0.0691489254635539,-0.0483215914883015,2.75230552274285e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.0723390584632559,0.00654908546211139,-0.0851752659689942,-0.0595028509575176,3.03383765049271e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,39979,-0.0780066927106215,0.00706946429988145,-0.0918628427383892,-0.0641505426828539,3.62617194516917e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.0586356078473602,0.00531709053203861,-0.0690571052901559,-0.0482141104045645,3.72282210672275e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.0876558142065736,0.00794558556504495,-0.103229161914062,-0.0720824664990855,3.72664517324037e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.117940685028529,0.0107195519798872,-0.138951006909108,-0.0969303631479503,4.89352372070042e-28
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,41994,0.0301796486009667,0.00276209304077754,0.0247659462410427,0.0355933509608907,1.12831695615582e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0540446087384548,0.00495236633766964,-0.0637512467602873,-0.0443379707166223,1.29952594717263e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.110451879344184,0.0101287602039017,-0.130304249343831,-0.0905995093445363,1.49842681581523e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_E,,42119,-0.0322241506345165,0.00295790971131699,-0.0380216536686978,-0.0264266476003352,1.59793115266166e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0823459308275669,0.0075590111121868,-0.097161592607453,-0.0675302690476808,1.60642361812775e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.0175213847295105,0.00160858389288649,0.014368560299453,0.0206742091595681,1.62366934372606e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,41830,-0.0541763598835855,0.00498360847756168,-0.0639442324996064,-0.0444084872675646,2.0710434335339e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.074066645546523,0.00681787318094043,-0.0874296769811662,-0.0607036141118797,2.3419892726555e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0514928621723448,0.00475402280029838,-0.0608107468609296,-0.04217497748376,3.15177212162327e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0432736243680202,0.00399382392504506,-0.0511015192611085,-0.0354457294749319,3.21345164158513e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.0238403688503012,0.00220074445055781,-0.0281538279733945,-0.0195269097272079,3.26381417276849e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.088366699842876,0.00816419791026651,-0.104368527746998,-0.0723648719387536,3.6372502493328e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0407164010985249,0.00376655063326006,-0.0480988403397147,-0.0333339618573352,3.97426138760114e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,42166,-0.0634738558797887,0.00589064115516034,-0.075019512543903,-0.0519281992156745,5.78489002087315e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFI,Complement factor I,39979,-0.021164701656031,0.00196694678387956,-0.025019917352435,-0.0173094859596271,7.14588019568516e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0388115343547255,0.00361099616478869,-0.0458890868377114,-0.0317339818717397,7.73370063527576e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.0973296791095211,0.00905673014751379,-0.115080870198648,-0.0795784880203941,7.90373096031403e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.030190790262274,0.00281116020116612,-0.0357006642565596,-0.0246809162679884,8.49529652202352e-27
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.040791727584749,0.00381526144151914,-0.0482696400101265,-0.0333138151593715,1.4210270017849e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0663433072524434,0.00621661844004522,-0.078527879394932,-0.0541587351099548,1.76229732805295e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.0349583690340471,0.00327506738525014,-0.0413775011091373,-0.0285392369589568,1.79720631232788e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0559731866720261,0.00524735837938505,-0.0662580090956208,-0.0456883642484314,1.84774803834849e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.0981912110625833,0.00921254928727986,-0.116247807665652,-0.0801346144595148,2.02789128864666e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0453467148457364,0.00425893985796264,-0.0536942369673432,-0.0369991927241296,2.27498350582621e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.101881007687796,0.00958631447706261,-0.120670184062839,-0.0830918313127533,2.81053969970482e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.0824812937210032,0.00777100882454569,-0.0977124710171128,-0.0672501164248937,3.25672293563822e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.029513626391591,0.00278463001700745,-0.0349715012249256,-0.0240557515582564,3.81965206436217e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.0894848702903616,0.00844807245309091,-0.10604309229842,-0.0729266482823034,4.0967457622116e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.0853680449263195,0.00807256277882741,-0.101190267972821,-0.0695458218798178,5.14109383811094e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.0321724644614513,0.00304957825952242,-0.0381496378501153,-0.0261952910727874,6.71081661306882e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.0445720733136192,0.00422517266995642,-0.0528534117467337,-0.0362907348805046,6.75609635973343e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0536825427697928,0.00509607664907973,-0.0636708530019891,-0.0436942325375966,7.57465536302577e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.064138091159978,0.00609113070096083,0.0521994749860948,0.0760767073338612,7.90847497761661e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0581994478667544,0.00552760317875015,-0.0690335500971047,-0.0473653456364041,7.98044223215905e-26
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.109221892579667,0.01039664814834,-0.129599322950414,-0.0888444622089208,1.0695783263727e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,39966,0.061103309634796,0.00581923321643366,0.049697612530586,0.072509006739006,1.12927892654124e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.105816666224454,0.0100854942557118,-0.125584234965649,-0.0860490974832591,1.18007682927501e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,41881,-0.0548255053921765,0.00522529741899034,-0.0650670883333976,-0.0445839224509554,1.18043745731721e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.07187475375722,0.00685758094858362,-0.0853156124164438,-0.0584338950979961,1.32027899654539e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.0886218378024222,0.00846826269467065,-0.105219632683977,-0.0720240429208678,1.63184053048352e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0243252834578863,0.00232536549337791,-0.028882999824907,-0.0197675670908656,1.63657249270117e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0630503753770841,0.0060349003520503,-0.0748787800671027,-0.0512219706870656,1.87953721214731e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.0887649012674884,0.00854535653687598,-0.105513800079765,-0.0720160024552114,3.51291037229385e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0450600965709383,0.00433796136264971,0.0365576923001449,0.0535625008417318,3.51412727517365e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.0735677845220533,0.0070815722127515,-0.0874476660590462,-0.0596879029850604,3.62352325946008e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0496403499043752,0.00480150150819517,-0.0590512928604377,-0.0402294069483126,5.84382928366432e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.0608725663238641,0.00588839290355571,-0.0724138164148333,-0.0493313162328949,5.8907045890432e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.079678146653006,0.00770811198231934,-0.0947860461383519,-0.0645702471676601,5.94045033291215e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0589936908909864,0.00571372609556018,-0.0701925940382843,-0.0477947877436884,6.7136404772593e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.0390161873828838,0.00377987612934474,-0.0464247445963995,-0.0316076301693681,6.91501865689391e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,39929,-0.0405783412834363,0.00393106795226363,-0.048283234469873,-0.0328734480969995,7.18691297372208e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.0684681655386297,0.00664526509699121,-0.0814928851287324,-0.0554434459485269,8.40098972211543e-25
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,42119,-0.0341527132814679,0.00332162537713742,-0.0406630990206572,-0.0276423275422785,1.04820514448599e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.0327400417469578,0.00318862368407127,-0.0389897441677375,-0.0264903393261781,1.27041462438391e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,42129,-0.0324132202010415,0.00316805566350016,-0.0386226093015018,-0.0262038311005812,1.7635843478636e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,39958,-0.0336485874185886,0.00329121132409035,-0.0400993616138057,-0.0271978132233715,1.97986314443624e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.0775340537511398,0.00758788568680934,-0.0924063096972861,-0.0626617978049935,2.11497718218748e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.0586567879819567,0.00575112618365626,-0.0699289953019229,-0.0473845806619904,2.44237626963637e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0405023893255924,0.00398185209192005,-0.0483068194257557,-0.032697959225429,3.23737779305685e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.0848833436142266,0.00838235787023933,-0.101312765039896,-0.0684539221885575,5.13278433404836e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.0437453222362246,0.00431998122312122,-0.0522124854335422,-0.0352781590389071,5.14531468955455e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0401126743820752,0.00396464803149739,-0.0478833845238101,-0.0323419642403403,5.627720104064e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.0869670929048353,0.00860940454540129,-0.103841525813822,-0.0700926599958488,6.91543396098115e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,42115,-0.0941376041189331,0.00932649038227271,-0.112417525268188,-0.0758576829696786,7.16670513724195e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0289715444471963,0.00287247212698956,-0.0346015898160958,-0.0233414990782968,7.75100678119814e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,42145,-0.0381319639322819,0.00378469549676093,-0.0455499671059333,-0.0307139607586305,8.61595621986177e-24
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.105577384234835,0.0104942706917142,-0.126146154790595,-0.0850086136790756,1.00100224483647e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,42262,-0.039672420395425,0.00394784903806812,-0.0474102045100385,-0.0319346362808115,1.12012251177448e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0595578256194283,0.00592802813725374,-0.0711767607684457,-0.047938890470411,1.19157212140558e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.0649513928977344,0.00649023748881913,-0.0776722583758199,-0.0522305274196489,1.71116521037714e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0261446443640001,0.00262673372125687,-0.0312930424576635,-0.0209962462703366,2.93627200186928e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,42153,0.0509256112754739,0.00512023681267415,0.0408899471226326,0.0609612754283153,3.1548491757176e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0611564124404283,0.00614929534113766,-0.0732090313090582,-0.0491037935717985,3.1897954595532e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,42119,-0.0924445779792123,0.00931395228044478,-0.110699924448884,-0.0741892315095406,3.87376736417245e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.0758792091994937,0.00764699192684502,-0.09086731337611,-0.0608911050228775,3.96734163997359e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.0855775787183015,0.008632925518155,-0.102498112733885,-0.0686570447027177,4.39697907146599e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0517708359582451,0.0052261665165026,-0.0620141223305902,-0.0415275495859,4.85928984783802e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0290990097793612,0.00293769656841111,-0.034856895053447,-0.0233411245052754,4.91140974317596e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0777119270351181,0.00784869078308135,-0.0930953609699576,-0.0623284931002787,5.13271179870328e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0662699361370413,0.0067043306746078,-0.0794104242592725,-0.05312944801481,5.82744089584262e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,42249,0.0373233925954033,0.00377856944835305,0.0299173964766314,0.0447293887141753,6.21193344506831e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0393850744267518,0.00398794663295258,-0.0472014498273389,-0.0315686990261648,6.32157175737921e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,42119,-0.0960725174417367,0.00973606041602726,-0.11515519585715,-0.0769898390263233,6.86681065015349e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.0205603613239495,0.00208453284358134,-0.024646045697369,-0.0164746769505301,7.20997292745708e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.0594798401635039,0.00603674273131638,-0.071311855916884,-0.0476478244101238,7.94355789863536e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.0942016306427262,0.0095618954055332,-0.112942945637571,-0.0754603156478811,8.01966745443049e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.030094656670148,0.00305449948153844,-0.0360814756539633,-0.0241078376863326,8.2657844333262e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0254420773054064,0.00258255949125537,-0.0305038939082669,-0.0203802607025459,8.33428083711927e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0490267043178429,0.00498049872616121,-0.0587884818211189,-0.039264926814567,8.73410979677096e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0289070791107088,0.00293902789411429,-0.0346675737831728,-0.0231465844382448,9.42810829457476e-23
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0328477737644174,0.00334382379005307,-0.0394016683929214,-0.0262938791359134,1.06205014079454e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0456016287493968,0.00464675243212223,-0.0547092635163564,-0.0364939939824373,1.17251097485533e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0573640911192378,0.00584987774692772,-0.0688298515032161,-0.0458983307352594,1.3050398392415e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.0841739665731855,0.00858719005043292,-0.101004859072034,-0.0673430740743369,1.30931226949486e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.0840769193859976,0.00857987842034138,-0.100893481089867,-0.0672603576821285,1.352865992914e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,41797,-0.0694432777204662,0.00709824221564316,-0.0833558324631268,-0.0555307229778056,1.58623100961072e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0363478987058817,0.0037166039415937,-0.0436324424314053,-0.029063354980358,1.63256348539464e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0297597507162784,0.00304344505435833,-0.0357249030228207,-0.0237945984097361,1.65630300295923e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.0741930625918431,0.00758908286603479,-0.0890676650092713,-0.0593184601744149,1.69589186878111e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0604091914308502,0.00618478093156123,-0.0725313620567102,-0.0482870208049902,1.8504709660655e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,42025,-0.0713165498125064,0.00730228022608393,-0.0856290190556309,-0.0570040805693819,1.86518434239204e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0320530613356518,0.00329089332927185,-0.0385032122610246,-0.025602910410279,2.50441631534952e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.0850733976287542,0.00877528985267201,-0.102272965739991,-0.067873829517517,3.74981830023332e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.112320879919764,0.0116097095278557,-0.135075910594362,-0.0895658492451673,4.71272447158693e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0242942337356379,0.00251149693025438,-0.0292167677189364,-0.0193716997523393,4.76369151171363e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.0376387346227113,0.00389828637010088,0.0299980933373136,0.045279375908109,5.49538922215658e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,39806,-0.0263877130409513,0.00273237776498602,-0.0317431734603238,-0.0210322526215787,5.56869628989026e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.033551373413652,0.00347470143918213,-0.040361788234449,-0.0267409585928551,5.63622667375128e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,39934,-0.050646950116206,0.00526179044531176,-0.060960059389017,-0.0403338408433949,7.56967532554699e-22
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,42249,-0.0219977063073242,0.00229353648316146,-0.0264930378143207,-0.0175023748003278,1.01959426628075e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.0260371838664099,0.00271788241382361,0.0207101343353156,0.0313642333975042,1.13732392543873e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,42143,-0.0348386564518416,0.00363949972061628,-0.0419720759042495,-0.0277052369994336,1.2231755754246e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0265430213366817,0.00277416975256432,-0.0319803940517077,-0.0211056486216556,1.27616436321534e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,41997,-0.066921356496377,0.00699498540455533,-0.0806315278893055,-0.0532111851034486,1.28961145109663e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0376373757932571,0.00394010227644552,-0.0453599762550903,-0.0299147753314239,1.48122348026508e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0496546425859855,0.00520022839401482,-0.0598470902382546,-0.0394621949337165,1.5936021517872e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,42084,-0.0774450278569611,0.00811539203562495,-0.093351196246786,-0.0615388594671362,1.62284633915473e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0448710972396358,0.0047119052129422,-0.0541064314570025,-0.035635763022269,2.02398082718054e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0300843786434967,0.00316812275536921,-0.0362938992440204,-0.0238748580429731,2.53978562375943e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.106227294233979,0.0111894195906894,-0.12815855663173,-0.0842960318362278,2.68040555440028e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,41913,-0.0424505949761893,0.00447999542047453,-0.0512313860003194,-0.0336698039520593,3.09440071876449e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0660683212718446,0.00697112296504059,-0.0797317222833242,-0.0524049202603651,3.13833527040188e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0480501470610451,0.00507437850112781,-0.0579959289232556,-0.0381043651988346,3.2747094936703e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0406531199191999,0.00429824141875947,-0.0490776730999685,-0.0322285667384314,3.63918745498213e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.0506368099315559,0.00535970899514802,-0.061141839562046,-0.0401317803010658,4.02936126771775e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.0228630666736045,0.00242152747957546,-0.0276092605335724,-0.0181168728136366,4.2632554017214e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,42123,-0.0260740910459151,0.00276239369995397,-0.0314883826978248,-0.0206597993940053,4.37201277954371e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0301516503911559,0.00319665557476672,-0.0364170953176987,-0.0238862054646132,4.66064602365754e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.0775626505314971,0.00822706867395753,-0.0936877051324539,-0.0614375959305404,4.85476271654385e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.0439466660913222,0.00466869045006367,-0.053097299373447,-0.0347960328091974,5.58545084308015e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,39978,-0.0532050343262958,0.00566683812222047,-0.0643120370458479,-0.0420980316067437,7.21726802564159e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0733122318488375,0.00782312331281546,-0.0886455535419558,-0.0579789101557192,8.5213929789662e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,39966,-0.0267027362633949,0.00285050734330579,-0.0322897306562742,-0.0211157418705155,8.80615243342144e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,41880,-0.0343235127170707,0.00366774048505348,-0.0415122840677755,-0.0271347413663658,9.39365997926814e-21
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.0918204304618391,0.00984267987492148,-0.111112083016685,-0.0725287779069931,1.27491495720443e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREH,Trehalase,39966,-0.0712066511725709,0.00763675923629438,-0.0861746992757079,-0.0562386030694339,1.32443093383853e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.043510321941268,0.00467200377086723,-0.0526674493321678,-0.0343531945503683,1.4758224522234e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0379279403918696,0.00408235243619129,-0.0459293511668045,-0.0299265296169347,1.76302806074918e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.0790757078064822,0.00852454969991648,-0.0957838252183185,-0.0623675903946459,2.08424376535739e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0783505616917206,0.00846464908279105,-0.0949412738939911,-0.0617598494894502,2.441351783632e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0367294888730932,0.00396685587574488,-0.0445045263895532,-0.0289544513566332,2.44247804692671e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.0587858950555986,0.00635395322858221,-0.0712396433836197,-0.0463321467275774,2.59985155511016e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0581299059345688,0.00628479856720133,-0.0704481111262834,-0.0458117007428542,2.66382913221919e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0272521647378973,0.00295080739834367,-0.0330357472386509,-0.0214685822371437,3.02797867560209e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0273630845098376,0.00296351264984689,-0.0331715693035375,-0.0215545997161376,3.09194379300962e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.032193516539292,0.003487979178973,-0.039029955730079,-0.0253570773485049,3.10738258340619e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,42070,-0.066188816439923,0.00717804138621056,-0.0802577775568957,-0.0521198553229503,3.37432073516146e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,39757,-0.120825018504296,0.0131160615382086,-0.146532499119185,-0.0951175378894068,3.77308972797025e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0551395619563556,0.00598853270846783,-0.0668770860649525,-0.0434020378477587,3.82147924900698e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0487079591351478,0.0052957835597907,-0.0590876949123376,-0.0383282233579581,4.19721670374688e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0546436389594547,0.00594136290919652,-0.0662887102614799,-0.0429985676574295,4.20618955454221e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0322985269354192,0.00351240109482906,-0.0391828330812842,-0.0254142207895543,4.26727779228698e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.0804919918301324,0.00876326795142716,-0.0976679970149297,-0.0633159866453352,4.82213688904324e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNST,Consortin,42145,-0.101049961863434,0.0110055866244323,-0.122620911647321,-0.0794790120795465,4.85062968806541e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0240180656277047,0.00262355476135538,0.0188758982954482,0.0291602329599613,6.22000066970784e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,39358,-0.02246029421946,0.00245982987686565,-0.0272815607781167,-0.0176390276608034,8.01317741804761e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0491180974159025,0.00538450549413542,-0.0596717281844079,-0.038564466647397,8.41770447155768e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.071471346791382,0.00783599194868116,-0.086829891010797,-0.0561128025719669,8.49247507391876e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,42181,-0.0515744104315581,0.00565526556093157,-0.062658730930984,-0.0404900899321322,8.57660183127471e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0592514250841629,0.00649722010127331,-0.0719859764826586,-0.0465168736856672,8.81678362243776e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0220804791566033,0.00242336527636626,-0.0268302750982811,-0.0173306832149254,9.2533442229292e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBIN,Erbin,42070,-0.0943242616454036,0.0103526036185295,-0.114615364737721,-0.0740331585530857,9.28583379152199e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.0580864847034947,0.00638030683183555,-0.0705918860938924,-0.045581083313097,9.9354385476062e-20
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,42016,-0.0612827923013915,0.00673231076277526,-0.074478121396431,-0.048087463206352,1.00313754261232e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.0314696278967662,0.00345878522144646,-0.0382488469308012,-0.0246904088627311,1.04199126611757e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.03513250880298,0.00386340659526277,-0.042704785729695,-0.027560231876265,1.08874108276276e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0322829394919817,0.0035536234461893,-0.0392480414465128,-0.0253178375374507,1.18629055203106e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,41843,-0.0360969271043542,0.00397351791078072,-0.0438850222094844,-0.028308831999224,1.18909106231461e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,42145,0.0349876283677586,0.00385840623145786,0.0274251521541012,0.042550104581416,1.37808951891964e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.052680830706981,0.00581792527273159,-0.0640839642415349,-0.0412776971724271,1.55012413886624e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.0720184609318679,0.00798375355464414,-0.0876666178989704,-0.0563703039647653,2.12462832209895e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.112876525600145,0.0125154549390895,-0.137406817280761,-0.08834623391953,2.21170339114611e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.0176138118965646,0.00195555039307672,-0.021446690666995,-0.0137809331261342,2.39663034900832e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.127929512458302,0.014260963686417,-0.155881001283679,-0.0999780236329243,3.41146362471046e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0362450344465611,0.00404305444051031,-0.0441694211499613,-0.0283206477431609,3.59572637600029e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.0884455448225238,0.00986961983935783,-0.107789999707665,-0.0691010899373824,3.61537801146117e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,42083,-0.0318180546040704,0.00355093184593161,-0.0387778810220963,-0.0248582281860444,3.65216265422298e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.123958336842984,0.013851649564974,-0.151107569990334,-0.0968091036956353,4.05083904091925e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.103320701220353,0.0116093136961112,-0.126074956064731,-0.0805664463759748,6.44377327786285e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.035681697756764,0.00401066481477862,-0.0435426007937301,-0.0278207947197979,6.49210411448579e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.0598087589998104,0.0067209693728984,-0.0729818589706912,-0.0466356590289295,6.51576294627055e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,41913,-0.0423279530773955,0.00476560056140664,-0.0516685301777525,-0.0329873759770385,7.40086097624549e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.0593075728111626,0.00667707204042772,-0.0723946340104009,-0.0462205116119243,7.53651902142423e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.0695960079476748,0.00784128164011125,-0.0849649199622929,-0.0542270959330568,7.81687383822758e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0405099287717622,0.00456788365564282,-0.0494629807368221,-0.0315568768067023,8.33824668904281e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0330430773581402,0.00372671741392371,-0.0403474434894307,-0.0257387112268498,8.47856838878905e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPN,Asporin,39958,0.0250519529537399,0.00282501519578358,0.019514923170004,0.0305889827374757,8.56470267193258e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0369633761698322,0.0041692360417028,-0.0451350788115697,-0.0287916735280947,8.75507625437239e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.021190334639604,0.00239096020809414,-0.0258766166474685,-0.0165040526317394,8.76645300815558e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0598812464893627,0.00675474398558762,-0.0731205447011145,-0.046641948277611,8.78051024471297e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0213822369619618,0.00241364918951108,-0.0261129893734035,-0.0166514845505201,9.08715292103875e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.0594210009114887,0.00670987713980014,-0.072572360105497,-0.0462696417174805,9.35909191605494e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.036109037448319,0.00407776234498075,-0.0441014516444813,-0.0281166232521567,9.37451769622819e-19
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0557760840070023,0.00630270186419886,-0.0681293796608321,-0.0434227883531725,1.00889427727534e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.038611767062752,0.00436751749786631,-0.0471721013585699,-0.030051432766934,1.06792744593974e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0414707518088805,0.00469220338880164,-0.0506674704509317,-0.0322740331668293,1.09106580752306e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0654073339252411,0.00741353486553835,-0.0799378622616963,-0.0508768055887859,1.28123245954776e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0546340381729467,0.00619697306334132,-0.0667801053770957,-0.0424879709687977,1.32672798484075e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,42119,-0.07709424233781,0.00874713323068867,-0.0942386234699598,-0.0599498612056602,1.3575485431403e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,42070,-0.0478999364505519,0.00543580661921175,-0.0585541174242069,-0.0372457554768969,1.37911859335126e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0378564588317866,0.0043039836665532,-0.0462922668182309,-0.0294206508453423,1.59187009332442e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,42185,-0.042082033620605,0.00479084461558745,-0.0514720890671564,-0.0326919781740536,1.76694698484398e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0749662623404233,0.00853415838473767,-0.0916932127745091,-0.0582393119063375,1.80019883336806e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.0476186303059008,0.00542285931634506,-0.0582474345659371,-0.0369898260458645,1.81219429632124e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.0405468039559433,0.00462411635928882,-0.0496100720201494,-0.0314835358917372,2.06840940161752e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.036700755626267,0.00419056710220858,-0.0449142671465958,-0.0284872441059382,2.27035851685886e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.0386367234604001,0.00441314464218212,-0.047286486959077,-0.0299869599617231,2.33701739195644e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,42016,0.022982170763104,0.00263304984534838,0.0178213930662212,0.0281429484599869,2.88634367936068e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,39638,-0.0655705352327333,0.00752498036174642,-0.0803194967417563,-0.0508215737237103,3.36037086658958e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.076779165224712,0.00882036845599126,-0.0940670873984549,-0.0594912430509691,3.62239327250193e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.017602828371832,0.00202443489657292,-0.0215707207691149,-0.0136349359745491,3.8591035212795e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0172128759398115,0.00198122771027563,-0.0210960822519517,-0.0133296696276713,4.1039882655432e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.073246427640475,0.00843016557711152,-0.0897695521716135,-0.0567233031093364,4.1813689709489e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0292157670453937,0.00336357000784756,-0.0358083642607749,-0.0226231698300125,4.18223867729499e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0514657367699585,0.00592777562612671,-0.0630841769971669,-0.0398472965427502,4.33454704807916e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZN,Kazrin,39930,-0.0925864454258044,0.0106647941276041,-0.113489441915908,-0.0716834489357003,4.43941887333999e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,42119,-0.0345658844079919,0.0039870088650429,-0.042380421783476,-0.0267513470325078,4.82417965656419e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.0939788140606756,0.0108555398328624,-0.115255672133086,-0.0727019559882652,5.48661195537241e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0303111573064454,0.0035037503100962,0.0234438066986569,0.037178507914234,5.6723289566926e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0635459347345956,0.0073436127459108,-0.0779394157165808,-0.0491524537526105,5.68191160861218e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.033718351449241,0.0038997998972893,-0.041361959247928,-0.0260747436505539,5.91838990582305e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.0860576666015567,0.00995508820867087,-0.105569639490552,-0.0665456937125618,6.0146111254928e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0548280802623284,0.00634408613891958,-0.0672624890946107,-0.042393671430046,6.11622487472863e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0271031486834449,0.00313526690380827,-0.0332482718149091,-0.0209580255519807,6.12387248059579e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.0300877943572732,0.00348073639922796,-0.03691003769976,-0.0232655510147864,6.16489989387934e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0657452866718762,0.00760970509297067,-0.0806603086540987,-0.0508302646896537,6.39088464045225e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,39906,-0.0285223873520387,0.00330853159956738,-0.0350071092871907,-0.0220376654168866,7.52905157964701e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,42119,-0.070004376211922,0.00812260408810485,-0.0859246802246075,-0.0540840721992365,7.5323518532224e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.07372375403187,0.00857694966114314,-0.0905345753677106,-0.0569129326960294,9.19038554940285e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.0950791301117717,0.0110599137251164,-0.116756561013,-0.0734016992105436,9.27738646494523e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0191496843967224,0.00222995217857057,0.0147789781267241,0.0235203906667207,9.86939087979989e-18
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.0440824591961507,0.00513977580820387,0.0340084986120711,0.0541564197802303,1.08113837862971e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0413732096357868,0.00482393241778493,-0.0508281171746452,-0.0319183020969283,1.08332833426963e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,41839,-0.0293110459152793,0.0034258865253526,-0.0360257835049704,-0.0225963083255882,1.29875967725734e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0661987941161029,0.00774527700770448,-0.0813795370512037,-0.0510180511810021,1.39763746919301e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0419065379744053,0.00490517734540503,-0.0515206855713992,-0.0322923903774115,1.44485839603129e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0274402639978216,0.00321411056592739,-0.0337399207070393,-0.021140607288604,1.5520504014135e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.048752817314545,0.00571235451047071,-0.0599490321550676,-0.0375566024740224,1.55787654760712e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.0817794732637937,0.00958565321424274,-0.100567353563709,-0.0629915929638779,1.59704213959754e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,39966,-0.0224712162564617,0.00263398628766378,-0.0276338293802827,-0.0173086031326407,1.63090254699095e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0508259434637257,0.005962421716519,-0.0625122900281029,-0.0391395968993484,1.70158606324295e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0381781039742038,0.00448100614022868,0.0293953319393556,0.046960876009052,1.76313976743569e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.0776449789481952,0.00911469177799281,-0.0955097748330612,-0.0597801830633293,1.81783394022626e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.107749246240096,0.0126552318172394,-0.132553500601885,-0.0829449918783064,1.85193369386651e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,39736,-0.0267487094230703,0.00315186082458979,-0.0329263566392663,-0.0205710622068743,2.39612804827986e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0270643708023663,0.00318978294757726,-0.0333163453796177,-0.0208123962251148,2.43862808229587e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0628570244471736,0.00741171889616857,-0.077383993483664,-0.0483300554106832,2.52218322651557e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0340084430548143,0.00401301026050233,-0.0418739431653989,-0.0261429429442297,2.59858712978758e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0689609287730129,0.00814937175374948,-0.0849336974103618,-0.0529881601356639,2.89347552374763e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,41693,-0.0770364135103821,0.00910658678301402,-0.0948853236050896,-0.0591875034156746,2.97019668082544e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,42249,-0.0519341564442467,0.00614134132481981,-0.0639711854408935,-0.0398971274475999,3.03306287560944e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0682578512068802,0.00808803709537508,0.052405298499945,0.0841104039138153,3.51198899906785e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0433824399012188,0.00514678381807645,-0.0534701361846486,-0.033294743617789,3.83141566560502e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0538984216877117,0.00639653369554044,-0.066435627730971,-0.0413612156444525,4.0016967633817e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.0807362860797331,0.00960204876531554,-0.0995563016597516,-0.0619162704997147,4.58280405629201e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0524798877288482,0.00624940754846935,-0.0647287265238481,-0.0402310489338482,5.0081788030379e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,39934,0.0417780486523776,0.00497474933583897,0.0320275399541332,0.051528557350622,5.08053777337793e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,39657,-0.038764422514267,0.00461903654894287,-0.047817734150195,-0.0297111108783389,5.3465515784968e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.0808468332380298,0.00963685500360378,-0.0997350690450932,-0.0619585974309664,5.36521551832788e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,39990,-0.024695581284248,0.00294862905286484,-0.0304748942278631,-0.0189162683406329,6.15383263175242e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.0323351871761055,0.00386713782760168,-0.0399147773182048,-0.0247555970340062,6.80528676437829e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0541731324910279,0.00648036134490821,-0.066874640727048,-0.0414716242550078,7.02844177180732e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0317431673944448,0.0038009212825574,-0.0391929731082573,-0.0242933616806323,7.40543845797446e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.058443547317286,0.0070051448315866,-0.0721736311871957,-0.0447134634473763,7.94319579505226e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0652912022076999,0.00783992297494851,-0.0806574512385989,-0.0499249531768008,9.1632415164476e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0483610461764176,0.00580878385451076,-0.0597462625312587,-0.0369758298215766,9.3762596053632e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00773250290938896,0.000929232003753033,0.00591120818203302,0.00955379763674491,9.50989832752258e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDK,Midkine,42129,-0.0430151687264528,0.00516941372918864,-0.0531472196356626,-0.0328831178172431,9.54431367575124e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0352877078685081,0.00424276897752803,-0.043603535064463,-0.0269718806725532,9.8815037821108e-17
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,39736,-0.0996454742955055,0.0119890599518729,-0.123144031801176,-0.0761469167898347,1.05581126467176e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAYN,Layilin,41997,-0.0299028504058743,0.00360774147630328,-0.0369740236994288,-0.0228316771123199,1.25500425950699e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0615834360531807,0.00742871212044519,-0.0761437118092533,-0.0470231602971082,1.26091321735106e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.0233869565324099,0.00282308372607134,-0.0289202006355097,-0.0178537124293101,1.29879019984714e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0281505231939653,0.00340090753871339,0.021484744418087,0.0348163019698435,1.37538590473814e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.0623901050503433,0.00754560129322094,-0.0771794835850563,-0.0476007265156303,1.51318146024486e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,39657,-0.0800853754706231,0.00969423677977721,-0.0990860795589864,-0.0610846713822597,1.60742623260522e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.034052439146598,0.00413004054316394,-0.0421473186111993,-0.0259575596819967,1.83205511522071e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,42181,-0.035541239220779,0.00431435601827468,-0.0439973770165973,-0.0270851014249606,1.91182351301965e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.0475613459955548,0.00577943817110383,-0.0588890448109183,-0.0362336471801913,2.05078329076262e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.0738513025385944,0.00897583808867286,-0.0914439451923932,-0.0562586598847956,2.11535416052401e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0698484905455919,0.00849007110997381,-0.0864890299211406,-0.0532079511700432,2.12782264621502e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0197843370066109,0.00240812165965569,-0.024504255459536,-0.0150644185536857,2.30038114413859e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0248155861256202,0.00302791614294941,0.0188808704854393,0.030750301765801,2.71517783190891e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0335756011534045,0.00409852747889705,-0.0416087150120427,-0.0255424872947663,2.79333589888819e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0184759037762965,0.00225575330789625,-0.0228971802597732,-0.0140546272928199,2.87896406510269e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COCH,Cochlin,39958,-0.0382001441677875,0.00466459944229294,-0.0473427590746816,-0.0290575292608933,2.90654203784405e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,42168,-0.0266752479341431,0.00325873358768577,-0.0330623657660072,-0.020288130102279,2.94540930478221e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,39813,-0.0917163473975396,0.011206670129239,-0.113681420850848,-0.0697512739442312,3.0402035038018e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSG,Basigin,42284,-0.0172611940925483,0.00210993377983336,-0.0213966643010217,-0.0131257238840749,3.06372493058638e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0521035841242509,0.00637076878757145,-0.0645902909478909,-0.0396168773006109,3.18770131252127e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.037219824549252,0.00455284163043221,-0.0461433941448991,-0.0282962549536049,3.27644850985473e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0354461215742719,0.00433750979610626,-0.0439476407746401,-0.0269446023739036,3.30331460302248e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0378555640467744,0.00463570134115746,-0.046941538675443,-0.0287695894181057,3.52352650238481e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,39736,-0.0578969858698207,0.00709027912852716,-0.0717939329617339,-0.0440000387779074,3.5407230885029e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0511402136712193,0.00628997370457444,-0.0634685621321852,-0.0388118652102534,4.73474721561936e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0404462495088653,0.00497801347434314,-0.0502031559185778,-0.0306893430991527,4.93894004705596e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0122548393376914,0.00150914384805803,0.00929691739549765,0.0152127612798851,5.12666298655827e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0750324976951974,0.00924973526166722,0.0569030165823296,0.0931619788080651,5.42531235409248e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0408641497340336,0.00504055619073866,-0.0507436398678814,-0.0309846596001858,5.62922046438162e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0542634765350795,0.00670418872234109,-0.0674036864308681,-0.041123266639291,6.25866051583966e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0225362827598036,0.00278431205071037,0.0170790311404112,0.0279935343791959,6.35927410312217e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0450395436615812,0.00557089563084917,-0.0559584990980456,-0.0341205882251168,6.76487927182976e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.0199180268444453,0.00246605290179305,-0.0247514905319597,-0.015084563156931,7.20094616172396e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,39930,-0.0717856247943095,0.0089000966639871,-0.0892298142557242,-0.0543414353328948,8.01357727617969e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0332672202896355,0.00412734931138718,-0.0413568249399544,-0.0251776156393167,8.40693408206208e-16
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0269691447373235,0.00335758632017545,-0.0335500139248674,-0.0203882755497796,1.03443526599078e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0628256894929912,0.0078337086630497,-0.0781797584725686,-0.0474716205134138,1.16406508084671e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.0740550093328323,0.00923799044287837,-0.092161470600874,-0.0559485480647907,1.19891724604358e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0282148879639064,0.00352174322562571,-0.0351175046861328,-0.02131227124168,1.24566576884817e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0409008841802547,0.00510571363485297,-0.0509080829045665,-0.0308936854559428,1.25106670172026e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0230939412290857,0.00288400978873053,-0.0287466004149975,-0.0174412820431738,1.26385053784001e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.02192889012277,0.00274983570287721,-0.0273185681004093,-0.0165392121451306,1.65006650504316e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0416185484710032,0.0052189735968882,-0.0518477367209041,-0.0313893602211023,1.65533551763166e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0314362716960222,0.00394777780913731,-0.0391739162019313,-0.0236986271901131,1.81513892969602e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0400413793394628,0.00503974789820887,-0.0499192852199522,-0.0301634734589734,2.0926068121774e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0472259902755448,0.00594974560785068,-0.0588874916669321,-0.0355644888841575,2.22347827167988e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0559509252648185,0.00706004004901484,-0.0697886037608876,-0.0421132467687494,2.46174964276696e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0497128166321169,0.00628602376458779,-0.062033423210709,-0.0373922100535248,2.8065961130426e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.0652255598321425,0.00825099982758236,-0.0813975194942039,-0.049053600170081,2.92342128553753e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.0336257497882455,0.00426296771981397,-0.0419811665190808,-0.0252703330574101,3.30940028086385e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0222329705744073,0.00282310038597604,-0.0277662473309203,-0.0166996938178943,3.66079147650171e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASN,Vasorin,41975,0.0218164776500037,0.00277233882891823,0.016382693545324,0.0272502617546834,3.83804229636084e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0538044220367371,0.00683623751529522,-0.0672034475667158,-0.0404053965067585,3.86025747594277e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0632989468565918,0.00804356026944268,-0.0790643249846994,-0.0475335687284841,3.89304555376365e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.0231334384767907,0.00294299029304737,-0.0289016994511635,-0.0173651775024179,4.11347237114002e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,39929,-0.0487559505866324,0.00620341383897306,-0.0609146417110196,-0.0365972594622452,4.20438522584658e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.0865485723649455,0.011015442783293,-0.1081388402202,-0.0649583045096911,4.28909442504701e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.0217439860761741,0.00276954245522822,-0.0271722892884214,-0.0163156828639268,4.43142490810299e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,39492,-0.0562391720947622,0.00716922041433748,-0.0702908441068636,-0.0421875000826607,4.75208604578365e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0579506184011162,0.00739140848812429,-0.0724377790378399,-0.0434634577643926,4.8974344642595e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0430907523302537,0.00549876498766448,-0.053868331706076,-0.0323131729544313,5.05581237487415e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.045743084972425,0.00584050862015504,-0.0571904818679289,-0.0342956880769211,5.15593965875719e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0512063372869266,0.00654124775598374,0.0383854916851985,0.0640271828886547,5.31543446943209e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0261826387837123,0.00334492173868799,-0.0327386853915407,-0.0196265921758838,5.41397295179858e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.0249717693586463,0.00319519240023861,-0.031234346463114,-0.0187091922541787,5.88992590678596e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.0305783059175986,0.0039152278643535,0.0229044593034657,0.0382521525317314,6.2167764944487e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0616741848417011,0.00790522317447019,-0.0771684222636627,-0.0461799474197395,6.64362272436965e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0272327601452882,0.00349261538641425,-0.0340782863026601,-0.0203872339879163,6.8790725849381e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,42199,-0.0252543556003274,0.00324997848908402,-0.0316243134389321,-0.0188843977617227,8.36831227262335e-15
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.0191004522158233,0.00246713601740626,-0.0239360388099396,-0.014264865621707,1.04845314326108e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0575965096941296,0.00744555018767,-0.0721897880619628,-0.0430032313262964,1.10085192067612e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0407464079379159,0.00527225774252491,-0.0510800331132647,-0.0304127827625671,1.16680234853619e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.0385745976996172,0.00499191427413131,-0.0483587496769146,-0.0287904457223199,1.17466267138827e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,42070,-0.0243363911651989,0.0031496920813512,-0.0305097876446472,-0.0181629946857505,1.18252818473399e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0238057322210516,0.00308109472807349,-0.0298446778880756,-0.0177667865540276,1.18338012902791e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.0224526168486512,0.00290659480301611,-0.0281495426625628,-0.0167556910347397,1.19956972014035e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0213476186465316,0.00276305073548138,0.0159320392049881,0.0267631980880751,1.2020735415917e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,42144,-0.0254156529916081,0.00329554441283639,-0.0318749200407674,-0.0189563859424488,1.32350779115877e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0445427141578552,0.0057782146089864,-0.0558680147914685,-0.0332174135242418,1.36067824176669e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0256427759180788,0.00332687790723812,0.019122095219892,0.0321634566162655,1.36936318754483e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0216110800597317,0.00280388955790005,-0.0271067035932158,-0.0161154565262476,1.39049343988449e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0434676902315364,0.00566139499085949,-0.054564024413621,-0.0323713560494518,1.74989178541091e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0494422854851204,0.00644579451009007,-0.062076042724897,-0.0368085282453439,1.83084063982377e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FST,Follistatin,42166,0.0377174831811207,0.00492239512022915,0.0280695887454716,0.0473653776167698,1.94803012813577e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,39929,-0.084464611379329,0.0110237195193817,-0.106071101637317,-0.0628581211213408,1.97859081681428e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0290728249610711,0.00379832655355619,-0.0365175450060412,-0.0216281049161009,2.08035359840766e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0403388221797315,0.00527296987007835,-0.0506738431250851,-0.0300038012343779,2.14302238484218e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0487585852049915,0.00637463611072553,-0.0612528719820135,-0.0362642984279694,2.19760049531052e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,39736,0.0364440912226546,0.00477002078595883,0.0270948504821753,0.0457933319631339,2.34603950922614e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.0467104628753427,0.00611667253195275,-0.0586991410379701,-0.0347217847127153,2.38129334821274e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0371211188554161,0.00486265676860664,-0.0466519261218852,-0.0275903115889471,2.46009938489411e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.0487112503736462,0.00638713984964393,-0.0612300444789483,-0.0361924562683441,2.57716580699075e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.0250235154684716,0.00328114169510121,-0.0314545531908699,-0.0185924777460732,2.57997564209401e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0559182015908807,0.00733672350506135,-0.070298179660801,-0.0415382235209605,2.67157757686117e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0224866545001669,0.00295187465863311,-0.0282723288310878,-0.016700980169246,2.75081312984783e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0207760484917407,0.00272755275197878,-0.0261220518856191,-0.0154300450978623,2.76549409393745e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0542919277593239,0.00712786666298144,-0.0682625464187675,-0.0403213090998802,2.81155316733329e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0261438856879249,0.00343831138671129,-0.032882976005879,-0.0194047953699708,3.06640393885764e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0617115239049994,0.00813117726626311,-0.0776486313468751,-0.0457744164631237,3.42145803277812e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0428764888993832,0.00566470208248788,-0.0539793049810595,-0.031773672817707,4.00411362229506e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.0288188019541853,0.00380983592271955,-0.0362860803627156,-0.021351523545655,4.15446308198119e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.037639427721269,0.00497920522023567,-0.0473986699529309,-0.027880185489607,4.37277149233277e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,39930,-0.053659595260855,0.00710121676635282,-0.0675779801229066,-0.0397412103988035,4.46310312479017e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0259365798760929,0.00343262118401004,-0.0326645173967526,-0.0192086423554332,4.47966415570595e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.0862490243770786,0.0114187879574894,-0.108629848773758,-0.0638681999803993,4.51713780280434e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,39919,-0.0478455966555405,0.00633994542471973,-0.0602718896879912,-0.0354193036230898,4.80701884614393e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,39930,-0.0548370011322347,0.00726680670486179,-0.0690799422737638,-0.0405940599907056,4.82352155664011e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,42296,-0.0362801502490314,0.0048110603008694,-0.0457098284387355,-0.0268504720593274,4.95720674866513e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0399903205958898,0.00530658094904878,0.0295894219357542,0.0503912192560254,5.15428843717247e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0207743709411362,0.00275912991075977,-0.0261822655662253,-0.015366476316047,5.42005481074409e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0280643895067864,0.00372820592423388,-0.0353716731182848,-0.020757105895288,5.5610249648939e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,42145,-0.0935277495136375,0.0124283238935376,-0.117887264344971,-0.0691682346823038,5.58829597873375e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.0429048552168694,0.00570160103715262,-0.0540799932496886,-0.0317297171840503,5.6081121222378e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,41839,-0.0541053593101417,0.00720395125485037,-0.0682251037696484,-0.0399856148506349,6.26654076001575e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.0393209599406483,0.00524045032183176,-0.0495922425714386,-0.0290496773098581,6.61234407636689e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0422708660278807,0.00563380600003809,-0.0533131257879554,-0.031228606267806,6.61889645708855e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.0720001956725498,0.00959868215781531,-0.0908136127018678,-0.0531867786432318,6.73199237725541e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.0717778042070954,0.00957136590965516,-0.0905376813900195,-0.0530179270241713,6.82249169998008e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.0437543847307764,0.00584065677529081,-0.0552020720103464,-0.0323066974512064,7.2335317570303e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0391755442586209,0.00523254097217986,-0.0494313245640934,-0.0289197639531484,7.4949977184085e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0404718723320429,0.0054060755381966,-0.0510677803869082,-0.0298759642771775,7.62632666212394e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.0223115527552908,0.0029815036383926,-0.0281552998865403,-0.0164678056240413,7.69420666702874e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.029247276464922,0.00392009869266936,-0.0369306699025539,-0.02156388302729,9.1317989610482e-14
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,39826,0.0833145163995881,0.0111953447621884,0.0613716406656989,0.105257392133477,1.06507751509769e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.0802485665066468,0.0107938808554855,-0.101404572983398,-0.0590925600298953,1.11127999654177e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,39930,-0.0437192907131296,0.00588064983245236,-0.0552453643847362,-0.032193217041523,1.12588173734761e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,42170,0.0277676291514329,0.00373877474922123,0.0204396306429593,0.0350956276599065,1.17771553593171e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.036692226350959,0.00494698107802541,-0.0463883092638888,-0.0269961434380292,1.28489870477354e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0226243816641388,0.00305313234617188,-0.0286085210626357,-0.0166402422656419,1.33558765494815e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0373794551361828,0.00504676658622994,-0.0472711176451935,-0.0274877926271722,1.392193482979e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.0215064639210118,0.00290473550837757,-0.0271997455174318,-0.0158131823245917,1.4014492049611e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.0231399231993837,0.00313010843479337,-0.0292749357315787,-0.0170049106671887,1.54452010209247e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.022842358329604,0.00309020561234076,-0.0288991613297918,-0.0167855553294161,1.54988290443725e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGRN,Neugrin,39929,-0.0168235404079107,0.00227847796737464,-0.021289357223965,-0.0123577235918564,1.64774765613047e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELL,L-selectin,39979,0.0174379028614264,0.00236507995997496,0.0128023461398755,0.0220734595829773,1.78311080802276e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0341043679178686,0.00462903996801035,-0.0431772862551689,-0.0250314495805683,1.86001320528039e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0761537665213156,0.010344902600201,-0.0964297756177096,-0.0558777574249216,1.92316609843671e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,42196,-0.0219740539450546,0.00299034856419115,-0.0278351371308693,-0.01611297075924,2.12146691449396e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.0184455929947583,0.0025114775153004,-0.0233680889247471,-0.0135230970647696,2.1830056234785e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0401062783890414,0.0054610644705767,-0.0508099647513717,-0.0294025920267111,2.21449853220886e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0261240828197545,0.00355945802519374,-0.0331006205491343,-0.0191475450903748,2.26867608777354e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.044408116519058,0.00605330003087812,0.0325436484585368,0.0562725845795791,2.32447479359017e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,42146,-0.0418270829373159,0.00570584951384696,-0.0530105479844559,-0.0306436178901758,2.42176628748635e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELP,P-selectin,42217,-0.041309413736541,0.00563746101314378,-0.0523588373223028,-0.0302599901507792,2.47379814684966e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0560160750563086,0.00765590587040404,-0.0710216505623005,-0.0410104995503167,2.68514060406892e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NADK,NAD kinase,42145,-0.0404165594785866,0.00553162298396139,-0.0512585405271509,-0.0295745784300223,2.89618414146139e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.0417948948391088,0.00572422206331793,-0.0530143700832119,-0.0305754195950056,3.01017953039716e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,42051,-0.0508888145948201,0.00698415708824318,-0.0645777624877767,-0.0371998667018635,3.36273815431882e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,42166,-0.0226220648098306,0.00310663034805884,-0.0287110602920259,-0.0165330693276353,3.47368696955766e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0309167077833371,0.00424662574437407,-0.0392400942423103,-0.0225933213243639,3.52487891080505e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,42119,0.0326881888005534,0.00449122592967928,0.023885385978382,0.0414909916227248,3.56878349666012e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0489946070291536,0.00673710236007362,-0.0621993276548979,-0.0357898864034093,3.76549222646165e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.0247518790290452,0.00341084301897741,-0.0314371313462409,-0.0180666267118495,4.18363247488799e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,41992,-0.036885814004882,0.00508815485941466,-0.0468585975293347,-0.0269130304804292,4.41732403585841e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0326583955194098,0.00450490691305169,-0.0414880130689911,-0.0238287779698285,4.45487481459384e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0226517610946907,0.00312720555504258,0.0165224382068073,0.0287810839825742,4.60738866700832e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,39930,-0.0501029910490414,0.006915916884261,-0.0636581881421929,-0.0365477939558898,4.61897365389429e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.043597382355603,0.00602292976724101,0.0317924400118106,0.0554023246993954,4.77656468841372e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.031877390642517,0.00440383055098736,-0.0405088985224522,-0.0232458827625818,4.82712423120782e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,39958,-0.0396091525177063,0.00549456084627107,-0.0503784917763976,-0.028839813259015,6.00320301379002e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,39948,-0.0323024631991928,0.00449094736111263,-0.0411047200269735,-0.023500206371412,6.7473954489539e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0293132047183402,0.00408628572511071,0.0213040846971232,0.0373223247395572,7.6936548402635e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0341878163156287,0.0047683230577947,-0.0435337295089063,-0.0248419031223511,7.89689612126082e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0237087917310933,0.00330610918310288,0.0172288177322116,0.0301887657299749,7.90876164287786e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0205482170027566,0.00286651811341491,0.0149298415004633,0.0261665925050498,7.97871255865251e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0344244855510444,0.00481429224033034,-0.0438604983420919,-0.024988472759997,9.10219600531328e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0496706377205453,0.00694732121578478,-0.0632873873034834,-0.0360538881376071,9.14494278183262e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0709397451394595,0.00992704677936848,-0.0903967568270217,-0.0514827334518972,9.38476608345687e-13
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.080431258668944,0.0112728912918093,-0.10252612560089,-0.0583363917369978,1.018154818345e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,39638,-0.0504002488222152,0.00706272013106255,-0.0642431802790978,-0.0365573173653326,1.02041744221973e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0302309763710245,0.00424445012794669,0.0219118541202489,0.0385500986218,1.12470741137805e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0176964449687455,0.00248806205893902,0.012819843333225,0.022573046604266,1.20759426833347e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0702040941545091,0.00987113040729689,-0.089551509752811,-0.0508566785562072,1.21382935773574e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0259101449144658,0.0036440387043466,-0.0330524607749851,-0.0187678290539465,1.21613279156308e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0597078687373909,0.00839959134507855,-0.0761710677737449,-0.043244669701037,1.23272270747673e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0197650926551831,0.00278254663185764,-0.0252188840536241,-0.0143113012567421,1.29353635450503e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0302318564069236,0.00425911901276913,0.0218839831418961,0.0385797296719511,1.32716680079645e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.0723476340982419,0.0101930637278529,-0.0923260390048335,-0.0523692291916502,1.33098061225899e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,42070,-0.0214911447759967,0.00303192246715445,-0.0274337128116195,-0.015548576740374,1.42538885047301e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.0594065834941078,0.00838911350570716,-0.0758492459652938,-0.0429639210229217,1.51142866639807e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0222925147031308,0.00314867751983408,-0.0284639226420057,-0.016121106764256,1.51244118486563e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.019548826112134,0.00276228725418853,0.0141347430939245,0.0249629091303435,1.54492813037127e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.0181304300999028,0.00256192749067749,-0.0231518079816307,-0.0131090522181749,1.54608148386027e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0447319530888647,0.00632468466598213,0.0323355711435398,0.0571283350341897,1.59543370953201e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,42145,-0.0306611735695704,0.0043357420515414,-0.0391592279905916,-0.0221631191485492,1.60523634582254e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0557499163689582,0.00788451780051659,0.0402962614799457,0.0712035712579707,1.61625898977305e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0306034016975363,0.004329935283767,-0.0390900748537196,-0.0221167285413529,1.65108582617291e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.0177652577506827,0.0025138359783064,-0.0226923762681633,-0.0128381392332022,1.67877097324376e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.018282903822629,0.00259427808495877,-0.0233676888691482,-0.0131981187761098,1.91078453417676e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.0332475583470516,0.00472184932684805,-0.0425023830276738,-0.0239927336664295,1.99674122308725e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0604288901093977,0.00858816818134595,-0.0772616997448358,-0.0435960804739596,2.08803419478834e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0411984791498415,0.00585659927477013,-0.0526774137283909,-0.029719544571292,2.11648448053501e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0562020897933333,0.00800252490501751,-0.0718870386071676,-0.040517140979499,2.2982915855407e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0451819473873282,0.00643687401955031,-0.0577982204656469,-0.0325656743090096,2.35822830787694e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0396575529123434,0.00565112166343456,-0.0507337513726752,-0.0285813544520117,2.36477288975483e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,39929,-0.0386524067401379,0.00551187076866711,-0.0494556734467254,-0.0278491400335504,2.47288898443449e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.040453474667856,0.00577123256853614,-0.0517650905021869,-0.0291418588335252,2.50748572525814e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0469990808978151,0.00671937746939273,-0.0601690607378249,-0.0338291010578054,2.78513441421528e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,39929,-0.0203846052294057,0.00291453308647242,-0.0260970900788917,-0.0146721203799198,2.81954391201254e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,41846,-0.0396664566543318,0.0056762085686233,-0.0507918254488335,-0.0285410878598302,2.91762472703827e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0322411066942525,0.00461526553845,-0.0412870271496145,-0.0231951862388905,2.96411348276711e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0488280947148179,0.00700126021898932,-0.062550564744037,-0.0351056246855988,3.24773882312273e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,39979,-0.0214969704730174,0.00309154444728714,-0.0275563975897002,-0.0154375433563346,3.75919939423974e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,42137,0.0197276614410557,0.00284148241709076,0.0141583559035578,0.0252969669785536,4.0210608245479e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0279291727302757,0.00402326537905161,0.0200435725873346,0.0358147728732169,4.0443675945516e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,39958,-0.0214613573161705,0.00309120474976001,-0.0275201186257001,-0.0154025960066409,4.05605012968899e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0534548987794492,0.00769965350420872,-0.0685462196476982,-0.0383635779112001,4.06827482905813e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0286573765072215,0.00413058317967947,-0.0367533195393932,-0.0205614334750497,4.19799207447992e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,42119,-0.0241928707092199,0.00348788812569994,-0.0310291314355918,-0.017356609982848,4.20946339507126e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0238664412712187,0.00344269622928629,-0.0306141258806198,-0.0171187566618176,4.36550201285116e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0201073659920195,0.00290111007485886,-0.0257935417387429,-0.0144211902452962,4.36966234082175e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0465673280965991,0.00672302324476153,-0.0597444536563317,-0.0333902025368665,4.54586445424128e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0267150799326317,0.00387691572338784,-0.0343138347504719,-0.0191163251147916,5.7937901407679e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0465347438538614,0.00675622236495334,-0.05977693968917,-0.0332925480185529,5.9708179630535e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0361997613156906,0.0052664245551085,0.025877569187678,0.0465219534437033,6.53023429094746e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0320110293734122,0.00465921113135898,-0.0411430831908758,-0.0228789755559486,6.74262232881963e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0299850566197779,0.00436822547241553,-0.0385467785457123,-0.0214233346938435,6.96831377568066e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,42145,-0.0170002302865714,0.0024770138970236,-0.0218551775247376,-0.0121452830484051,7.02659191634581e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0361131912272795,0.00526551473162305,-0.0464336001012607,-0.0257927823532983,7.26074232407924e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,41959,-0.0300890834298917,0.00439036744121039,-0.038694203614664,-0.0214839632451193,7.52615406198648e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,39979,0.0210498023917006,0.00307103278782911,0.0150305781275555,0.0270690266558456,7.53632665866155e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.0658759230810833,0.00961210124310096,-0.0847156415175611,-0.0470362046446054,7.58370143678231e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,42296,-0.0599017986495286,0.00874738851929047,-0.077046680147338,-0.0427569171517193,7.8101714247113e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,42096,-0.0303406936873002,0.00443798929321003,-0.0390391527019919,-0.0216422346726086,8.45890276255032e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0357735066731009,0.00523280367930552,-0.0460298018845397,-0.0255172114616621,8.47295245685938e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.0718200269956183,0.0105073157430478,-0.092414365851992,-0.0512256881392447,8.53604979384015e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0243245350074238,0.00355963998970089,-0.0313014293872375,-0.01734764062761,8.64271303911946e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0353708935176506,0.00517579711271331,-0.0455154558585686,-0.0252263311767325,8.69503021188602e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0405976788915047,0.00594978034841597,-0.0522592483744,-0.0289361094086094,9.34482461746893e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0384604484944081,0.00563752546970368,-0.0495099984150273,-0.0274108985737889,9.43262718147524e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0578329666364351,0.00847777539379153,-0.0744494064082665,-0.0412165268646037,9.45429958029288e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0326815741784155,0.00479291166774744,-0.0420756810472005,-0.0232874673096305,9.58313664913475e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0533069749327648,0.00781976077073833,-0.068633706043412,-0.0379802438221177,9.70171953367144e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0215524374470834,0.00316241766172694,-0.0277507760640682,-0.0153540988300986,9.81339873661067e-12
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0612690997823143,0.00900703430528631,-0.0789228870206755,-0.0436153125439531,1.07262740373956e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0338960349774797,0.00498378496409236,-0.0436642535071007,-0.0241278164478586,1.08923084026079e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOST,Sclerostin,42129,-0.0266189371269836,0.00391879109218442,-0.034299767667665,-0.0189381065863021,1.14700552276965e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.0466015845372544,0.00686329289803465,-0.0600536386174023,-0.0331495304571065,1.16844770293605e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.0240992396896406,0.00355573729417964,-0.0310684847862327,-0.0171299945930485,1.2721750777157e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.0277970001427353,0.00410365339293675,-0.0358401607928913,-0.0197538394925792,1.31733471146491e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0324042806140949,0.00478482957478702,-0.0417825465806775,-0.0230260146475124,1.32016809528308e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0480533087841321,0.00709884947995705,-0.0619670537648479,-0.0341395638034163,1.34849390656042e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0193295155632643,0.0028570592466922,-0.024929351686781,-0.0137296794397476,1.38238105600323e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0278727688806681,0.00412116167974552,-0.0359502457729693,-0.0197952919883669,1.41500718809132e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0653786376366269,0.0096789138560707,-0.0843493087945255,-0.0464079664787283,1.48933557676007e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.0373730552271209,0.00553249543158206,-0.0482167462730218,-0.0265293641812201,1.49783729752024e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0295190998358157,0.00438022269737767,-0.0381043363226759,-0.0209338633489555,1.65841085946392e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.051938537520608,0.00771588984214292,-0.0670616816112081,-0.0368153934300078,1.76184613271695e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0250843935986934,0.00372818741244629,-0.0323916409270881,-0.0177771462702987,1.78673321620477e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.0226559301345779,0.00336922255584923,-0.0292596063440424,-0.0160522539251135,1.84831061632761e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0337674547564438,0.00503158143952965,-0.0436293543779219,-0.0239055551349657,2.02375969354779e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0323866330778102,0.00482662215286048,-0.0418468124974168,-0.0229264536582037,2.02386620442805e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.0701463660463174,0.010452576804353,-0.0906334165828492,-0.0496593155097856,2.02632546014254e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.0453487669828447,0.0067635665361124,-0.058605357393625,-0.0320921765720644,2.11498511876384e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0534050112589792,0.00796741629393655,-0.0690211471950949,-0.0377888753228636,2.13980665055576e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.041181150482303,0.00614964650639088,-0.0532344576348291,-0.0291278433297769,2.21853964218943e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.020754086392002,0.00310244700454663,-0.0268348825209133,-0.0146732902630906,2.3434474208981e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,39638,-0.0199874302720946,0.00298878839965432,-0.0258454555354171,-0.0141294050087721,2.38032697142725e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0401363483482135,0.00600993131947817,-0.0519158137343907,-0.0283568829620363,2.51261326893596e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0462742017251202,0.00692971240078225,-0.0598564380306534,-0.032691965419587,2.54157827591207e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.0369573000290254,0.00553531551956043,-0.0478065184473639,-0.026108081610687,2.54180158760966e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0302469050140548,0.00453906336762141,0.0213503408135168,0.0391434692145927,2.79418342691604e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.0685248085027802,0.0102863097492799,-0.0886859756113689,-0.0483636413941915,2.81058977822594e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,42146,-0.0367892540724517,0.0055278081705139,-0.047623758086659,-0.0259547500582445,2.93586586757637e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NBN,Nibrin,41913,-0.0365023123700442,0.00549019008146562,-0.0472630849297168,-0.0257415398103716,3.07343301340307e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0225259486790806,0.00339089490202544,-0.0291721026870504,-0.0158797946711107,3.18848165192844e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0160853813445571,0.00242291299617865,0.0113364718720469,0.0208342908170672,3.28099785165598e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,42069,-0.0296986254271646,0.00447589197712613,-0.0384713737023318,-0.0209258771519974,3.36355806840918e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,41839,-0.0548044566295627,0.00826907338583395,-0.0710118404657973,-0.0385970727933282,3.54301016687806e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0557999510959778,0.00843112506774091,-0.07232495622875,-0.0392749459632056,3.77381421178911e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.0299295005872185,0.00453428185449934,-0.0388166930220372,-0.0210423081523998,4.27909588596045e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0359684957869879,0.0054526706122082,-0.046655730186916,-0.0252812613870599,4.36927402971429e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0284915550956178,0.00432352662089094,0.0200174429186715,0.036965667272564,4.56530991035087e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0183162984958763,0.00278275591626243,-0.0237705000917507,-0.012862096900002,4.80825242826001e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,41839,-0.045277525686191,0.00688097077342241,-0.058764228402099,-0.0317908229702831,4.87799960624298e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0638827623910684,0.00971724734262977,-0.0829285671826227,-0.044836957599514,5.07618485649359e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.0262858097865826,0.0039993458336324,-0.0341245276205021,-0.0184470919526631,5.17111460278767e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.0749519936159017,0.0114085364353147,-0.0973127250291184,-0.052591262202685,5.22037354602607e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.029672288305369,0.0045184655780136,-0.0385284808382756,-0.0208160957724623,5.36790880832363e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,39934,-0.0368453096769262,0.00561388484721565,-0.0478485239774689,-0.0258420953763835,5.49457251872296e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0339900213035303,0.00519002962046763,-0.0441624793596469,-0.0238175632474138,5.99708481813071e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0684530557180443,0.0104636980544237,-0.0889619039047146,-0.0479442075313739,6.34056770715768e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0524661229339593,0.00802228610982537,-0.068189803709217,-0.0367424421587016,6.37588765336969e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0242581049857138,0.00371108377146618,-0.0315318291777875,-0.0169843807936401,6.56758346342266e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0220856239610292,0.00338950186047358,-0.0287290476075574,-0.015442200314501,7.47924904208802e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0478148940695119,0.007346507700929,-0.0622140491633327,-0.0334157389756911,7.8571567517942e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,41984,-0.0230932248302386,0.00354880697365419,-0.0300488864986008,-0.0161375631618764,7.92269943567812e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0315887075151985,0.00485468173299121,-0.0411038837118613,-0.0220735313185357,7.99754804435325e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,41647,-0.0403962011972121,0.00621835511504897,-0.052584177222708,-0.0282082251717161,8.53162147353414e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0391502896584564,0.00602809386670453,-0.0509653536371973,-0.0273352256797155,8.61897489581922e-11
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.0522348292517916,0.00807796282060038,-0.0680676363801683,-0.0364020221234148,1.04643804018164e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0267585121481036,0.00414135912760394,-0.0348755760382073,-0.0186414482579999,1.08072549803829e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0204929276596002,0.00317286149977794,-0.026711736199165,-0.0142741191200354,1.09826827250656e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.0509334551998204,0.00788764094689501,-0.0663932314557347,-0.0354736789439062,1.10141127324741e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0362476056878786,0.00561462845912153,-0.0472522774677568,-0.0252429339080004,1.11943276944597e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0324455829943622,0.00503023142760549,-0.042304836592469,-0.0225863293962555,1.15648557166254e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0303233735459148,0.00470779028440716,0.0210961045884768,0.0395506425033528,1.22581502298377e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.0319675646404338,0.00497001882798113,-0.0417088015432768,-0.0222263277375908,1.31104000897544e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,39649,-0.0325631693975241,0.00506580899713245,-0.0424921550319037,-0.0226341837631445,1.34595627072329e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.049636720690663,0.0077248081550541,-0.064777344674569,-0.0344960967067569,1.36596643211804e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0271341145558617,0.00422714843529067,-0.0354193254890314,-0.018848903622692,1.41702419161123e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0287760120965809,0.00448322078483524,-0.037563124834858,-0.0199888993583038,1.42119681875171e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,42262,-0.0719326559344919,0.0112109376965321,-0.0939060938196948,-0.0499592180492889,1.44237160924451e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,41997,-0.0407456396579552,0.0063559103062202,-0.0532032238581468,-0.0282880554577636,1.49738249295148e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0314030503618467,0.00490043845338369,-0.0410079097304787,-0.0217981909932147,1.53075583067899e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.0178060499206,0.00277946935583499,-0.0232538098580366,-0.0123582899831635,1.55010832365429e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,39575,-0.0429904731017122,0.0067211076743241,-0.0561638441433874,-0.029817102060037,1.6562250846622e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0405954008421961,0.00635100588117896,-0.0530433723693068,-0.0281474293150853,1.69092807968026e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.017460434930362,0.0027318850042328,-0.0228149295386583,-0.0121059403220657,1.71055411272477e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.0166320967938215,0.00260360843803355,-0.0217351693323672,-0.0115290242552757,1.7472424389409e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0280831369546934,0.00439793494042505,-0.0367030894379265,-0.0194631844714603,1.76510053230917e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0134329339015998,0.00210369603899173,-0.0175561781380236,-0.00930968966517601,1.76563540344877e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,42249,-0.0237502401136187,0.00372205935592621,-0.0310454764512341,-0.0164550037760034,1.81686488360907e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.0259834326779452,0.00407310205339228,-0.033966712702594,-0.0180001526532963,1.84986506527274e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.0568646931411746,0.00891409940499712,-0.0743363279749689,-0.0393930583073802,1.85156477267944e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0502830471217373,0.00788375470468072,-0.0657352063429115,-0.034830887900563,1.86518937993728e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.0174055770552003,0.00272959948813818,-0.0227555920519511,-0.0120555620584495,1.86936339843358e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0496140499965323,0.00778160478981703,-0.0648659953845737,-0.0343621046084909,1.89070378680453e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0559988617127955,0.00878380212408301,-0.0732151138759982,-0.0387826095495927,1.89782457278905e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LXN,Latexin,41960,0.044068205503589,0.00691883619581576,0.0305072865597901,0.0576291244473879,1.96102255509343e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0246545524376913,0.00387733098943981,-0.0322541211769933,-0.0170549836983893,2.10012659689701e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0191473766654922,0.00301196625699715,-0.0250508305292066,-0.0132439228017778,2.12339633663776e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0322879173321475,0.00508257393917287,-0.0422497622529263,-0.0223260724113686,2.19846921843345e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0301642569359145,0.00476323925702928,-0.0395002058796919,-0.0208283079921371,2.4999583324545e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0181249558397404,0.00286566826294661,-0.0237416656351157,-0.012508246044365,2.63319602559002e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0416409112954711,0.00658784454267405,-0.0545530865991122,-0.02872873599183,2.70118540126296e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.0240247175304093,0.00380392593843171,-0.0314804123697355,-0.0165690226910832,2.79141267887734e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.01937631982462,0.00306950480486227,-0.02539254924215,-0.01336009040709,2.83031711469715e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,42137,0.0316737521638553,0.00502210675380781,0.021830422926392,0.0415170814013187,2.93594864568864e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0462528987122831,0.00735562389711006,-0.0606699215506189,-0.0318358758739474,3.3126165067675e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0203862478755377,0.00324892210680842,-0.0267541352048822,-0.0140183605461932,3.60866459485132e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,42107,-0.0181752632821583,0.00289788717255661,-0.0238551221403692,-0.0124954044239473,3.67535614021969e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.0338284322500941,0.00539306824215101,-0.04439884600471,-0.0232580184954781,3.68411677901608e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0461391173120381,0.007369273575414,-0.0605828935198495,-0.0316953411042266,3.94245067779902e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,42166,-0.0552057637184575,0.00881985348239911,-0.0724926765439597,-0.0379188508929552,3.98450433814821e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0403927219371541,0.00645550923427678,-0.0530455200363366,-0.0277399238379716,4.04064206170314e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.021278744520738,0.00340703885861768,-0.0279565406836287,-0.0146009483578474,4.35128038409539e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.0282089319950325,0.00452047562713852,-0.037069064224224,-0.019348799765841,4.52867074560182e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.0367013645158603,0.00588549508760315,-0.0482369348875625,-0.0251657941441581,4.62837622746898e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,39946,-0.0301679071400566,0.00484588616229072,-0.0396658440181465,-0.0206699702619668,4.97078775566913e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.033184375755045,0.00533452259054911,-0.0436400400325212,-0.0227287114775687,5.12756868459976e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0217868666593975,0.00350291736139694,-0.0286525846877355,-0.0149211486310595,5.13047405325722e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0416361066929875,0.00669803465701131,-0.0547642546207297,-0.0285079587652454,5.27348783269739e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0654655187372429,0.010541363270303,-0.0861265907470367,-0.0448044467274491,5.44161530978996e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.0405571085368473,0.00653736373455131,-0.0533703414565679,-0.0277438756171267,5.70046146367534e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0378686265215866,0.00611121331506958,-0.049846604619123,-0.0258906484240502,5.97057853708659e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.0683695385276303,0.0110464662228594,-0.0900206123244347,-0.046718464730826,6.21821980458872e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.019331133325004,0.00314125240056707,-0.0254879880301155,-0.0131742786198926,7.76777083001608e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.0415532361108319,0.00675429800042065,-0.0547916601916563,-0.0283148120300074,7.85840626754649e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0343633109441221,0.00558916630642314,-0.0453180769047115,-0.0234085449835328,8.05440072832825e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,42035,-0.0421838556534335,0.00686434176107826,-0.0556379655051469,-0.0287297458017201,8.20374919984769e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFH,Complement factor H,39418,-0.0147083896316939,0.00239304582682037,-0.0193987594522619,-0.010018019811126,8.21030399244473e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.0199356437761294,0.00324411353961959,0.013577181238475,0.0262941063137838,8.21052701890737e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,42181,-0.0334141245008343,0.00543810780410729,-0.0440728157968846,-0.022755433204784,8.24889317200545e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.0650383018558928,0.0105934770596069,-0.0858015168927224,-0.0442750868190633,8.55702078521698e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0291371522319993,0.00474891997710644,-0.0384450353871279,-0.0198292690768707,8.7784148383872e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0772067881128543,0.012595080054846,-0.101893145020353,-0.0525204312053561,9.10111262177482e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.0819530021111501,0.013387635251525,-0.108192767204139,-0.0557132370181611,9.58179776670208e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0330810654556998,0.00541027418695114,-0.043685202862124,-0.0224769280492756,9.95828631240848e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.0149740945103004,0.00244922697521771,0.0101736096388737,0.0197745793817271,9.99713371062302e-10
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.0142033917405747,0.00232632674172838,-0.0187629921543623,-0.00964379132678707,1.05309957075468e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.0594613683291234,0.00975351375442501,-0.0785782552877965,-0.0403444813704504,1.11456122339122e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0473297199278834,0.00776615620789646,-0.0625513860953604,-0.0321080537604063,1.12915518591955e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0325064456270541,0.00533347642334651,-0.0429600594168132,-0.0220528318372949,1.13144379917854e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0275649554232005,0.00452575515145216,-0.0364354355200468,-0.0186944753263543,1.15540695001556e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0349566412181007,0.00573991285513409,-0.0462068704141635,-0.0237064120220379,1.15896768386892e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.031311268624434,0.00514333363275924,-0.0413922025446421,-0.0212303347042259,1.17668111093311e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTD,Biotinidase,39979,-0.0126705370941354,0.00208518639734302,-0.0167575024329277,-0.00858357175534311,1.26800736371225e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.0731333428014047,0.0120920511187734,-0.0968337629942006,-0.0494329226086087,1.51231028702546e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,39638,-0.0317089871438827,0.00524586346817048,-0.0419908795414969,-0.0214270947462686,1.54650167470121e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0445681714389634,0.00737819577739339,-0.0590294351626545,-0.0301069077152724,1.57614699616314e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0173312717378676,0.00286987974788642,-0.0229562360437249,-0.0117063074320102,1.590765730197e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,39930,-0.0214484902328609,0.00355372285883395,-0.0284137870361754,-0.0144831934295464,1.63429862272372e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,42137,0.0159457991292212,0.0026424798040052,0.010766538713371,0.0211250595450713,1.63712654018946e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,42230,0.0166584247816732,0.00276122333210401,0.0112464270507493,0.022070422512597,1.65125536864108e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0371236482212442,0.00616660973488704,-0.0492102033016228,-0.0250370931408656,1.78816448321662e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,42144,-0.0145800330569421,0.002422264509742,-0.0193276714960364,-0.00983239461784778,1.79837752472684e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.0445774179241064,0.00741918249066749,-0.0591190156058147,-0.0300358202423982,1.93269184308417e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0557638392573258,0.00929545811378833,-0.073982937160351,-0.0375447413543007,2.04532763614167e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,42145,0.01908477158634,0.00318297262341961,0.0128461452444375,0.0253233979282424,2.07515460091308e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,42137,-0.0273387353138459,0.00456001637778532,-0.0362763674143051,-0.0184011032133866,2.08259190912797e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.0354045800239969,0.0059047565577935,-0.0469779028772721,-0.0238312571707216,2.08481308564725e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0305893676122138,0.00510264031383848,-0.0405905426273372,-0.0205881925970904,2.10138604549073e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0524853520895293,0.00877010807502195,-0.0696747639165724,-0.0352959402624863,2.23651696245075e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.0344457076958085,0.00576384220338331,-0.0457428384144398,-0.0231485769771772,2.35487658456676e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0337048068474418,0.00564408742730518,-0.0447672182049599,-0.0226423954899236,2.4201056326442e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.0354004277208409,0.00593031308868828,-0.0470238413746699,-0.0237770140670119,2.44041984107954e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0392391368131725,0.0065743830307024,-0.0521249275533492,-0.0263533460729958,2.46639821013485e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.0219569971525865,0.00368062790572238,-0.0291710278478024,-0.0147429664573707,2.51322467404367e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0160055574711857,0.00268471132623071,0.0107435232717735,0.0212675916705979,2.55716395682816e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.036998469001354,0.00621238380657415,-0.0491747412622393,-0.0248221967404687,2.6701678478109e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0162016251446718,0.00272103593065601,-0.0215348555687576,-0.0108683947205861,2.67831290006641e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0437311847665526,0.00734833399744206,-0.058133919401539,-0.0293284501315661,2.74249579949913e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0150421436645846,0.00253630069793334,-0.020013293032534,-0.0100709942966353,3.08899114748295e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.0369614010855195,0.00623699284017981,-0.0491859070522719,-0.024736895118767,3.17813101417367e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RETN,Resistin,42105,-0.0256812225897079,0.00433556550033619,-0.0341789309703669,-0.017183514209049,3.23052798497427e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPSE,Heparanase,39866,-0.0575012870256468,0.00970892564187373,-0.0765307812837193,-0.0384717927675743,3.26306898828511e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRN,Progranulin,42077,-0.0150125578392775,0.00253753795669716,-0.0199861322344039,-0.0100389834441511,3.37476176763262e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,39929,-0.0433849137052606,0.00733785243650749,-0.0577671044808153,-0.0290027229297059,3.46712091326387e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0411885401375801,0.00696922147154235,0.0275288660533571,0.0548482142218031,3.50242377724726e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.0182758607759944,0.00309368775680788,0.012212232772651,0.0243394887793379,3.57391733871765e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,42143,-0.062941436471601,0.0106599042214606,-0.0838348487456637,-0.0420480241975383,3.62183195752551e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.0322301812931497,0.00546104723914975,-0.0429338338818832,-0.0215265287044162,3.68095588078297e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0396780654218187,0.00672659641046951,-0.052862194386339,-0.0264939364572985,3.77152356404952e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.0242372790293162,0.00411567166186207,-0.0323039954865658,-0.0161705625720665,3.97616886290557e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0218939407351844,0.00371988889127205,-0.0291849229620776,-0.0146029585082911,4.05936906364268e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.0644153139687798,0.0109554220114117,-0.0858879411111468,-0.0429426868264128,4.22410935686527e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.0161663742693143,0.0027522409484031,-0.0215607665281844,-0.0107719820104443,4.3757253762482e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.0256299333929543,0.00436756747009593,-0.0341903656343423,-0.0170695011515663,4.52994703926339e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,41900,-0.0294563304492239,0.0050303458781355,-0.0393158083703695,-0.0195968525280783,4.86141721611504e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.0138486937685028,0.00236585394949843,-0.0184857675095197,-0.0092116200274859,4.94824413300898e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.0269923413623748,0.00461127832001268,-0.0360304468695997,-0.01795423585515,4.94866944905558e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0287637888853561,0.00491966498087402,-0.0384063322478692,-0.019121245522843,5.1523294587231e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.0162154679622925,0.00277657288330493,0.0107733851110148,0.0216575508135702,5.36074357352612e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,41913,-0.0673633086325055,0.0115409023980304,-0.0899834773326451,-0.0447431399323659,5.44134725212813e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,42082,-0.0517664804693231,0.0088729572782166,-0.0691574767346276,-0.0343754842040186,5.52945772310373e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.019534355966285,0.00335347797626094,0.0129615391328136,0.0261071727997565,5.86245097251705e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0263372292229187,0.00452318151494754,0.0174717934536216,0.0352026649922159,5.92100040698894e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.0398135786871945,0.00684302673347514,-0.0532259110848057,-0.0264012462895832,6.11752493871196e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,41756,-0.0432297552772721,0.00743720130037874,-0.0578066698260144,-0.0286528407285298,6.29220551879977e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0218595143351967,0.00376539514672486,-0.0292396888227775,-0.014479339847616,6.5695820553627e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0400310363615403,0.0069038127482093,-0.0535625093480305,-0.0264995633750501,6.87720674275147e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,41913,-0.0415189186229381,0.00716426466854764,-0.0555608773732915,-0.0274769598725847,6.97517963179633e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.034405926584526,0.00594333015404141,-0.0460548536864472,-0.0227569994826049,7.2733506707105e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,42137,-0.0263007138572386,0.0045471311737418,-0.0352130909577725,-0.0173883367567047,7.45462654692695e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0154469744313372,0.00267176443707781,-0.0206836327280097,-0.0102103161346647,7.56423206572241e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0369435056639194,0.00639529772298431,-0.0494782892009686,-0.0244087221268701,7.82103996583455e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0207970622215463,0.00360563508191528,-0.0278641069821002,-0.0137300174609923,8.23509568303144e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0490393821141675,0.00850689740807059,-0.0657129010339858,-0.0323658631943491,8.36086576727987e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.013584392021452,0.00235939465404972,-0.0182088055433895,-0.0089599784995146,8.71590155773398e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.037616484159775,0.00654609888220376,-0.0504468379688944,-0.0247861303506556,9.31121461817975e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0527028652109769,0.00917247834332827,-0.0706809227639003,-0.0347248076580535,9.35227304066439e-09
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.0128264911284688,0.00223906820941648,-0.0172150648189251,-0.00843791743801249,1.03474101767308e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0298591652566447,0.00521254365895235,-0.0400757508281913,-0.0196425796850981,1.03564642264101e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,39709,-0.0300410262672735,0.00524542309514551,-0.0403220555337587,-0.0197599970007883,1.04817321878062e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0466981214713115,0.0081565889045293,-0.062685035724189,-0.0307112072184341,1.05502166053329e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGN,Mimecan,42137,-0.0250247718370733,0.00437207580661788,-0.0335940404180444,-0.0164555032561023,1.06392875632555e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0464176879775815,0.00811803051300191,-0.0623290277830653,-0.0305063481720978,1.10178852852523e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0199100261540066,0.00348588051072152,-0.0267423519550208,-0.0130777003529925,1.14270615200646e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0455300319686858,0.00797229331315081,-0.0611557268624614,-0.0299043370749102,1.1467428938924e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.0187378284974477,0.00328893730325888,-0.0251841456118351,-0.0122915113830603,1.2427369113538e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,39979,-0.0238819759832213,0.00419371613837435,-0.032101659614435,-0.0156622923520075,1.26646567387885e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0137406784492584,0.00241689992566679,0.0090035545949515,0.0184778023035653,1.33318096145955e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,42144,-0.0170088399608959,0.00299709628645325,-0.0228831486823443,-0.0111345312394475,1.41443403241465e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.0844173102941274,0.0148769166278922,-0.113576066884796,-0.0552585537034587,1.42604467957279e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,39876,-0.0272997879689881,0.00481187890180698,-0.0367310706165298,-0.0178685053214464,1.43426239998163e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0176328200184418,0.00311342220347415,-0.0237351275372512,-0.0115305124996325,1.52003870925533e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0190098600188713,0.00336058338716005,-0.025596603457705,-0.0124231165800376,1.58103019168093e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,42119,-0.0273570588451611,0.00483748160067161,-0.0368385227824774,-0.0178755949078447,1.58792309565192e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0489720269703433,0.00866345475776497,-0.0659523982955627,-0.031991655645124,1.61112072083873e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0342897646177738,0.00607599962536907,0.0223808053520504,0.0461987238834971,1.69962270997759e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNC,Tenascin,42217,0.0275558244133714,0.00488526519342784,0.0179807046342528,0.03713094419249,1.72831974620238e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,39990,-0.0430683692005642,0.00763682517392932,-0.0580365465414657,-0.0281001918596628,1.74540987283609e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0198102665659888,0.00351340415934022,-0.0266965387182956,-0.0129239944136819,1.74983725452117e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0311850565780677,0.00553621172867453,-0.0420360315662697,-0.0203340815898656,1.81477374859972e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0208390463658336,0.00370098197210947,-0.0280929710311681,-0.013585121700499,1.83770137213784e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,39736,-0.0380850181927245,0.00676692318642656,-0.0513481876381205,-0.0248218487473284,1.86594108329255e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0258760085424298,0.00460766984361784,0.0168449756489389,0.0349070414359208,1.99534336651504e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.059201827062597,0.010552437242324,-0.079884604057552,-0.038519050067642,2.06013174552989e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0402946677249537,0.00718691388179987,-0.0543810189332814,-0.0262083165166259,2.10274211233622e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0530442707037992,0.00946130357372613,-0.0715884257083024,-0.034500115699296,2.10566974104874e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.0258598973501558,0.00462934067273238,-0.0349334050687112,-0.0167863896316003,2.36717402135441e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,42137,0.0178347135840406,0.00319283119980354,0.0115767644324256,0.0240926627356555,2.3702575540674e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0251799158900151,0.00451021002519585,0.0163399042406312,0.0340199275393989,2.41121682360146e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.030864732107098,0.00553135983708435,-0.0417061973877834,-0.0200232668264127,2.46094091714938e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0295936020055326,0.00531163491190051,-0.0400044064328576,-0.0191827975782076,2.58374780250212e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0214104105347101,0.00385024766634995,-0.028956895960756,-0.0138639251086641,2.73644708888052e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0286654718412171,0.00515573217547977,-0.0387707069051574,-0.0185602367772767,2.76158355353135e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0212712868555263,0.00382750233670278,-0.0287731914354637,-0.0137693822755888,2.80078527736592e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.025438142526631,0.00459069095725095,-0.0344358968028429,-0.0164403882504192,3.05966071065514e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0560761688801377,0.0101250240023786,-0.0759212159247997,-0.0362311218354757,3.12084789327776e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.0249057201299054,0.00450035854224511,-0.0337264228727058,-0.016085017387105,3.18658333550732e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0269634524377369,0.00487370919258434,-0.0365159224552022,-0.0174109824202716,3.22802278375864e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0179308318489327,0.00324178920247198,0.0115769250120876,0.0242847386857778,3.2395705959141e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0431402861011289,0.00780444842919564,-0.0584370050223523,-0.0278435671799054,3.31723191736208e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.0300951994104752,0.00545056101292055,-0.0407782989957995,-0.019412099825151,3.43551862951153e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,39990,0.0300445327959631,0.00544160098003974,0.0193789948750853,0.040710070716841,3.43939955129187e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,42099,-0.0268440922119368,0.00486714002856562,-0.0363836866679254,-0.0173044977559482,3.54441429907026e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0359037773416316,0.00651210410500281,-0.0486675013874371,-0.0231400532958261,3.58576284245044e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.027017399995841,0.00490190170552128,-0.0366251273386627,-0.0174096726530192,3.63342252828406e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,42296,-0.0269583921531976,0.00490087105753611,-0.0365640994259684,-0.0173526848804269,3.84995021986155e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0423198104935497,0.00769800040997385,-0.0574078912970984,-0.0272317296900009,3.92157608248344e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0476362216517167,0.00866402255777846,-0.0646177058649624,-0.0306547374384709,3.92304087911989e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0514966434478846,0.00937217027680932,-0.0698660971904308,-0.0331271897053383,3.98571278656438e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0235864413244655,0.00429366176493656,-0.0320020183837412,-0.0151708642651899,4.01486073703624e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0292223724478741,0.00532003235944115,-0.0396496358723787,-0.0187951090233694,4.04072428626246e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.024364963795676,0.00444183647551334,-0.0330709632876822,-0.0156589643036699,4.21776070864686e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0228460500331584,0.00416711176385278,-0.0310135890903099,-0.014678510976007,4.2696029582564e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0300622689445452,0.00549526608436265,-0.040832990469896,-0.0192915474191944,4.58276857775346e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.0157790714803606,0.00289131848638775,-0.0214460557136806,-0.0101120872470406,4.93305821001606e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0199478548341158,0.00366252064430333,-0.0271263952969503,-0.0127693143712812,5.22928890924262e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0428306739240767,0.0078660452484276,-0.0582481226109948,-0.0274132252371586,5.27101886825626e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,39958,-0.0150612024421502,0.00276725518106964,-0.0204850225970467,-0.00963738228725374,5.35843694535016e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0590372826818914,0.0108532969863779,-0.0803097447751922,-0.0377648205885906,5.45186194471064e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0267148550276574,0.0049264165455947,-0.036370631457023,-0.0170590785982918,5.96888835858284e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0308011389958692,0.00568196044818565,-0.0419377814743131,-0.0196644965174253,6.03293530873764e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0139832329373252,0.00258173590101214,-0.019043435303309,-0.00892303057134143,6.21131167614947e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.0194705781261954,0.00360404960503653,-0.026534515352067,-0.0124066409003239,6.68809084177513e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0339504588151001,0.00628831880007774,-0.0462755636632524,-0.0216253539669477,6.81801014480858e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.0342829769647914,0.00635842270834304,-0.0467454854731438,-0.0218204684564391,7.11783308734153e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0257524841210292,0.00478051116211436,-0.0351222859987734,-0.0163826822432851,7.28427295322291e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0370363409430725,0.00688926608200084,-0.0505393024637942,-0.0235333794223509,7.74316012272995e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0701024216050903,0.0130733743067757,-0.0957262352463708,-0.0444786079638099,8.35509355881932e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0146273908063483,0.00272990530154318,-0.019978005197373,-0.00927677641532371,8.54264104020308e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0226922075829636,0.00423653916291726,-0.0309958243422814,-0.0143885908236458,8.66527934200846e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0187614195153726,0.00350559966657479,-0.0256323948618592,-0.011890444168886,8.87875103106741e-08
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0360253942317504,0.00676074203720837,-0.0492764486246788,-0.022774339838822,1.00923909050169e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,39757,-0.0292576200928805,0.00550137739442781,-0.040040319785959,-0.018474920399802,1.06803585943788e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,41900,0.0124773593065402,0.00234952246383969,0.00787229527741443,0.017082423335666,1.11028141740718e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.00899417138548062,0.00169401002478925,-0.0123144310340675,-0.0056739117368937,1.12059204533248e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0503208521873557,0.00948184004204234,-0.0689052586697587,-0.0317364457049527,1.13500134924926e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0443508596555155,0.00836273539394476,-0.0607418210276473,-0.0279598982833838,1.15865362942362e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.020070995585288,0.00378742721612243,-0.027494352928888,-0.0126476382416881,1.18383025067324e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,42119,-0.0184285206574472,0.00348137039139907,-0.0252520066245894,-0.011605034690305,1.21895935834548e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0649516224026029,0.0122741964426981,-0.0890090474302912,-0.0408941973749147,1.2350578626347e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0240722164705345,0.00455383742711522,-0.0329977378276803,-0.0151466951133887,1.26875783005698e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.0142849846057369,0.00270549152911557,0.00898222120867041,0.0195877480028034,1.31566496376741e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.0177988967410372,0.00337194912868443,0.0111898764488157,0.0244079170332587,1.32258669206745e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRL,Prolactin,42249,-0.0392653469264134,0.00743987998654428,-0.0538475117000402,-0.0246831821527866,1.32828996411932e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,41751,-0.0400595106674858,0.00760691317620466,-0.054969060492847,-0.0251499608421247,1.41473360295542e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0624922229510342,0.0118676836359376,-0.0857528828774719,-0.0392315630245965,1.41785038456489e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0356158218934774,0.00678786009444117,-0.0489200276785821,-0.0223116161083727,1.57396178998019e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0358527090943568,0.00684622183602908,-0.0492713038929738,-0.0224341142957398,1.65776244922633e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.036346840357362,0.00694133836811427,-0.049951863558866,-0.0227418171558581,1.66295609131045e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2,Complement C2,42199,-0.0119697501130608,0.00228594919102979,-0.0164502105274792,-0.00748928969864241,1.66334575099374e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0172886528487322,0.00330954723956167,-0.0237753654382731,-0.0108019402591914,1.77785981024163e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0470953343623492,0.0090233536817306,-0.0647811075785412,-0.0294095611461573,1.82797097353725e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.037704342986578,0.00724098211369139,-0.0518966679294131,-0.0235120180437429,1.94632315332495e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,42185,-0.021896198755762,0.00420549052422717,-0.0301389601832473,-0.0136534373282767,1.95165923278981e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,41839,-0.0251685920767538,0.00483437865305936,-0.0346439742367501,-0.0156932099167575,1.9566556535298e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0168678618107406,0.00324803161227248,-0.0232340037707946,-0.0105017198506865,2.09643447292889e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.0130485167593522,0.00251567587052449,-0.0179792414655802,-0.00811779205312422,2.16917880182049e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,42070,0.0158001854334382,0.00304661957566865,0.00982881106512763,0.0217715598017487,2.17813475883587e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0342094625437518,0.00660103220947533,-0.0471474856743235,-0.0212714394131802,2.22758656317028e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.0128338079851755,0.0024777016950891,0.00797751266280091,0.0176901033075502,2.25365044399099e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0318506421176276,0.0061495585302926,-0.0439037768370011,-0.0197975073982541,2.25941400296859e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,41814,-0.0191461140718536,0.00369736649751173,-0.0263929524069766,-0.0118992757367306,2.27193040030025e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,39657,-0.0224533655775586,0.0043386455301628,-0.0309571108166776,-0.0139496203384395,2.31657430867465e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.00869192600516722,0.00168076152094828,-0.0119862185862258,-0.00539763342410859,2.36266853955306e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0271499351985252,0.00525182609466752,-0.0374435143440735,-0.0168563560529768,2.37989062674777e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,41751,-0.0568058290286542,0.0109948557709588,-0.0783557463397335,-0.0352559117175749,2.41901616153338e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,42217,-0.0243487821308483,0.00472071846134474,-0.0336013903150839,-0.0150961739466126,2.53300902612415e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,42137,-0.0197627014339358,0.00383845435759995,-0.0272860719748317,-0.0122393308930399,2.66104597603253e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0279615224191161,0.00543102292723827,-0.0386063273565031,-0.0173167174817291,2.66303506946469e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.0128527370450543,0.00249658819056567,-0.017746049898563,-0.00795942419154559,2.66754136518848e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OPTC,Opticin,42070,0.0236613290386113,0.00459631538635026,0.0146525508813648,0.0326701071958578,2.67142160577233e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0145339331373678,0.00282655738546141,0.0089938806618634,0.0200739856128721,2.75792204295689e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0264247871738768,0.00514113396679866,-0.0365014097488022,-0.0163481645989514,2.79501403403869e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0361452919718025,0.00703852734728697,-0.049940805572485,-0.0223497783711201,2.8644976263163e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.008046371214545,0.00156724914954319,0.00497456288144035,0.0111181795476496,2.88221273001364e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,39934,-0.0133201356326285,0.00259811941831877,-0.0184124496925333,-0.0082278215727237,2.99509035120367e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0378467877574467,0.00738517371388304,-0.0523217282366574,-0.0233718472782359,3.03082700775124e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.0256260977778105,0.00500073682491723,-0.0354275419546483,-0.0158246536009727,3.0342051900734e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0298425586556308,0.00583132979924423,-0.0412719650621495,-0.0184131522491121,3.13739543088629e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.0235255499693595,0.00459989905380568,-0.0325413521148186,-0.0145097478239004,3.19127866985048e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,42070,-0.0305441796281495,0.00597367394685986,-0.0422525805639949,-0.0188357786923042,3.21208512573459e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0431664192053613,0.00845008951849792,-0.0597285946616173,-0.0266042437491054,3.29338013292176e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,42167,0.0108972010500648,0.00213456367513558,0.00671345624679904,0.0150809458533305,3.35061909088636e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.0114155178766296,0.00224017083830899,-0.0158062527197152,-0.00702478303354395,3.51860866420306e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,42299,-0.0174824065944311,0.00343441705707863,-0.0242138640263052,-0.010750949162557,3.62128737420765e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,41913,-0.0395607934706315,0.00777481379210688,-0.054799428503161,-0.024322158438102,3.66156867839105e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,42296,-0.0300860995121856,0.00591368963187142,-0.0416769311906535,-0.0184952678337176,3.67547765595423e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0153398471849509,0.00302353386287856,-0.0212659735561929,-0.0094137208137089,3.96771251433161e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0240587466061779,0.00474301564061134,-0.0333550572617761,-0.0147624359505797,3.99080182078081e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.014290307526028,0.00282091856476085,0.00876130713909674,0.0198193079129593,4.11905369975654e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.0151675522842482,0.00299884857301866,-0.0210452954873648,-0.00928980908113166,4.29618185282534e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0536955045564517,0.0106169566426106,-0.0745047395759685,-0.0328862695369349,4.30343696146845e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0348952351736856,0.00690755905720188,-0.0484340509258013,-0.0213564194215699,4.43620175714997e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0333140781373244,0.00660080906411885,-0.0462516639029973,-0.0203764923716514,4.54829271747041e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0300744492310326,0.00596686501446986,-0.0417695046593935,-0.0183793938026717,4.72245838536497e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0367787039047749,0.00729983624971759,-0.0510863829542214,-0.0224710248553285,4.76953844218059e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0681945116797753,0.0135450836465751,-0.0947428756270625,-0.041646147732488,4.84952535383295e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.0196573283365318,0.0039124112640774,-0.0273256544141235,-0.0119890022589401,5.11722734047877e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0186324555464623,0.00371060735454104,-0.0259052459613627,-0.0113596651315618,5.20759977568608e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0161004502219881,0.00321110438538232,-0.0223942148173374,-0.00980668562663875,5.39901501673841e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0208530454167369,0.00415878691440753,-0.0290042677689757,-0.0127018230644982,5.40523962457969e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0303591370333225,0.00605553875417512,-0.0422279929915058,-0.0184902810751393,5.42711077894452e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0710528480406807,0.0141750134515091,-0.0988358744056384,-0.0432698216757229,5.44066358540876e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,42310,0.0153902792858961,0.00307106924515206,0.00937098356539809,0.0214095750063941,5.47161643853418e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,42070,-0.0378908691096401,0.00756383043898275,-0.0527159767700463,-0.0230657614492339,5.52683338163295e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.0165579857671327,0.00330892008926758,-0.0230434691420972,-0.0100725023921683,5.68428296858236e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0256784737493169,0.00513596270783258,-0.0357449606566688,-0.0156119868419651,5.81202952312715e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.0196686972664199,0.0039340613935697,-0.0273794575978165,-0.0119579369350233,5.83117845094992e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0281276152498675,0.0056321126835785,-0.0391665561096814,-0.0170886743900536,5.98360731891683e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0215528382949641,0.00431696595250657,-0.030014091561877,-0.0130915850280512,6.04852646663108e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.0626438565275667,0.0125503039882756,-0.087242452344587,-0.0380452607105465,6.06821002260154e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0145966318716213,0.00292531155536413,-0.0203302425201349,-0.00886302122310757,6.13465986723305e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0283054576927639,0.00567329528817116,-0.0394251164575794,-0.0171857989279484,6.1361934867907e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0468003779170987,0.00938718553428601,-0.0651992615642993,-0.0284014942698982,6.25600486167832e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPART,Spartin,39736,-0.0394594142537464,0.00792444384866133,-0.0549913241971226,-0.0239275043103702,6.47191357566833e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,42247,-0.0154291025555334,0.00309951587009882,-0.0215041536609271,-0.00935405145013972,6.50597193995666e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.0166406801373029,0.00334615777472004,-0.0231991493757542,-0.0100822108988516,6.67121826605078e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0462301083114683,0.00930002440151693,-0.0644581561384415,-0.0280020604844951,6.76207704735603e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.0597500933302856,0.0120290489302771,-0.0833270292336286,-0.0361731574269425,6.89615559376873e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0469305970587611,0.00945187837101127,-0.0654562786659431,-0.028404915451579,6.946888345608e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0286955128061577,0.00579113905799617,-0.0400461453598302,-0.0173448802524852,7.33484024761103e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,39929,-0.0691668519245613,0.0139682714023332,-0.0965446638731344,-0.0417890399759883,7.46239888056309e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.0231862814082795,0.00468302709949904,-0.0323650145232976,-0.0140075482932613,7.4664899953948e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0311208347761972,0.00629538315620392,-0.0434597857623569,-0.0187818837900375,7.76684327445031e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPL,Periplakin,39657,-0.0162600778558403,0.00328894611784144,-0.0227064122468096,-0.0098137434648711,7.77165257405665e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.029910161129118,0.00605613404491234,-0.0417801838571462,-0.0180401384010898,7.97150773910674e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,38503,-0.0536750260799762,0.0108784655994984,-0.074996818654993,-0.0323532335049594,8.18476959129109e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0483126080992607,0.00981774680971455,-0.0675553918463013,-0.0290698243522202,8.71505492685104e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0397181286891059,0.0080834904447985,-0.055561769960911,-0.0238744874173009,9.05346347219311e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.0134075261298222,0.00272945360104521,-0.0187572551878708,-0.00805779707177361,9.13317439718529e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0189041482349238,0.00384875186573639,0.0113605945780805,0.0264477018917671,9.13399771973848e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0343021075573684,0.00698888784315273,-0.0480003277299478,-0.0206038873847891,9.30390446261903e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0347142453625895,0.00707521023680424,0.0208468332984532,0.0485816574267259,9.38440540065432e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0446989421975661,0.0091207878418103,-0.0625756863675143,-0.0268221980276179,9.65695290803506e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0439045955259168,0.00896771956722526,-0.0614813258776783,-0.0263278651741553,9.92661961128693e-07
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,42123,-0.0177521884814224,0.00363315441864031,-0.0248731711419574,-0.0106312058208874,1.03997695498562e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,39649,-0.0214765058348736,0.00439624916080065,-0.0300931541900429,-0.0128598574797043,1.04779421075252e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.0521113787719238,0.0106730957862554,-0.0730306465129845,-0.0311921110308631,1.06204546433702e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.0127739549581173,0.00261674732694127,0.00764513019731236,0.0179027797189221,1.06654733289205e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0435328946297302,0.00894838154967843,-0.0610717224670999,-0.0259940667923604,1.16066168240165e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.0179546309188676,0.00369139489185626,0.0107194969308293,0.0251897649069058,1.16392380928278e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0196867582789715,0.00404792616582288,-0.0276206935639843,-0.0117528229939586,1.16697296551535e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEXN,Nexilin,39990,-0.0345770578079985,0.00711035659708011,-0.0485133567382755,-0.0206407588777215,1.1721581585755e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0260801874467511,0.00537508507452934,0.0155450207006736,0.0366153541928286,1.23539896797777e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0197325434706909,0.00406959569523025,-0.0277089510333422,-0.0117561359080397,1.25595497791068e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,42296,-0.0174027513068018,0.0035926638791154,-0.024444372509868,-0.0103611301037357,1.28663339326116e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0478328840690062,0.00989368062613584,-0.0672244980962324,-0.0284412700417799,1.34850779819162e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0292164860107927,0.00604897381622466,-0.041072474690593,-0.0173604973309923,1.38326771472292e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.0108015876505234,0.00223706300529068,0.00641694416015364,0.0151862311408931,1.3938027146884e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0403341901974877,0.00835579514473727,-0.0567115486811727,-0.0239568317138026,1.40053337584189e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0145850071818652,0.00302202119609301,-0.0205081687262075,-0.00866184563752292,1.40948757515135e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.026797918482043,0.00555552993400377,-0.0376867571526904,-0.0159090798113956,1.42849830222826e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.0114387185682627,0.00237392179410369,0.00678583185181946,0.0160916052847059,1.46197660904009e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0186474756818197,0.00387422554612982,-0.0262409577522342,-0.0110539936114053,1.50162559632805e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0280589534277292,0.00582983349565192,-0.039485427079207,-0.0166324797762515,1.50305822780745e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0214143981764722,0.00445089644570733,-0.0301381552100586,-0.0126906411428858,1.51982231597674e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.015272067241549,0.00317744864105624,-0.0214998665780192,-0.00904426790507873,1.5535610657858e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0185324323255704,0.0038648826513512,0.010957262328922,0.0261076023222187,1.64332741037722e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.034279149036987,0.00714986544492484,0.0202654127649343,0.0482928853090397,1.64916115306542e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.0257313598938819,0.00537431605746286,-0.0362650193665091,-0.0151977004212547,1.70776678309073e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.0151437766463127,0.00316423062103339,-0.0213456686635382,-0.00894188462908729,1.72351123068128e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,42296,-0.0296007469450735,0.00618560237843096,-0.0417245276067982,-0.0174769662833488,1.72405384134169e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0189840703577804,0.00396962886457955,-0.0267645429323563,-0.0112035977832045,1.75155740549082e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.0169612983095175,0.00354996355230602,-0.0239192268720373,-0.0100033697469977,1.79449278822785e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0250665565455312,0.00525410197266629,-0.0353645964119571,-0.0147685166791052,1.85339973462865e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0129220580328898,0.00271003790482626,0.00761038373943034,0.0182337323263493,1.87805816104244e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,41997,-0.0386102647535251,0.00809892107800957,-0.0544841500664239,-0.0227363794406263,1.88642641050043e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0563791808295761,0.0118321716746416,-0.0795702373118737,-0.0331881243472785,1.90914489082044e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,41997,0.0220485998329335,0.00463758804900546,0.0129589272568828,0.0311382724089842,2.01182778724652e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0136201666125272,0.00286768507655092,0.00799950386248737,0.019240829362567,2.05977888455133e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0227528508743729,0.00479346029713656,-0.0321480330567606,-0.0133576686919853,2.09350402789894e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.0189191892565161,0.00399242239992141,-0.026744337160362,-0.0110940413526701,2.1762818926108e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,42119,0.0211561549396143,0.00447142345276455,0.0123921649721958,0.0299201449070328,2.25218191503131e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.0343270175343345,0.00726313844448266,-0.0485627688855205,-0.0200912661831485,2.31038022595598e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0256865697679208,0.00543840154868655,-0.0363458368033464,-0.0150273027324952,2.34968386475573e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.00839515743342594,0.00177823024874063,-0.0118804887209576,-0.00490982614589431,2.36952121782471e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0109255189353571,0.00231560381693003,-0.0154641024165399,-0.00638693545417422,2.40270907297999e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0366404780479126,0.00776708812373698,-0.0518639707704371,-0.0214169853253881,2.41262408255237e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0174706798387137,0.00370323225610776,-0.0247290150606849,-0.0102123446167425,2.4149228531732e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,39966,-0.0408304529779368,0.00866509670080968,-0.0578140425115238,-0.0238468634443499,2.48133645205085e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0589098107180771,0.012518285535601,-0.083445650367855,-0.0343739710682992,2.55327715027708e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.030225430765688,0.00642397269884916,-0.0428164172554324,-0.0176344442759437,2.5622323309406e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,42145,0.0224834353678436,0.00479659710455293,0.0130821050429199,0.0318847656927674,2.79432212987681e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0423862440795254,0.00904588480612122,-0.060116178299523,-0.0246563098595278,2.82261783132942e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.0110347153311547,0.00236010358066484,-0.0156605183492578,-0.00640891231305161,2.96581661673403e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0182142810307116,0.00390617226281743,-0.0258703786658337,-0.0105581833955894,3.14703318906221e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,42189,-0.0169914649541946,0.00364551151463459,-0.0241366675228784,-0.00984626238551084,3.17779117833016e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCT,Secretin,39649,-0.0227856270679435,0.00490246924088698,-0.0323944667800819,-0.013176787355805,3.39399387465157e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DMD,Dystrophin,39638,-0.0242854418906558,0.00524005963791909,-0.0345559587809772,-0.0140149250003344,3.61771729924516e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0287041397584304,0.00619412418488455,-0.0408446231608041,-0.0165636563560566,3.62637274364524e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0325073636351902,0.00701492237147887,-0.0462566114832888,-0.0187581157870917,3.62684598327244e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0394671048263928,0.00852918267132813,-0.056184302862196,-0.0227499067905897,3.73973561856604e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,39914,-0.0459008871486499,0.00992252477584249,-0.0653490357093012,-0.0264527385879986,3.77062365876879e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0184851858960387,0.00399856618546409,-0.0263223756195483,-0.010647996172529,3.82488347115164e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLGN,Calmegin,39649,-0.0214969017960256,0.0046508751990027,-0.0306126171860709,-0.0123811864059803,3.8414120572428e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.0314350265594455,0.00680316555139088,-0.0447692310401717,-0.0181008220787194,3.86072612138629e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.0129463956300475,0.00280664768382424,-0.018447425090343,-0.007445366169752,4.00980159736549e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0419838783145738,0.00911817512685663,-0.0598555015632128,-0.0241122550659349,4.18113699533906e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,39636,-0.020990131754043,0.00455896551720841,-0.0299257041677714,-0.0120545593403145,4.18793553860915e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTG,Protogenin,42262,-0.0114480345062539,0.00248711819679716,-0.0163227861719764,-0.00657328284053149,4.20337864371891e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0266057464418344,0.00578627588234203,0.015264645712444,0.0379468471712248,4.30313407911344e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.0202276131735194,0.00439886467496837,-0.0288493879364574,-0.0116058384105814,4.30539691731478e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0229639458842934,0.0049960859965217,-0.0327562744374759,-0.0131716173311109,4.34526451665155e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0152006552886812,0.00331197169291052,0.00870919077057658,0.0216921198067858,4.48045766293288e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.0333896074552466,0.00729512515325274,-0.047688052755622,-0.0190911621548713,4.76014453809109e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,42310,0.0123492348993507,0.00270041456481425,0.00705642235231478,0.0176420474463866,4.8479408388587e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,39966,0.0231399908984576,0.00506067326853743,0.0132210712921243,0.033058910504791,4.87000696919773e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0199914669879831,0.00437299240932661,0.011420401865703,0.0285625321102633,4.893307866009e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,39930,-0.0366533708943824,0.00801818545677138,-0.0523690143896543,-0.0209377273991105,4.89884887892244e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0218595664856831,0.00479053233107366,-0.0312490098545875,-0.0124701231167787,5.0854800793326e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.0185271604350999,0.00406078651247961,-0.0264863019995599,-0.0105680188706399,5.10903449347219e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,42137,-0.0293756424804574,0.00644380094171993,-0.0420054923262285,-0.0167457926346863,5.19111088654573e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0173658659681172,0.00381037953880329,-0.0248342098641717,-0.00989752207206278,5.23171139021733e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.0587549018832155,0.0129198026173064,-0.0840777150131361,-0.0334320887532949,5.47141263314998e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0318845295719914,0.0070115834367792,-0.0456272331080786,-0.0181418260359042,5.47842693218684e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.0282874024922005,0.00622382114373736,0.0160887130504753,0.0404860919339258,5.54008546889394e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.0436262641004547,0.00961037894135549,-0.0624626068255114,-0.0247899213753979,5.68776291675074e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0284180515466532,0.00626500655165467,-0.0406974643878964,-0.0161386387054101,5.79195205093729e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0144087851880028,0.00317787914296859,-0.0206374283082213,-0.00818014206778437,5.83579895721138e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,39586,-0.0296403200669748,0.00654895478412278,-0.0424762714438554,-0.0168043686900942,6.07530865558131e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,42103,-0.0303217835087688,0.00670696056211614,-0.0434674262105164,-0.0171761408070212,6.20885367170675e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0307338923484798,0.00679963562386147,-0.0440611781712483,-0.0174066065257114,6.23954791509554e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0396644479902382,0.00881768917648313,-0.0569471187761451,-0.0223817772043312,6.90779011821556e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0254119901187421,0.00564934635688443,-0.0364847089782356,-0.0143392712592486,6.92078938137725e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0190802442329634,0.00424220311609747,-0.0273949623405144,-0.0107655261254124,6.92525574328653e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0195813331872725,0.00435455388447487,-0.0281162588008433,-0.0110464075737018,6.97084265084179e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0331006112554599,0.00736262674482952,-0.0475313596753257,-0.018669862835594,6.99074654825351e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0360105058044115,0.008014762829187,-0.051719440949618,-0.020301570659205,7.0806536879601e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0164213113175792,0.00365586998033584,-0.0235868164790374,-0.00925580615612095,7.13339756453059e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0383727619785989,0.00854723778130203,-0.0551253480299509,-0.021620175927247,7.20986565336404e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00983658080074604,0.00219142288219046,-0.0141317696498393,-0.00554139195165274,7.23754081091318e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0179964034202755,0.00401075975986394,-0.0258574925496088,-0.0101353142909422,7.29343086127519e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0307221937953122,0.00684832734594765,-0.0441449153933696,-0.0172994721972548,7.328152102085e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0511084698754219,0.0113986452152479,-0.0734498144973078,-0.028767125253536,7.39532660700198e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0339482468890903,0.0075754426382864,-0.0487961144601316,-0.0191003793180489,7.4909309458473e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0174289322289846,0.0038913222132559,0.009801940691003,0.0250559237669661,7.56435060352406e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,42113,-0.0108548104902087,0.00242864897199577,-0.0156149624753204,-0.00609465850509701,7.90458676507282e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.0253812680145557,0.00568072844211688,-0.0365154957611048,-0.0142470402680066,7.97591333835764e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0292735581925694,0.00656465688106794,-0.0421402856794625,-0.0164068307056762,8.30317085675124e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0249868447418625,0.00560411105277615,-0.0359709024053037,-0.0140027870784213,8.3133592833949e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0270939046498625,0.00607916829946163,-0.0390090745168074,-0.0151787347829177,8.38369950449807e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0336610220704637,0.00755550062345386,-0.0484698032924333,-0.0188522408484941,8.46454510733186e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7,Complement component C7,39722,-0.0150908640695418,0.00338859975341999,-0.021732519586245,-0.00844920855283867,8.53367667799138e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0449878115933126,0.0101038884324679,-0.0647914329209497,-0.0251841902656756,8.5551754570535e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.011558298619306,0.00260081426610399,-0.0166558945808698,-0.00646070265774217,8.89661325481334e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0268570017580764,0.0060516009315505,-0.0387181395839154,-0.0149958639322375,9.15169909681591e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0203227929109214,0.00457991402410604,-0.0292994243981693,-0.0113461614236736,9.17980805385638e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.0225881435706086,0.00509147902457431,-0.0325674424587742,-0.012608844682443,9.21882674555168e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.0137215937119318,0.00309596789958365,-0.0197896907951157,-0.00765349662874782,9.40543139210094e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0409815098958039,0.00925476406449006,-0.0591208474622044,-0.0228421723294033,9.57898837888886e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.0104980579942307,0.00237093621142121,0.00585102301984511,0.0151450929686163,9.59373770117846e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPARC,SPARC,42181,-0.031306444038174,0.00707238261783339,-0.0451683139691274,-0.0174445741072205,9.64870426614118e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.0131600898239664,0.00297614489599525,-0.0189933338201171,-0.00732684582781574,9.87833581033785e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,42016,-0.019247833091619,0.00435445957418043,-0.0277825738570127,-0.0107130923262254,9.93574015562673e-06
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,39929,-0.0379461100996742,0.00860519185857444,-0.0548122861424801,-0.0210799340568683,1.0447964109145e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0307514006860695,0.00698780296429444,-0.0444474944960867,-0.0170553068760524,1.08891831615371e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0463068646491315,0.0105262322448778,-0.0669382798490921,-0.0256754494491709,1.09490807546078e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0224545932252048,0.00512321662471943,0.0124130886407547,0.0324960978096549,1.18159490897399e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0183424997102789,0.00418730479225918,-0.0265496171031069,-0.0101353823174509,1.19316015211724e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,39990,-0.00970030851455933,0.00221955587349823,-0.0140506380266159,-0.0053499790025028,1.25127877053289e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.0209579179929377,0.00479606819175713,-0.0303582116487817,-0.0115576243370937,1.25303350464355e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,42181,-0.0135692769546533,0.00310627036648084,-0.0196575668729557,-0.00748098703635082,1.26116678921319e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0291627941774192,0.00668112711710164,-0.0422578033269384,-0.0160677850279,1.28314850072849e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0220937824388274,0.00506671094905355,-0.0320245358989724,-0.0121630289786825,1.30671773542911e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,39726,0.00931957018065791,0.00213758609188188,0.00512990144056943,0.0135092389207464,1.3131702589412e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0442147119268965,0.0101459767085066,-0.0641008262755695,-0.0243285975782236,1.32499549368556e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0357753191976854,0.00821195287469279,-0.0518707468320833,-0.0196798915632875,1.33151832535115e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0290049727849276,0.00666675755247147,-0.0420718175877716,-0.0159381279820835,1.36722505177601e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.028025669987556,0.0064413130808246,0.0154006963491398,0.0406506436259722,1.36790085031695e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.0177929545830737,0.00409068483087355,-0.0258106968515858,-0.00977521231456152,1.37558825201747e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,39713,0.0128226321846756,0.00295027207959938,0.00704009890866081,0.0186051654606904,1.3971336893913e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0208347432064783,0.00479518705542759,-0.0302333098351163,-0.0114361765778402,1.40565709353366e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0193117206960363,0.004452674957691,-0.0280389636131107,-0.010584477778962,1.45420807783305e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TF,Serotransferrin,39979,-0.00945202489783662,0.00217997191784183,-0.0137247698568066,-0.00517927993886663,1.46449038092678e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,39575,-0.0257990612932068,0.00596022807689679,-0.0374811083239245,-0.0141170142624891,1.51434299972869e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI3,Elafin,41966,-0.024601906287612,0.00568512308050537,-0.0357447475254025,-0.0134590650498214,1.51963470074313e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0161622410320099,0.00373525344352702,-0.0234833377813228,-0.00884114428269691,1.52299533479188e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.0343736725503936,0.00794756808699664,0.0187964390998802,0.049950906000907,1.53582937026596e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0235242418871543,0.00544171963869613,-0.0341900123789987,-0.0128584713953099,1.55273735530242e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0179219565805911,0.00415159425170888,-0.0260590813139405,-0.00978483184724166,1.59374738664702e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0133052047388859,0.00308414555197439,-0.0193501300207557,-0.00726027945701608,1.61418636817084e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.028601201993099,0.00663161707024282,-0.0415991714507749,-0.0156032325354231,1.62552607715298e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.0311973461596918,0.00723771908649344,0.0170114167501646,0.0453832755692189,1.6434843994687e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,39930,-0.0148689740125585,0.00345095597838598,-0.021632847730195,-0.00810510029492196,1.65636819885552e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.0331775481702563,0.00771084167347497,-0.0482907978502672,-0.0180642984902453,1.70178524266276e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0182703733246309,0.00424916724346526,-0.0265987411218228,-0.00994200552743894,1.72176558162004e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0292921402650874,0.00681303397348245,-0.042645686853113,-0.0159385936770618,1.7269538840453e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,39657,-0.0251771279838824,0.00585958259385779,-0.0366619098678436,-0.0136923460999211,1.7480737653037e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAT,Catalase,39827,-0.0228681155568772,0.00532935835360544,-0.0333136579299438,-0.0124225731838105,1.79385252587736e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.0101044152362735,0.00235799528945639,-0.014726086003608,-0.00548274446893898,1.8384513567679e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.129754422962314,0.0302959319901344,-0.189134449662977,-0.0703743962616503,1.8574726913461e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0241462192006254,0.00564052664143734,-0.0352016514178426,-0.0130907869834082,1.87466810788397e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,39575,-0.0170964569105201,0.00399448860231272,-0.024925654571053,-0.00926725924998712,1.88470235108346e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0159814910540238,0.00373658290632955,-0.0233051935504297,-0.00865778855761786,1.90953350231262e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,39850,-0.0428633099653439,0.0100417035586327,-0.0625450489402641,-0.0231815709904237,1.98378441841336e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0202372902918796,0.00474162562396674,0.0109437040689047,0.0295308765148544,1.9888379721328e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.03025862071178,0.00710172040098181,-0.0441779926977044,-0.0163392487258557,2.05143460437149e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0284567637512849,0.00670024278584687,-0.0415892396115448,-0.015324287891025,2.17980002520933e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0201794573678179,0.00475461753571754,-0.0294985077378243,-0.0108604069978115,2.20869425722276e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,42137,-0.032578932778386,0.00768598317922077,-0.0476434598096587,-0.0175144057471133,2.26261452330214e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.016591286569352,0.00391426350752989,-0.0242632430441106,-0.00891933009459345,2.26336314518829e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.0138972134673402,0.00327880510532454,0.00747075546090411,0.0203236714737763,2.26832537831416e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.0106053224193671,0.00250346897279527,0.00569852323268839,0.0155121216060458,2.28781258581103e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,41900,-0.0190988779894707,0.00451238785827443,-0.0279431581916886,-0.0102545977872528,2.32613524059514e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.0134194803393888,0.00317074485547137,0.00720482042266493,0.0196341402561127,2.3321557136215e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.024155568760156,0.00571034076034815,-0.0353478366504384,-0.0129633008698736,2.35397290361729e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0290994396368953,0.00688571149679636,-0.0425954341706162,-0.0156034451031744,2.39374705646175e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0241220834676603,0.0057139007662002,-0.0353213289694127,-0.0129228379659079,2.444752101121e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,42148,-0.0403273065410119,0.00955518889478637,-0.0590554767747932,-0.0215991363072306,2.45391112124273e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,39929,-0.016359399676149,0.00388040094703538,-0.0239649855323384,-0.00875381381995969,2.50710268674022e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0269544771831355,0.00640182864136129,-0.0395020613202036,-0.0144068930460673,2.56901378750792e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,41638,-0.0100527609527598,0.00239221061777855,-0.0147414937636058,-0.00536402814191386,2.65988974558308e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.014559611675787,0.00347126449052176,-0.0213632900772096,-0.00775593327436434,2.7543201517755e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0243173939450895,0.00579798732357929,-0.035681449099305,-0.0129533387908741,2.76087766723564e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGMN,Legumain,42185,-0.0154017850027036,0.00367393365370751,-0.0226026949639703,-0.00820087504143691,2.78038361122521e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,42070,-0.0138191425279152,0.00331614013894359,-0.0203187772002447,-0.00731950785558579,3.1023855207573e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0162672907784444,0.00390605191597431,0.00861142902313476,0.0239231525337541,3.13760637368943e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0332363973951573,0.00798008945580626,-0.0488773727285375,-0.017595422061777,3.13775218092756e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,42016,0.0176081335417209,0.00423075791494287,0.00931584802843287,0.0259004190550089,3.17532662528982e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0440127168945993,0.0105758559580633,-0.0647413945724033,-0.0232840392167953,3.18375020279227e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.011306782240815,0.0027183135941928,-0.0166346768854329,-0.00597888759619713,3.20938081712673e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0447163463278252,0.010770377463502,-0.065826286156289,-0.0236064064993613,3.32337559193817e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,39908,-0.0361808599635133,0.00872230425156166,-0.0532765762965742,-0.0190851436304525,3.37718911406657e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0319224042449551,0.00769869541989133,-0.0470118472679421,-0.0168329612219681,3.40101385680934e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,39586,-0.0176936082521036,0.00426769876625756,-0.0260582978339685,-0.00932891867023882,3.40969423869257e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0174054200652143,0.00420211799923768,-0.0256415713437201,-0.00916926878670843,3.46272347115069e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0256185616095451,0.00619123999003279,0.0134837312290808,0.0377533919900094,3.53061536826312e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,42016,0.0139412914714832,0.0033763368181771,0.00732367130785613,0.0205589116351103,3.66362500324242e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.0150114817816139,0.0036423392290945,-0.0221504666706391,-0.00787249689258866,3.79329635362474e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0426666844275182,0.010366230486388,-0.0629844961808388,-0.0223488726741977,3.88441884365888e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.0110434596487623,0.0026885102426929,0.00577397957308418,0.0163129397244403,4.02499682431139e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.0118936537396909,0.00289680291426757,-0.0175713874516553,-0.00621592002772647,4.05754475899766e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0378430215627172,0.00922177974675082,-0.0559177098663488,-0.0197683332590856,4.09518235594637e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),39775,0.076032657034815,0.0185575320064502,0.0396598943021726,0.112405419767457,4.21252859922953e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.017654504955556,0.00430959383994157,-0.0261013088818415,-0.00920770102927054,4.2181886763242e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.0106429548577816,0.00259872683097036,-0.0157364594464835,-0.00554945026907973,4.23798602783602e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0151421808017678,0.00369865185263848,-0.0223915384329392,-0.00789282317059637,4.26528315089849e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,39990,0.0205850281494258,0.00503603232304099,0.0107144047962655,0.0304556515025862,4.38946838716372e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0218388887823176,0.00534683099873103,-0.0323186775398304,-0.0113591000248048,4.44924549849552e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,42185,0.0275095401020743,0.00673770336442924,0.014303641507793,0.0407154386963556,4.47270025180604e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.0368710913420574,0.00903264406194381,-0.0545750737034672,-0.0191671089806475,4.49673119663129e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.0171968699965033,0.00421336823089791,-0.0254550717290632,-0.00893866826394342,4.50602156718385e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.0165451079808549,0.00405642436681337,-0.0244956997398091,-0.00859451622190065,4.55944619415453e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0348469041432513,0.0085448597148039,-0.051594829184267,-0.0180989791022357,4.56671058760871e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,39934,-0.0251388513987943,0.00618221409289606,-0.0372559910208706,-0.013021711776718,4.80846066741328e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0173702200582509,0.0042743531333136,0.00899248791695629,0.0257479521995456,4.86008370973717e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0274898450993473,0.006769514637868,-0.0407580937895686,-0.014221596409126,4.92276078449132e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.0472097582225541,0.0116509298540369,-0.0700455807364663,-0.0243739357086418,5.11168966477987e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0458308606130386,0.0113149933451538,-0.0680082475695401,-0.0236534736565371,5.14084559899831e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGN,Biglycan,41820,0.0483890177899245,0.0119547149975318,0.0249577763947622,0.0718202591850869,5.20194653008101e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0219283011846613,0.00542846683104336,-0.0325680961735063,-0.0112885061958163,5.38577667894937e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.0123085771251362,0.00304922982456662,-0.0182850675812867,-0.00633208666898559,5.45283180914853e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0213501886396913,0.00529059341062233,-0.0317197517245111,-0.0109806255548715,5.47924100346954e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0217818580886837,0.0054003356921651,-0.0323665160453273,-0.0111972001320401,5.53298553409583e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0291985922935505,0.00723913636374484,-0.0433872995664903,-0.0150098850206106,5.53332975894554e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0373098864011546,0.00925152734448888,-0.0554428799963528,-0.0191768928059564,5.54787005076543e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,42016,0.00495829917069143,0.0012307018882724,0.00254612346967753,0.00737047487170534,5.63621185529676e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0297870192514928,0.00739711375321468,-0.0442853622077935,-0.015288676295192,5.68464643250582e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.0162382731635211,0.00403697455061967,-0.0241507432827356,-0.00832580304430653,5.79910897170289e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0363912939354044,0.00905278251037686,-0.0541347476557431,-0.0186478402150658,5.85389411989889e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.0268371954201614,0.00668995700273257,-0.0399495111455173,-0.0137248796948056,6.0642456443208e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0201598299531543,0.00503390284100339,-0.0300262795215209,-0.0102933803847876,6.24733730223033e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0300936612878145,0.00751749599552697,-0.0448279534390474,-0.0153593691365817,6.29093131483043e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,41843,-0.0218294519587173,0.00545385389058795,-0.0325190055842697,-0.0111398983331649,6.29985144279719e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.0440445558529313,0.0110064240264769,-0.065617146944826,-0.0224719647610365,6.32860596764233e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.019396926971309,0.00485472801428846,-0.0289121938793143,-0.00988166006330359,6.4913209748487e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,39649,-0.027883136848764,0.00697974148806504,-0.0415634301653714,-0.0142028435321565,6.51504321255171e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0272224514219501,0.00682864229115259,-0.0406065903126092,-0.013838312531291,6.74836609256274e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.0138755636098241,0.00348390262177218,0.00704711447115061,0.0207040127484975,6.84731623778743e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,39657,-0.0177388924470043,0.00445523332073817,-0.0264711497556511,-0.0090066351383575,6.8895127300507e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,42062,-0.0129281933986745,0.00326320190150266,-0.0193240691256197,-0.00653231767172932,7.47664793626688e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0325707886404785,0.00823795080098105,-0.0487171722104013,-0.0164244050705556,7.74155380235014e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0367006344810603,0.00928946421330555,-0.0549079843391392,-0.0184932846229814,7.83015625755441e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.0141596559783601,0.00358526202421659,-0.0211867695458246,-0.00713254241089557,7.88201636067099e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0397847862175546,0.0100744321070278,-0.0595306731473291,-0.0200388992877801,7.89254965921319e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0437642397601284,0.0110947783386954,-0.0655100053039715,-0.0220184742162854,8.04302124189093e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0349463610911249,0.00886328691966345,-0.0523184034536652,-0.0175743187285845,8.10214778580776e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAX,Protein max,41839,-0.0422996422261458,0.010742378282796,-0.0633547036604259,-0.0212445807918657,8.2707650139075e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.022549601084714,0.00572673208325022,-0.0337739959678844,-0.0113252062015435,8.28080747927571e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0244621086766403,0.00621589350397629,-0.0366452599444338,-0.0122789574088467,8.34726115318412e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0196882840960637,0.00500311882753458,0.0098821711940959,0.0294943969980314,8.36329223091326e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.043239869159659,0.0109972248421688,-0.0647944298503098,-0.0216853084690083,8.47104730100317e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0149646953579703,0.00380905508153864,-0.022430443317786,-0.00749894739815455,8.59062303547992e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,39930,-0.0412889680829601,0.0105354388197544,-0.0619384281696788,-0.0206395079962414,8.94194698883853e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0241487005920293,0.00616223803538747,-0.0362266871413887,-0.0120707140426699,8.94291399564549e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB1,Calbindin,42070,-0.0179595203207003,0.00458473426330127,-0.0269455994767708,-0.00897344116462983,9.00094008151627e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.025136941151381,0.0064247680691548,-0.0377294865669244,-0.0125443957358376,9.18944901784616e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.0144630929110353,0.00369932792342646,-0.0217137756409512,-0.00721241018111944,9.29680196074449e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0194582401771567,0.00498098006850585,-0.0292209611114282,-0.00969551924288527,9.41857560340805e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.0437595137133321,0.0112091641744579,-0.0657294754952695,-0.0217895519313946,9.51115646832264e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0199715626658623,0.00512042351422407,-0.0300075927537415,-0.00993553257798313,9.65086203110984e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0360730154533056,0.0092486327989752,-0.054200335739297,-0.0179456951673142,9.65094898028905e-05
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0223097143029721,0.00573633351520186,-0.0335529279927677,-0.0110665006131764,0.000101069117306726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.0202211977292728,0.00520067571533836,-0.030414522131336,-0.0100278733272096,0.000101486857108405
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.0103294104140254,0.00266057802994919,0.005114677475325,0.0155441433527258,0.000104034923074468
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.0107978246266168,0.00278906300347068,-0.0162643881134193,-0.00533126113981427,0.000108780341386561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0188990895871426,0.00488418310501167,-0.0284720884729654,-0.0093260907013197,0.000109693396393638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.0142565664106258,0.00368582119394058,-0.0214807759507493,-0.00703235687050223,0.00011038530153325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.0241213246866149,0.00623748708053078,0.0118958500087745,0.0363467993644552,0.000110728638413535
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0261579959606523,0.00677017272040601,-0.039427534492648,-0.0128884574286565,0.000112198940849434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0240834589311566,0.00623459262705101,-0.0363032604801766,-0.0118636573821367,0.000112699707739897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.014209217421542,0.0036828537641852,-0.021427610799345,-0.00699082404373902,0.000114751647283732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,42262,-0.0109744984103865,0.00284524293937859,-0.0165511745715685,-0.00539782224920444,0.000115248391276625
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,41654,0.0123103530254954,0.00319343683873714,0.00605121682157063,0.0185694892294202,0.000116335934451038
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0388921370653303,0.0100914422049893,-0.0586713637871094,-0.0191129103435512,0.000116878443633068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0280170938881624,0.00727227210837683,-0.042270747220581,-0.0137634405557438,0.000117411564680143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,41839,-0.0285757487716603,0.00742704009164511,-0.0431327473512847,-0.0140187501920359,0.000119875300171941
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,39930,-0.0171339363022355,0.00445839999770204,-0.0258724002977315,-0.00839547230673951,0.000122169110575106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0244080181405426,0.00635692973057157,-0.0368676004124629,-0.0119484358686223,0.000123926616040187
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0325191959785741,0.00847170372428141,-0.0491237352781657,-0.0159146566789826,0.00012443940861025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.0186542303191696,0.0048651862680954,-0.0281899954046366,-0.00911846523370262,0.000126641559638519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0291722129000476,0.00761945859288335,-0.044106351742099,-0.0142380740579962,0.000129541976627215
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.0254827384611897,0.00665845826297705,0.0124321602657546,0.0385333166566247,0.000130231862236567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0227514008410749,0.0059502059966632,-0.0344138045945348,-0.0110889970876151,0.00013210264436793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0154642484978517,0.00405103635754709,-0.023404279758644,-0.00752421723705939,0.000135491117234232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,42137,-0.0343571434089692,0.00902586131604855,-0.0520478315884244,-0.0166664552295141,0.00014155568181487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0288102212705852,0.00757681859504261,-0.0436607857168688,-0.0139596568243017,0.0001440548708722
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0322233813770268,0.00847781095628657,-0.0488398908513485,-0.0156068719027051,0.000144952733525737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0126144467666156,0.00332106655328191,-0.0191237372110481,-0.00610515632218304,0.000146324957197536
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.0152470658820228,0.00402195581889425,-0.0231300992870555,-0.00736403247699002,0.00015072321324904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.0148859513056098,0.00392767128979548,-0.022584187033609,-0.00718771557761069,0.000151441242237878
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,39886,-0.0110088147997801,0.00290482434195178,-0.0167022705100056,-0.00531535908955466,0.000151529378800537
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.032078937716282,0.00846761508452562,-0.0486754632819522,-0.0154824121506118,0.00015225706661863
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.0289208677417152,0.00764324133800595,-0.0439016207642069,-0.0139401147192236,0.00015510379228087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.010510997338047,0.00277796769705843,-0.0159558140242815,-0.00506618065181247,0.000155309201774172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,42200,0.0153384442031717,0.00405449621609987,0.00739163161961594,0.0232852567867274,0.000155569554007422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0319525151407505,0.00846664616654243,-0.0485471416271737,-0.0153578886543274,0.000161380433949787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0433978786903497,0.0115072259395926,-0.0659520415319512,-0.0208437158487481,0.000163048651348459
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0241405353858634,0.00641212219602595,-0.0367082948900743,-0.0115727758816526,0.000167384519467646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2,Brorin,41973,-0.0155384100712779,0.00413365127103278,-0.0236403665625021,-0.00743645358005363,0.000171317273849093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0352544035330599,0.00938388156876957,-0.0536468114078483,-0.0168619956582716,0.000172758437850378
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,42286,0.0166757616217607,0.00444820281989986,0.00795728409475702,0.0253942391487645,0.000178359816421327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.0112510582428498,0.00300482574356644,0.00536159978545954,0.01714051670024,0.000181622797197942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0330009287903767,0.00881912068953676,-0.0502864053418688,-0.0157154522388847,0.000183481080677806
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.0216796894303205,0.00579858422528342,-0.033044914511876,-0.010314464348765,0.000185668036979795
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,42087,-0.0250271380347876,0.00669978032165487,-0.0381587074652311,-0.011895568604344,0.000188102453313176
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0187801768418525,0.00503025480823695,-0.028639476265997,-0.00892087741770813,0.000189651276555117
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,39929,0.0341815112391758,0.00916705945355756,0.0162140747102029,0.0521489477681486,0.000193383301492019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0332718872991358,0.00894382862524457,-0.0508017914046152,-0.0157419831936565,0.000200135812652615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,42181,-0.023073623178507,0.00620347730525545,-0.0352324386968077,-0.0109148076602063,0.00020044824166145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRNN,Cornulin,41749,0.025332900582966,0.00681614040858249,0.0119732653821443,0.0386925357837877,0.000202755188993751
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0162023409468514,0.00436045914466096,-0.0247488408703868,-0.00765584102331587,0.000203442030449296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,41900,-0.0175772338072354,0.00473069308293207,-0.0268493922497823,-0.00830507536468856,0.000203574334458051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,42310,-0.0330441526820805,0.00890175566433249,-0.0504915937841722,-0.0155967115799889,0.000206365465211668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.01787935621064,0.00482047779230091,-0.0273274926835498,-0.00843121973773017,0.000209038557064144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.0469059459977492,0.0126555082067797,-0.0717107420830375,-0.022101149912461,0.000211288464983153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,41890,-0.0211477681689029,0.00571122165523064,-0.0323417626131549,-0.00995377372465082,0.0002140577899671
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.0106935810582659,0.0028891533755119,0.00503084044226262,0.0163563216742693,0.000215360779454032
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0122718577611905,0.00331765086233948,-0.0187744534513759,-0.0057692620710051,0.000217341743631505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.012345016467657,0.0033415071470997,-0.0188943704759724,-0.00579566245934163,0.000221431715718853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0296498701702428,0.00802759369376834,-0.0453839538100288,-0.0139157865304568,0.000222261254407786
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.0128693489840854,0.00348838087330406,-0.0197065754957613,-0.00603212247240942,0.00022584876355082
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.00801219423037622,0.00217191536340238,-0.0122691483426449,-0.00375524011810756,0.000226023999022691
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.0117850193613798,0.0032087427069604,0.00549588365573744,0.0180741550670222,0.000241054812654744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.0163784724406951,0.00446208026807674,-0.0251241497661255,-0.00763279511526464,0.00024310170222935
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0318776630320138,0.00868796069866263,-0.0489060660013925,-0.014849260062635,0.000244448570547375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,39919,-0.0319341850028981,0.0087105832798894,-0.0490069282314813,-0.0148614417743149,0.00024736982665441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0283773814826051,0.00774997681831871,-0.0435673360465098,-0.0131874269187005,0.000251815918660883
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0207395554800464,0.00568353416034451,-0.0318792824343217,-0.00959982852577118,0.000264424501972489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.018100875619381,0.00496574543519784,-0.0278337366723688,-0.00836801456639326,0.000268261496000164
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,39897,-0.0343466068487046,0.0094285831253289,-0.0528266297743492,-0.0158665839230599,0.000270877527655962
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0285654831030587,0.00784696461437201,-0.0439455337472279,-0.0131854324588896,0.000273506091607533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.0171107525160635,0.00470216665450508,-0.0263269991588935,-0.00789450587323354,0.000275053259157937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0242926813886984,0.00667827917334864,-0.0373821085684617,-0.0112032542089351,0.000276248627208592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,42119,-0.0251477974137511,0.00691421320231562,-0.0386996552902898,-0.0115959395372125,0.000276732732997128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.0177913864841868,0.00490650731648342,0.00817463214387935,0.0274081408244944,0.000288814599860063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0310446061305502,0.00856451370826179,-0.0478310529987433,-0.0142581592623571,0.000290480127779229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.0152399804276211,0.00420630656232119,-0.0234843412897706,-0.00699561956547152,0.000292152885542596
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.0134485962545776,0.00371654708864837,-0.0207330285483284,-0.00616416396082682,0.000297565501571934
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,42216,-0.0214007366513374,0.00592280236298471,-0.0330094292827874,-0.00979204401988738,0.000303438321835252
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0195012269094838,0.00540021381425081,-0.0300856459854154,-0.00891680783355223,0.000305915411996566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00299567466738492,0.00082994051425307,0.0013689912594489,0.00462235807532093,0.000308120671903817
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0173803771671627,0.00481741644445173,-0.0268225133982881,-0.00793824093603729,0.000310129252203405
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.0101315630915741,0.00280865437808291,-0.0156365256726166,-0.00462660051053158,0.000310772185468051
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.0213130714101388,0.00591178078074991,-0.0329001617404086,-0.00972598107986894,0.00031326834985424
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,42124,0.021019653302392,0.00583142336193602,0.00959006351299738,0.0324492430917866,0.000313818840443685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0164623963671624,0.00457546702427584,-0.025430311734743,-0.00749448099958174,0.00032207778496993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGN,Cingulin,39649,-0.0137142949193618,0.00381225786383669,-0.0211863203324817,-0.0062422695062419,0.000322792283492705
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.0143721513015085,0.00400130217920228,-0.022214703572745,-0.00652959903027208,0.000329741188334153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0265273210070986,0.00739611624031196,-0.04102370883811,-0.0120309331760872,0.00033635353500533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.00776804901033531,0.00216602868470866,0.00352263278830635,0.0120134652323643,0.000336827667728338
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.027122397688014,0.00758116290785507,-0.0419814769874099,-0.0122633183886181,0.000348227563527703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.0106540900263727,0.00297884206332188,-0.0164926204704836,-0.0048155595822618,0.000349323709568415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0299181666013041,0.00836744153140166,-0.0463183520028513,-0.0135179811997568,0.000350717682823207
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.0307723840050534,0.00862402213727909,-0.0476754673941204,-0.0138693006159864,0.000360903314663031
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.0310300011240124,0.00869827690212201,-0.0480786238521715,-0.0139813783958533,0.000362102626781988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,39657,-0.00968307638085217,0.00272723101943571,-0.0150284491789462,-0.00433770358275818,0.00038607485617552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.0179724001016944,0.00506965768639423,-0.027908929167027,-0.00803587103636166,0.000393830850802324
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0141080266545694,0.00398039106498359,-0.0219095931419372,-0.00630646016720153,0.000394860443620839
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.0126916886893605,0.00358249687948233,-0.0197133825731459,-0.00566999480557513,0.000397401494871549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.0156096187128142,0.00440741580305257,-0.0242481536867972,-0.00697108373883115,0.000399197632425754
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,41839,-0.0219957899573416,0.00621226708562017,-0.0341718334451572,-0.0098197464695261,0.000400433496332612
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0143274474537715,0.00404643636382894,-0.0222584627268762,-0.00639643218066679,0.00040058382908332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,39657,-0.0177064403840843,0.00500195673360326,-0.0275102755819467,-0.00790260518622194,0.000401919184391577
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0317176128446671,0.00896371760109469,-0.0492864993428127,-0.0141487263465216,0.000404104038747756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.0105474202225958,0.00298448094286022,-0.0163970028706018,-0.00469783757458972,0.000410813905557773
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.0235445266471682,0.00666513333307675,-0.0366081879799986,-0.0104808653143377,0.00041334299212828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.00819691951577495,0.00232107871112143,-0.0127462337895729,-0.00364760524197695,0.00041483193067573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,42070,0.00541255421564292,0.00153357619585438,0.00240674487176834,0.00841836355951751,0.000417943064556463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.0156079645434596,0.00443344028994817,-0.024297507511758,-0.00691842157516119,0.000432456853170326
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0314353245420093,0.0089402847449403,-0.0489582826420923,-0.0139123664419263,0.000439578516834858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0129542073729562,0.00369063078680932,-0.0201878437151025,-0.00572057103080997,0.000449850296469888
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.00965822708895288,0.0027518522565657,0.00426459666608411,0.0150518575118217,0.000450040801916299
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.0143583240785755,0.00409657087661345,-0.0223876029967378,-0.00632904516041309,0.000458437444104507
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0168051897559915,0.00479814188977597,-0.0262095478599524,-0.00740083165203062,0.000462538836260898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0229149790038078,0.00654342001352023,-0.0357400822303075,-0.0100898757773082,0.000463573263505999
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.0159839577449779,0.00458279448389609,-0.0249662349334142,-0.00700168055654156,0.00048882683847881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.0144752730544663,0.00415053207310845,-0.0226103159177589,-0.00634023019117377,0.0004889851455618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.0240295739794673,0.00690100432330584,-0.0375555424531467,-0.0105036055057878,0.000499178141225555
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,41843,-0.0199827778855538,0.00577830476094148,-0.0313082552169991,-0.00865730055410848,0.00054542141898506
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.024318809110581,0.00703241200979268,-0.0381023366497747,-0.0105352815713874,0.000545991286060199
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.00777008636240178,0.00225001395472438,-0.0121801137136616,-0.00336005901114199,0.000555364643100116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,42113,-0.010278101723353,0.00297790569703061,-0.016114796889533,-0.00444140655717303,0.000559281978975779
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,42210,-0.0147594761816845,0.00427673211769162,-0.0231418711323601,-0.00637708123100891,0.000559979024512043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.0184935447457898,0.00536189165194205,0.00798423710798343,0.0290028523835963,0.000564232015192023
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0226062325649149,0.00655848063073853,-0.0354608546011624,-0.00975161052866734,0.000569230282820815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.0101493442036319,0.00294868930945645,-0.0159287752501665,-0.00436991315709726,0.000579580021471897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.0109102057751079,0.00317162953231269,-0.0171265996584407,-0.00469381189177499,0.000583997880198903
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.034480494732981,0.0100326452831708,-0.0541444794879959,-0.0148165099779662,0.000590673524831381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,41992,0.0114535593927974,0.00333423188887538,0.00491846489060169,0.0179886538949932,0.000594039471874174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0165905575486993,0.00484049105999954,-0.0260779200262984,-0.00710319507110016,0.000611432375052622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.0119994772677166,0.00350800083291841,0.00512379563519652,0.0188751589002367,0.000627076559713441
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0314870536331665,0.00921679545706598,-0.0495519727290158,-0.0134221345373171,0.000637139207157541
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.00984148263117483,0.00288165657003526,0.00419343575390571,0.0154895295084439,0.000639586476185335
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.0120439634243369,0.00352788100683278,0.00512931665094467,0.0189586101977292,0.000642629301064253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,41910,-0.0254023380959751,0.00744182866566353,-0.0399883222806756,-0.0108163539112745,0.000643361660375532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,39638,-0.0103553279603643,0.00303515953393007,-0.0163042406468672,-0.00440641527386134,0.000647692322700914
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,42116,-0.0139556792951076,0.00410491856375233,-0.0220013196800621,-0.00591003891015301,0.000676435089543446
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,39934,-0.0266591399907795,0.00784198073100351,-0.0420294222235464,-0.0112888577580126,0.000677315594025932
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,41913,-0.0175443529658959,0.00517355612918475,-0.027684522979098,-0.00740418295269375,0.000697999682269157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,41839,-0.0155664160572542,0.00460367448416144,-0.0245896180462106,-0.00654321406829778,0.000723517085164419
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0202724136340166,0.00600240465425761,-0.0320371267563615,-0.00850770051167166,0.000734335723330946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.0134731592064527,0.00399419866568941,0.00564452982170141,0.0213017885912039,0.000745166002872768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.0212157717250946,0.00630506031893509,-0.0335736899502074,-0.00885785349998186,0.000767895419345655
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0409699843558245,0.0122074668761171,-0.0648966194330141,-0.0170433492786349,0.000793025097179166
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0420287186730107,0.0125273640846785,-0.0665823522789806,-0.0174750850670408,0.000796454815315303
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,42020,-0.023804866644049,0.00710588459354857,-0.0377324004474042,-0.00987733284069376,0.000810279774857828
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0378097865932739,0.011288699813753,-0.0599356382282298,-0.0156839349583179,0.0008122806042237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSPN,Persephin,42119,-0.0292827925958385,0.00874785711103026,-0.0464285925334578,-0.0121369926582192,0.000817886733083824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0142375570602083,0.00426248697953663,0.00588308258031652,0.0225920315401001,0.00083993308716893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0388175343764626,0.0116510540525835,0.0159814684333989,0.0616536003195264,0.000866000610649431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,39575,-0.0257170473087369,0.00772498503063298,-0.0408580179687775,-0.0105760766486962,0.000874221827497122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,39736,-0.0133306259743532,0.00401014831339792,-0.0211905166686131,-0.00547073528009325,0.000889515817514524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.00788745487465657,0.00237308923295204,-0.0125387097712426,-0.00323619997807058,0.000890661406694174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,39721,-0.0196078332218003,0.00591189022544009,-0.0311951380636628,-0.0080205283799377,0.000913866879734382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0312222929029822,0.00941801531255157,-0.0496816029155833,-0.0127629828903812,0.000918294931592611
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,39966,-0.0145807404824166,0.00439874593397206,-0.0232022825130018,-0.00595919845183138,0.000920123529951802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,42016,-0.0109906399755826,0.00331733300996434,-0.0174926126751127,-0.00448866727605248,0.000925137124114605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0148921163904982,0.00449772984508215,-0.0237076668868593,-0.00607656589413721,0.00093253400312034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.0237191630346125,0.00716646475705792,-0.0377654339584461,-0.009672892110779,0.000936823213765731
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.0145833049008824,0.00441037497317902,-0.0232276398483133,-0.00593896995345152,0.00094688996374592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.00992918110435086,0.00301001776803642,-0.0158288159297022,-0.00402954627899948,0.000974364673463819
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.0200708409578625,0.0060873481958403,-0.0320020434217094,-0.00813963849401546,0.000979234188379655
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.0108618336566128,0.00329746426070976,-0.0173248636076039,-0.00439880370562163,0.000990761499837339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.022087934626383,0.00671070761029478,-0.0352409215425608,-0.00893494771020526,0.000999783212506882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.0135866743561518,0.00413015418039555,-0.021681776549727,-0.00549157216257648,0.00100581985437709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0185049762625217,0.00562584746636292,-0.0295316372965931,-0.00747831522845041,0.00100702481493304
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0283707338305961,0.00862734254269744,-0.0452803252142831,-0.0114611424469091,0.00100997142535
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,42137,-0.0242437457567682,0.00737596337367842,-0.0387006339691779,-0.00978685754435844,0.00101569784444406
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.012493554804395,0.00380391415916648,-0.0199492265563613,-0.00503788305242874,0.00102511729299573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0240139022768072,0.00731283958444655,-0.0383470678623225,-0.00968073669129201,0.00102732950026187
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0239832072684056,0.00731001567583655,-0.0383108379930452,-0.00965557654376595,0.0010375523974949
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,39575,0.0233323534730679,0.00711981128438455,0.00937752335567416,0.0372871835904616,0.00105204000333183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.0257822698867249,0.00789159883600004,-0.041249803605285,-0.0103147361681648,0.00108944355826127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.0136304487472306,0.00417571285928083,-0.0218148459514211,-0.00544605154304023,0.00110042201868601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0251409592807732,0.00770738761890367,-0.0402474390138244,-0.010034479547722,0.00110936450123226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0271774589128137,0.00835757198323519,-0.0435582999999547,-0.0107966178256727,0.00115007712098923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0186861097366335,0.00575462745390933,-0.0299651795462957,-0.00740703992697119,0.00116854148581312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,42310,-0.00645340163045899,0.00199089342802578,-0.0103555527493895,-0.00255125051152847,0.00119203045405753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLC,Galectin-10,42119,0.0220600805702744,0.00680924617292868,0.00871395807133423,0.0354062030692146,0.00119934476230241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0190210937802767,0.00587382194354956,-0.0305337847896339,-0.00750840277091959,0.00120547955863664
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0284734619556031,0.00879959381118291,-0.0457206658255216,-0.0112262580856846,0.00121675866419753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.0150865350977847,0.00466618654671727,-0.0242322607293506,-0.00594080946621889,0.00122721416864899
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.0105103438094813,0.00325145924253235,-0.0168832039248447,-0.0041374836941179,0.00123072215234665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.0121434592968605,0.00375696778502331,-0.0195071161555062,-0.0047798024382148,0.00123169650835975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0130968216358048,0.00406706414530596,0.00512537591100514,0.0210682673606045,0.00128465285877658
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.00649934685090587,0.0020193771276029,-0.0104573260210076,-0.00254136768080418,0.00129172165633335
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0133769278526553,0.00416274461413622,0.00521794840894834,0.0215359072963623,0.00131500887181554
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0193956061547848,0.00603876779787858,0.00755962127094282,0.0312315910386269,0.00132252460928305
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,41877,-0.0139243312115964,0.00434305800348522,-0.0224367248984275,-0.0054119375247654,0.00134860119285761
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.013025130754357,0.00406943195236384,-0.0210012173809901,-0.00504904412772384,0.00137470223033864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0188543634631902,0.00589152392568021,-0.0304017503575234,-0.00730697656885698,0.0013762562720177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0186809839212968,0.00583832289470543,-0.0301240967949194,-0.00723787104767414,0.00137951357543585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,-0.0211354456186045,0.00661007825664288,-0.0340911990016246,-0.00817969223558451,0.00139023696826291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0307942702856651,0.00966044441399282,-0.049728741337091,-0.0118597992342392,0.00143816146199861
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,42145,-0.0113031584563928,0.00354774521278716,-0.0182567390734556,-0.00434957783932995,0.00144575811572971
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0242282428839823,0.00761367955011051,-0.0391510548021989,-0.00930543096576573,0.00146493254858361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.0186367667118328,0.00585922265067776,-0.0301208431071612,-0.00715269031650444,0.00147224807199313
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00877088284501341,0.00275833529068168,-0.0141772200147495,-0.00336454567527731,0.00147720062040764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0120364861260762,0.00378597510049512,0.00461597492910574,0.0194569973230466,0.00148076950835853
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0469536795556688,0.0147823928998238,0.0179801894720141,0.0759271696393234,0.00149551740784202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0388363457536996,0.0122359573425256,-0.0628188221450498,-0.0148538693623495,0.00150780482994252
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.00739911946313315,0.00233718590429472,-0.0119800038355508,-0.00281823509071549,0.00155053226536339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00882750884883854,0.00278851044258478,-0.0142929893163047,-0.00336202838137237,0.00155074308115802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.0233010210002,0.00736990962002845,0.00885599814494422,0.0377460438554558,0.00157295470881371
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0380021713480083,0.0120832388082522,-0.0616853194121827,-0.014319023283834,0.00166427272581764
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0198106444502826,0.00629955056475171,-0.0321577635571959,-0.00746352534336924,0.00166573069052527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.034228181851217,0.0109068534231573,-0.0556056145606054,-0.0128507491418287,0.00170409190603934
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0151405593940163,0.00482663368282976,-0.0246007614123627,-0.00568035737567,0.00171119691115653
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.0149282364478011,0.00476203268448274,-0.0242618205093872,-0.00559465238621489,0.00172320458790312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00690337718763121,0.00220237687606513,0.00258671851054356,0.0112200358647189,0.00172591334925186
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00974306438606662,0.00311636847069019,0.00363498218351385,0.0158511465886194,0.00177398671508849
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,42264,-0.00651100280734393,0.00208504551109816,-0.0105976920090963,-0.00242431360559154,0.00179565372268901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,42018,0.0151637544024737,0.00485787028199328,0.0056423286497669,0.0246851801551806,0.00180325360426585
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRELP,Prolargin,42123,-0.00739266404897509,0.00236924313946533,-0.0120363806023271,-0.00274894749562305,0.00181069166730231
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.00768068176119196,0.0024618477821847,0.00285546010810994,0.012505903414274,0.00181373467091807
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.0233746622314788,0.00749348581632893,-0.0380618944314835,-0.00868743003147407,0.00181728987371015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIM,Vimentin,41900,-0.0361522233779137,0.0116134778076521,-0.0589146398809119,-0.0133898068749156,0.00185617641395281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0143590918072508,0.00461526766705778,-0.0234050164346841,-0.00531316717981759,0.00186781964644411
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0191086273295631,0.00614842484855039,-0.0311595400327219,-0.00705771462640438,0.00188899232755316
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.0148509812413718,0.00478052397482902,-0.0242208082320367,-0.0054811542507069,0.00189745888017242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0181455961740688,0.00584624285376884,-0.0296042321674557,-0.00668696018068184,0.00191451926877261
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.00805460000698623,0.00259750585858354,0.00296348852416249,0.01314571148981,0.00193406985114783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,39875,0.0230368706679176,0.00742968708532948,0.00847468398067186,0.0375990573551634,0.00193571520206059
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00948389630505387,0.00306031358910622,-0.0154821109397021,-0.00348568167040567,0.00194653721380831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,42016,0.0106723670791158,0.0034445239352171,0.00392110016609026,0.0174236339921413,0.00194998557210334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.00700188970965753,0.00226558425548386,-0.0114424348504059,-0.00256134456890917,0.00200192265656055
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.019675969537198,0.00636696753917118,-0.0321552259139735,-0.00719671316042251,0.00200425347083093
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.0144167714759483,0.00467410501489019,-0.0235780173051331,-0.00525552564676357,0.00204377185411226
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,39735,0.00976031603708172,0.00316529888694643,0.00355633021866672,0.0159643018554967,0.0020505618807579
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.015163150997496,0.00492081540705253,-0.024807949195319,-0.00551835279967302,0.00206429396856382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,41830,-0.0267010499743517,0.00868051124399307,-0.0437148520125781,-0.00968724793612531,0.00210242402332804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0213785034400938,0.00696247258149618,-0.0350249496998263,-0.00773205718036132,0.00214098897250839
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,42070,-0.0206017060844812,0.00673964206178076,-0.0338114045255715,-0.00739200764339088,0.00224155210947345
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.0101206924732541,0.00331100593594579,-0.0166102641077078,-0.00363112083880034,0.00224242216179078
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.0160751735640378,0.00527311015614196,-0.0264104694700761,-0.00573987765799959,0.00230411920538938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.0104939297647005,0.00344660963957297,0.00373857487113752,0.0172492846582636,0.00233452870072033
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.0177285088295068,0.00586184489204272,-0.0292177248179105,-0.00623929284110307,0.00249707421029963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.0103037467575635,0.00340987092624655,-0.0169870937730067,-0.00362039974212024,0.00251886672285451
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.00616695981368904,0.00204294750659253,-0.0101711369266104,-0.00216278270076769,0.00254462136776673
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0300292255279125,0.00994970695188979,-0.0495306511536165,-0.0105277999022085,0.00254947405802247
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,39990,-0.0283939029313204,0.00942450621269234,-0.0468659351081974,-0.0099218707544434,0.00259440736970101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.0150217296415974,0.00500121337067059,-0.0248241078481117,-0.00521935143508301,0.00267278290324162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALB2,Calretinin,41839,-0.00893468527279242,0.00297839413692004,-0.0147723377811557,-0.00309703276442914,0.00270630148795834
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0257485725217655,0.00861580749590938,-0.0426355552137479,-0.00886158982978314,0.00280829548357392
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0145946122255293,0.00488625280820107,-0.0241716677296034,-0.00501755672145518,0.00282363585546212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0179201460471105,0.00600799659632864,-0.0296958193759147,-0.00614447271830638,0.00286326989585614
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.0133615829048698,0.00448967215013602,-0.0221613403191364,-0.00456182549060319,0.00292483326022557
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0190744987148007,0.00641655350770269,-0.031650943589898,-0.00649805383970341,0.00295832242724054
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,39990,-0.0221571500376212,0.00746471703009439,-0.0367879954166062,-0.00752630465863617,0.00300123311892258
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,42015,-0.0176776218473245,0.00596606105854977,-0.0293711015220821,-0.00598414217256695,0.00305160895989508
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.013023868433486,0.00440151484786032,-0.0216508375352922,-0.00439689933167976,0.0030923389324001
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.014295205902518,0.00484632294979914,-0.0237939988841243,-0.00479641292091165,0.00318729368344964
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.0212251512676806,0.00719595485120626,-0.0353292227760448,-0.00712107975931631,0.00318851443834386
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0218546155909496,0.00741574477305613,-0.0363894753461396,-0.00731975583575955,0.00321362851461591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00612852082649808,0.00207985040480112,-0.0102050276199083,-0.00205201403308788,0.00321942221311708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,42145,-0.00882683262833291,0.00299611298975143,-0.0146992140882457,-0.00295445116842011,0.00322361703951207
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0132872717600379,0.00451271302503298,0.0044423542309733,0.0221321892891026,0.00324123097725329
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0177337606734677,0.00602295511549897,-0.0295387526998457,-0.00592876864708969,0.00324164835956124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0168755705781764,0.00573384983905906,0.00563722489362067,0.0281139162627322,0.00325446868342075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.022118422276424,0.00751728288944373,-0.0368522967397337,-0.00738454781311431,0.00326303814266073
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.0131238192909988,0.00446327913270577,0.00437579219089554,0.0218718463911022,0.0032845286832852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,39930,-0.00926607589370801,0.00315160620452554,-0.0154432240545781,-0.00308892773283795,0.00328756278392022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0158209436121042,0.00538407225829976,-0.0263737252383717,-0.00526816198583669,0.00330391408055791
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0166414153061373,0.00566568514022751,-0.0277461581809832,-0.00553667243129137,0.00331826095479768
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0147607772382768,0.00502540142114701,-0.0246105640237249,-0.00491099045282865,0.0033183833925566
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.0189068747406009,0.00643930985549464,-0.0315279220573704,-0.00628582742383141,0.00332976226615392
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0154074449283581,0.00525440287644402,-0.0257060745661883,-0.00510881529052779,0.0033716099644774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.00723972280176987,0.00246907877047727,-0.0120791171919053,-0.00240032841163441,0.00337184586706638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.00840758763827116,0.00286855355189526,-0.0140299525999859,-0.00278522267655645,0.00338501378392975
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,42016,-0.0107856736938972,0.00369410626051293,-0.0180261219645026,-0.0035452254232919,0.0035095384485646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0189968102169385,0.00650788218762591,-0.0317522593046853,-0.00624136112919173,0.00351813273559665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,39930,-0.0195081602780241,0.00669354207524128,-0.032627502745497,-0.00638881781055118,0.00356984741532657
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.0128196540756387,0.00440434057600534,-0.0214521616046092,-0.00418714654666825,0.00361338950410327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0322921212277247,0.0111035427637037,-0.0540550650445839,-0.0105291774108655,0.00364024181550101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.0115216662394072,0.00396435336190747,-0.0192917988287458,-0.00375153365006858,0.00366442521918849
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.016371796553885,0.00564568873354422,-0.0274373464716316,-0.00530624663613828,0.00374045552792659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.00921253649212907,0.00317775259105947,0.00298414141365252,0.0154409315706056,0.00375010593909721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0372958685138084,0.0128746084369877,-0.0625301010503043,-0.0120616359773125,0.00377658576440685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,42070,-0.0242034577450668,0.00836487351624133,-0.0405986098368998,-0.00780830565323377,0.00381629233089288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.00754042624155986,0.00260685389268503,-0.0126498598712225,-0.00243099261189721,0.00382869821706365
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.00668152387016866,0.00231145334811023,-0.0112119724324647,-0.00215107530787261,0.00385091180972374
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.0137339792021872,0.00475573629008509,-0.023055222330754,-0.00441273607362044,0.00388481265057433
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,39919,-0.0206976128900054,0.00717948837280541,-0.034769410100704,-0.00662581567930681,0.00394797852699491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.0109938340023899,0.00381548916092676,-0.0184721927578064,-0.00351547524697346,0.00396695317016367
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,42016,-0.0123611389672426,0.00429841293266759,-0.0207860283152711,-0.00393624961921411,0.00403709906164557
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,42296,-0.0124043746478329,0.00431734128966959,-0.0208663635755853,-0.00394238572008052,0.00407024113764401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLG,Plasminogen,39742,-0.00638541852907077,0.00222591089196658,-0.0107482038773253,-0.00202263318081627,0.00412967455086165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.014765008223584,0.00516568795932066,-0.0248897566238525,-0.00464025982331553,0.00426739543962063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.00843187299732328,0.00295228299267111,-0.0142183476629586,-0.00264539833168791,0.00429725966718526
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.0085680499435759,0.00300297133620571,-0.0144538737625391,-0.00268222612461271,0.00433478806498216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,41900,0.0112244275689364,0.00394192130875969,0.00349826180376741,0.0189505933341054,0.00441384072832898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.0133277022071236,0.00468740280123037,0.0041403927167121,0.0225150116975352,0.00447285841863508
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.0079372963430625,0.00279700961316693,0.00245515750125531,0.0134194351848697,0.00454958910271204
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0228557467169089,0.00808777789357336,-0.0387077913883127,-0.0070037020455051,0.00472095426881249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,39929,-0.0140386907222361,0.00497614795571668,-0.0237919407154408,-0.00428544072903142,0.00479281273447623
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.0100425079416344,0.00356510838251071,-0.0170301203713554,-0.00305489551191341,0.00485609471290286
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,42145,-0.0115475107149879,0.00410348698023958,-0.0195903451962575,-0.00350467623371831,0.00489886830853311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.0140268399955271,0.00498477568662587,-0.0237970003413139,-0.00425667964974042,0.00490255288137177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.00735711560348038,0.00261929461335881,-0.0124909330456637,-0.0022232981612971,0.0049795316170172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,42070,-0.0121134338252309,0.00431586489644322,-0.0205725290222596,-0.00365433862820219,0.00501202510735489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,42181,-0.00953106605612962,0.00340351448514616,-0.0162019544470161,-0.00286017766524314,0.00511177420273333
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.024929364788131,0.00890556928558426,0.00747444898838584,0.0423842805878761,0.00513021939655797
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00961863988323438,0.00343619390452537,-0.0163535799361041,-0.00288369983036465,0.00513161888325656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.00887810865766568,0.00317367712780947,-0.0150985158281722,-0.00265770148715911,0.00516016839061866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.00829908542933087,0.002969520897984,-0.0141193463893795,-0.00247882446928223,0.00520262387818159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0222251732092827,0.0079547496535119,-0.0378164825301661,-0.00663386388839943,0.00521433306498925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0184576272904809,0.00661715703549476,0.00548799950091114,0.0314272550800506,0.00528863421163743
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.0136910332020276,0.00490861541901375,-0.0233119194232946,-0.00407014698076064,0.00529292657862293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0201726747990099,0.00723419250083043,-0.0343516921006376,-0.00599365749738228,0.00530379189712021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.00773895699866258,0.00278018123349443,-0.0131881122163117,-0.0022898017810135,0.00538302475765054
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,41843,-0.0184871521206284,0.00664304486710268,-0.0315075200601496,-0.00546678418110715,0.00539461492518053
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,39966,-0.0238263079164425,0.00857088706512387,-0.0406252465640853,-0.0070273692687997,0.00544630966972675
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,42137,-0.0342526019084871,0.0123278503848808,-0.0584151886628536,-0.0100900151541207,0.00546902601754079
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.012419783842484,0.0044753004507424,-0.0211913727259391,-0.00364819495902886,0.00552609419560088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00522600942342388,0.00188361231359525,0.0015341292887772,0.00891788955807057,0.00553835327058146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0113885967914958,0.00410643147036341,-0.0194372024734081,-0.00333999110958348,0.005557224881598
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.0145194325963898,0.00526043342571148,0.0042089830819953,0.0248298821107843,0.00578590720770558
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBN1,Drebrin,39657,-0.0143341376289157,0.00520302299121369,-0.0245320626916945,-0.00413621256613683,0.00587947392254232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0245555744218601,0.00892719777340202,-0.0420528820577281,-0.00705826678599217,0.00595563486530478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.0108374521162093,0.00394985110534638,-0.0185791602826882,-0.00309574394973041,0.00608376114487836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.013506014519863,0.0049357522906766,-0.0231800890095892,-0.00383194003013691,0.00622191670510325
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,42249,0.00831191567968833,0.00304398448814474,0.00234570608292464,0.014278125276452,0.00632995595694015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,41900,-0.0217293983652497,0.00795893707242063,-0.0373289150271941,-0.00612988170330524,0.00633814551957498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0126346066399089,0.00462948724851986,0.00356081163280996,0.0217084016470078,0.00635778382648084
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0162172319148591,0.005943056708523,-0.0278656230635642,-0.00456884076615405,0.00636539268930012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.00830668698007791,0.00304940489355196,0.00232985338871607,0.0142835205714398,0.00645901729995356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,42286,-0.00832480212566624,0.00305986846315324,-0.0143221443134466,-0.00232745993788588,0.00652378877423897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,39966,0.0141377741230865,0.00521839330410878,0.00390972324703331,0.0243658249991397,0.00675427199817601
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00805855491104597,0.00297826502662182,0.0022211554588672,0.0138959543632247,0.00682293177082804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,41780,-0.00833081874659664,0.0030796596260949,-0.0143669516137426,-0.00229468587945064,0.00683694833005867
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLU,Clusterin,39979,0.00826997406216546,0.00306280871002233,0.0022668689905217,0.0142730791338092,0.0069415409004135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.0168081346471042,0.00623849453324137,-0.0290355839322573,-0.00458068536195108,0.00706484614378951
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0197492676187931,0.00733442331213541,-0.0341247373105786,-0.00537379792700774,0.00709838773193108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0165093405436143,0.00613788500309182,-0.0285395951496743,-0.00447908593755433,0.00715938204071437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,42249,-0.00761757787995064,0.00283653200345307,-0.0131771806067186,-0.00205797515318262,0.00725034952492735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.0157074343426335,0.00585145310564357,-0.0271762824296949,-0.00423858625557214,0.00727751111774851
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.0162791954616735,0.00607031102685339,-0.0281770050743062,-0.00438138584904089,0.00733411544750898
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0169369420631321,0.00631970737646132,0.00455031560526789,0.0293235685209963,0.00737275508854203
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.0108110300584909,0.00403780755601339,-0.0187251328682771,-0.00289692724870464,0.00742762869439631
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.015778963447268,0.00593527268944278,0.00414582897596015,0.0274120979185758,0.00785794842527624
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.0266564418078305,0.0100525015399901,-0.046359344826211,-0.00695353878944996,0.00801758214754322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.0106602883211252,0.00402140575885062,0.00277833303377801,0.0185422436084724,0.00803961747942336
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.0107215651386239,0.00406513540478964,-0.0186892305320116,-0.00275389974523618,0.00836477064966346
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.014223776765912,0.00540562203850297,0.00362875757044619,0.0248187959613778,0.00851751869704069
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.03237623414492,0.0123064770691663,-0.056496929200486,-0.00825553908935396,0.00852735387698829
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00739588013058315,0.00281223091319265,-0.0129078527204407,-0.00188390754072556,0.00855082052737753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.0135052638951879,0.00513763319886078,-0.023575024964955,-0.00343550282542075,0.00858321384612644
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,42107,-0.0107094866455315,0.00407423207465274,-0.0186949815118508,-0.00272399177921209,0.00858366384026066
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.00903612828457326,0.00344164418775019,-0.0157817508925636,-0.00229050567658288,0.00866138317735868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0284209930752939,0.0108341544069461,-0.0496559357129082,-0.00718605043767965,0.00872078563683621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,42119,-0.0131856013090909,0.00503214402083017,-0.023048603589918,-0.00332259902826376,0.00879571061026884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0235647724029358,0.00899525349028519,-0.0411954692438947,-0.00593407556197678,0.00881097596947824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.025561560078287,0.00976633326637509,-0.0447035732803822,-0.00641954687619185,0.00887446011617987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.0318020253978116,0.0121513428340393,-0.0556186573525286,-0.00798539344309468,0.00887631152202204
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0232901306552408,0.00891588365897701,-0.0407652626268357,-0.00581499868364583,0.0090080626366512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,39560,0.0106266560417198,0.00407147688862565,0.00264656134001349,0.018606750743426,0.00906587614292119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.0186204154623779,0.00713998289659309,-0.0326147819397003,-0.00462604898505539,0.00912191298834937
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.010165939024925,0.0038998356053853,-0.0178096168114801,-0.00252226123836977,0.00915231236902609
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.0193907106470072,0.00745170239700933,-0.0339960473451454,-0.00478537394886887,0.00927349551376118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.0127491940469284,0.00490773826634526,0.00313002704489174,0.0223683610489652,0.00939320019235972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.0106929790154555,0.00411888786697754,0.00261995879617951,0.0187659992347315,0.00943953670850699
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.0115331962001483,0.00445003607434419,0.00281112549443367,0.0202552669058629,0.00956231864383901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.00548188183171443,0.00211586873653642,-0.00962898455532582,-0.00133477910810305,0.00958445982826331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0216263063658375,0.00837606802792641,-0.0380433997005732,-0.00520921303110171,0.00983576474378527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0263068053916046,0.0102103806580209,-0.0463191514813256,-0.00629445930188356,0.00999383606629066
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,39657,0.0143491400788409,0.00557426622824311,0.00342357827148438,0.0252747018861974,0.0100608211596097
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00693214343710222,0.00270102457705115,-0.0122261516081225,-0.00163813526608198,0.0102841576257009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C3,Complement C3,39445,-0.0120603334802181,0.00470091718072932,-0.0212741311544475,-0.0028465358059886,0.0103152170571209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0291894302647562,0.0113916965708134,0.00686170498596187,0.0515171555435506,0.0104076854741039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.00925235355390194,0.00362031900157138,-0.0163481787969818,-0.00215652831082204,0.0106090770812248
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.0162895125966095,0.00637571941944349,-0.0287859226587188,-0.00379310253450029,0.0106318423526793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.0104250877724192,0.00408571859354722,0.00241707932906664,0.0184330962157717,0.0107361781272348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,39657,0.0078040834927579,0.00305870349301904,0.00180902464644058,0.0137991423390752,0.0107413704324872
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.00975624316908783,0.00382478983997399,-0.0172528312554368,-0.00225965508273881,0.0107612491005652
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,42138,-0.0105012671615491,0.00414049938216126,-0.0186166459505851,-0.00238588837251301,0.0112163876511775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.00872007667340559,0.00343965591890159,0.00197835107235848,0.0154618022744527,0.0112533763555941
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F3,Tissue factor,42174,0.00671427953665369,0.00264866830532543,0.00152288965821585,0.0119056694150915,0.0112570117411963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00446300163981356,0.00176270975619801,0.00100809051766545,0.00791791276196167,0.0113559360784209
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.0190764048542926,0.00754106486633825,-0.0338568919923156,-0.00429591771626962,0.0114283547810312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0380986737131893,0.0150655878868321,-0.0676272259713803,-0.00857012145499835,0.0114550745661524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.00633463441629246,0.00250568077326206,-0.0112457687318861,-0.00142350010069881,0.0114815762947179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.0116738085498439,0.00461790969908841,0.00262270553963067,0.0207249115600572,0.0114871329501697
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.0092338521222659,0.00365339234636104,-0.0163945011211335,-0.00207320312339826,0.0115001261715844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.00817231881157102,0.00323519581065946,-0.0145133026004636,-0.00183133502267849,0.0115487083894311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.0113335109928566,0.00450029623147795,-0.0201540916065534,-0.00251293037915982,0.0118032187641372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,39934,-0.00775185866035595,0.00307836552872769,-0.0137854550966622,-0.00171826222404967,0.0118101785794672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.012365641656714,0.00491124892574717,-0.0219916895511784,-0.00273959376224951,0.0118220314343323
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.0133814801193292,0.00531665320902479,-0.0238021204090178,-0.0029608398296406,0.0118529739247004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.0136065071636298,0.00541750142077124,-0.0242248099483415,-0.00298820437891819,0.0120308246682994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,42181,0.00699170719784315,0.00278662000796457,0.00152993198223259,0.0124534824134537,0.012117944028341
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0182914221389826,0.00729746811633401,-0.0325944596469973,-0.00398838463096799,0.0122036917239157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.026029541232924,0.0103863408850306,-0.046386769367584,-0.00567231309826408,0.0122202744420738
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.00791925131294535,0.00316269429921455,0.00172037048648483,0.0141181321394059,0.0122945443377858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,39586,-0.0109732292793881,0.00439141510409851,-0.0195804028834212,-0.00236605567535501,0.0124762594615366
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,39657,-0.00906315464904322,0.00363015966639521,-0.0161782675951778,-0.00194804170290861,0.0125525142260832
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.0211780296295546,0.00849202078795135,-0.0378223903739392,-0.0045336688851699,0.0126477890187692
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0197830901247161,0.00795610178991621,-0.0353770496329519,-0.00418913061648032,0.0129138348988146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0302773311813472,0.0121858274505504,-0.054161552984426,-0.00639310937826835,0.012980388563465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00525392946862769,0.0021211845351985,0.00109640777963863,0.00941145115761676,0.0132684230135332
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.0124543309703025,0.00503293736054693,0.0025897737436305,0.0223188881969744,0.0133520279380938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.00855840284962568,0.00346124343295878,0.00177436572102648,0.0153424399782249,0.0134241681584388
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00896883842604502,0.00363133131068923,0.00185142905709413,0.0160862477949959,0.0135291928260707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,39979,0.00567927008031583,0.0023011109031509,0.00116909271014005,0.0101894474504916,0.0135995106298458
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00949538940211045,0.00384835765561754,-0.0170381704071208,-0.00195260839710007,0.0136254678366877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,39930,-0.0156861726907739,0.00635923544076091,-0.0281502741546653,-0.00322207122688254,0.0136520603933831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0107121492636488,0.00434459278623911,-0.0192275511246775,-0.00219674740262018,0.0136896588137694
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0145405565630322,0.00591748862625258,0.00294227885557715,0.0261388342704872,0.0140171468708038
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.0120880153243364,0.00493331048183088,0.00241872677994787,0.0217573038687249,0.014286857741277
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0134131040517457,0.00548361368322709,0.00266522123262059,0.0241609868708708,0.0144566686031588
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0135650441445645,0.00555228151662801,-0.0244475159171554,-0.00268257237197364,0.0145749349883872
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00742462392217563,0.00304492460643325,0.00145657169356646,0.0133926761507848,0.0147696852848755
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,39736,-0.0112908769879047,0.00464045061325041,-0.0203861601898755,-0.00219559378593388,0.0149840444195887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,42224,-0.0171097718740968,0.00703264631806371,-0.0308937586575017,-0.00332578509069192,0.0149909420256664
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0215163954112572,0.00885936295934526,-0.0388807468115739,-0.00415204401094047,0.0151675919740349
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.00999429110138157,0.00412262132861197,-0.018074628905461,-0.00191395329730211,0.0153528725447002
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,41668,-0.00898043009172082,0.00370922699188753,-0.0162505149958204,-0.00171034518762127,0.0154869141080533
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.00469351885836068,0.00194709927851564,0.000877204272470029,0.00850983344425133,0.0159430146680677
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,41913,-0.00830018581288309,0.00344875625046241,-0.0150597480637894,-0.00154062356197677,0.0161100984078921
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,42310,-0.0061758843880858,0.00256869828414403,-0.0112105330250081,-0.0011412357511635,0.0162172866745836
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,42145,-0.00946279931803231,0.00394622384860342,-0.017197398061295,-0.0017282005747696,0.0165011139327526
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.0140474074282683,0.00585902497047196,0.0025637184861433,0.0255310963703934,0.0165209331061966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERVV_1,,39575,0.0106190752610181,0.00444005935823222,0.00191655891888291,0.0193215916031532,0.01678948501554
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0226721659031367,0.00950353251756775,-0.0412990896375695,-0.00404524216870395,0.0170623931858687
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00646389712771927,0.00270974852050332,0.00115279002753277,0.0117750042279058,0.0170763969431702
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0207842489912435,0.00872825020347017,-0.037891619390045,-0.00367687859244196,0.0172702814437135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,42145,-0.0200462933219208,0.00842080582805166,-0.0365510727449021,-0.00354151389893959,0.0172997586427072
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0230381044189749,0.00969812862990391,-0.0420464365335865,-0.00402977230436322,0.017541309495384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00522949255642791,0.00220385712969871,0.000909932582218447,0.00954905253063737,0.017663893537904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0155872978768673,0.00657388536699421,-0.0284721131961759,-0.00270248255755861,0.0177525751003894
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.0157631914419932,0.00665177317219662,-0.0288006668594986,-0.00272571602448782,0.0178156881422662
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.02294202270313,0.0097030344047036,-0.0419599701363491,-0.00392407526991096,0.0180724698954862
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.0200279892797805,0.00848917239022433,-0.0366667671646202,-0.00338921139494079,0.0183266323341454
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,41913,0.0111344152895597,0.00472017942709671,0.0018828636124501,0.0203859669666692,0.0183437250987322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0166607966002357,0.00707225051927581,-0.0305224076180163,-0.00279918558245511,0.018500434408736
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.011224077336255,0.00477170616466548,0.00187153325351066,0.0205766214189994,0.0186795901413392
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TTN,Titin,39575,-0.0165745649341891,0.00705570689467617,-0.0304037504477544,-0.00274537942062379,0.018836456031931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0141644221414318,0.00603011170982416,-0.0259834410926872,-0.0023454031901765,0.0188441432233478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.0109080235657448,0.00464447338181571,-0.0200111913941036,-0.001804855737386,0.0188582871054481
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.00955462619556175,0.00407297017575775,-0.0175376477400469,-0.00157160465107656,0.0190002940741515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.00752128848604269,0.00320664398135853,-0.0138063106895054,-0.00123626628257998,0.0190175155505897
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0113086457765077,0.00482503828212054,-0.0207657208094639,-0.00185157074355139,0.0191090070899314
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00726700975009494,0.00310309720007678,0.00118493923794445,0.0133490802622454,0.019205877437694
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0304962880146665,0.0130371868239269,-0.0560491741895633,-0.00494340183976971,0.0193435501257367
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.00720271225963264,0.00308060658850296,-0.0132407011730984,-0.00116472334616683,0.0193976461879368
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,39699,-0.0105613926877816,0.00452910032472895,-0.0194384293242503,-0.00168435605131282,0.019723938070917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.00694977930637687,0.0029826234964774,0.00110383725328116,0.0127957213594726,0.0198158648278949
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.00990711683051845,0.00425413492295668,0.00156901238152335,0.0182452212795135,0.019886636107124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,39586,0.0114999767157138,0.00494001440068367,0.00181754849037377,0.0211824049410537,0.0199342170461402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,39854,-0.0101901279244539,0.00438754520373681,-0.018789716523778,-0.00159053932512971,0.0202231085930271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0227477305680862,0.00980816826823679,-0.0419717403738303,-0.00352372076234215,0.0203988918561483
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.00868561743592346,0.00374517744950163,-0.0160261652369466,-0.00134506963490028,0.0204021199847545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.007493479958147,0.00323172201519628,0.0011593048083623,0.0138276551079317,0.0204281384435686
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.00742768882342611,0.00320352853798118,-0.0137066047578692,-0.00114877288898301,0.0204346454888235
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.0158678467434548,0.00686993938299004,-0.0293329279341153,-0.00240276555279432,0.0209199727761854
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0256496991598517,0.011114701937162,0.00386488336301427,0.0474345149566892,0.0210292752557662
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.00890043421565916,0.00386851947214611,-0.0164827323810655,-0.00131813605025278,0.0214223994356101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.00952299367519658,0.00415740471621286,-0.0176715069189738,-0.00137448043141938,0.0220011707367602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0203567836431585,0.00889693720899843,-0.0377947805727954,-0.00291878671352156,0.0221522671195278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0104420799733622,0.00456716949751119,-0.0193937321884842,-0.00149042775824029,0.0222530465401714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,-0.00670642689748728,0.00295903374744237,-0.0125061330424743,-0.000906720752500236,0.0234415101460505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,39575,0.00811278990132494,0.00359507562201,0.00106644168218533,0.0151591381204645,0.0240501929817632
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0342501415784363,0.0151847817675706,-0.0640123138428746,-0.00448796931399797,0.0241143049797565
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0232747273318604,0.0103212041512472,-0.0435042874683049,-0.00304516719541598,0.0241468871925052
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.0121761828095558,0.00540087077488978,0.00159047609077185,0.0227618895283398,0.0241850106964372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.0087446162929483,0.00387996480151761,-0.0163493473039228,-0.00113988528197379,0.0242290389463088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,42261,-0.00788830535326175,0.00350156263243704,-0.0147513681128384,-0.00102524259368515,0.024287831929161
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.0193748293487025,0.00861365526393289,0.00249206503139407,0.036257593666011,0.024512143739651
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.0110882189634751,0.00493007298869795,0.00142527590562715,0.0207511620213231,0.0245260127840134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0383408657240133,0.0170716300371605,0.00488047085117878,0.0718012605968479,0.0247278753243614
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.0254648041798138,0.0114132600157943,-0.0478347938107707,-0.00309481454885702,0.0256906822557022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00782616283647275,0.00351111342366631,-0.0147079451468587,-0.000944380526086778,0.025832594452261
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.01385716357371,0.00623229234764205,-0.0260724565750884,-0.00164187057233162,0.0262059268947327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00774699221266624,0.00348825714415999,0.000910008210112654,0.0145839762152198,0.026379613984435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,-0.00637342064448167,0.0028778993384495,-0.0120141033478427,-0.000732737941120657,0.0268033957346075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.0120278831217206,0.00543577418437228,-0.0226820005230903,-0.00137376572035092,0.0269368742638878
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.00603325800172273,0.00272676019580942,-0.0113777079855092,-0.000688808017936264,0.0269442752733172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.0156161482589113,0.00706388495179729,-0.029461362764434,-0.00177093375338862,0.0270763385733018
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.0192251105736605,0.0087025949346047,-0.0362821966454858,-0.00216802450183533,0.0271863879567149
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0078894198376699,0.00357203116135788,-0.0148906009139313,-0.000888238761408457,0.0272145420255967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.0165893780934081,0.00751725042829815,-0.0313231889328725,-0.00185556725394375,0.0273422469717291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0265110214526917,0.0120215317641389,-0.050073223710404,-0.00294881919497943,0.0274501620302623
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.014112787666377,0.00640213647402169,-0.0266609751554595,-0.00156460017729444,0.027513676382843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,42189,-0.0101323074414894,0.00460145515635775,-0.0191511595479506,-0.00111345533502823,0.0276835331620014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,39979,0.00471649004985168,0.00214737739952949,0.000507630346773883,0.00892534975292947,0.0280837482638561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0128172341633328,0.00588214717849865,-0.0243462426331901,-0.0012882256934754,0.0293488557731475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0159209801820758,0.00731460670656847,-0.03025760932695,-0.0015843510372016,0.0295309512294589
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,39934,-0.00811056227054873,0.00372937865620084,-0.0154201444367024,-0.000800980104395083,0.0296675335395891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00912996634187043,0.00419817780109756,0.000901537851719213,0.0173583948320216,0.0296705811900337
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,42070,-0.00768818942841961,0.00353773911695529,-0.014622158097652,-0.000754220759187244,0.0297831706169572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.00901598520140106,0.00414890813340932,-0.0171478451428833,-0.000884125259918794,0.0297940785025289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.0118389418543439,0.00545246568430736,-0.0225257745955864,-0.00115210911310151,0.0299261940647615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0146400232847436,0.00675447901286683,-0.0278788021499626,-0.00140124441952466,0.0302180369213628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,42249,-0.00636548165068351,0.00293964036378409,-0.0121271767637003,-0.00060378653766669,0.0303747377839463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00791423018194915,0.00365971912824081,-0.0150872796733011,-0.000741180690597172,0.030595658132017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.0064850985747223,0.0029997152707117,-0.0123645405053172,-0.000605656644127357,0.0306431979667891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00829766059622508,0.00386376800403523,0.00072467530831602,0.0158706458841341,0.0317706794377618
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,39649,-0.0130595660552523,0.00612144727068289,-0.0250576027057908,-0.00106152940471386,0.0329129491187237
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,39638,-0.0170812432212552,0.00800718262177604,-0.0327753211599363,-0.00138716528257419,0.0329270240460841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00651236049654831,0.00306250063535749,0.000509859251247629,0.012514861741849,0.0334813680741807
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0168380523338476,0.00792898642481417,-0.0323788657264834,-0.00129723894121181,0.0337246143814859
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,42119,-0.00684743679465445,0.00322543180444171,-0.0131692831313602,-0.000525590457948709,0.0337759964950437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0255281273773064,0.0120248976423538,-0.0490969267563198,-0.00195932799829294,0.0337805545372701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,39966,-0.0200396346479021,0.00944170056150596,-0.0385453677484538,-0.00153390154735046,0.0338206640128221
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,39575,0.0109935190981825,0.00518854732236619,0.000823966346344742,0.0211630718500202,0.0341293660709447
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.00872974601731078,0.00413163192668342,-0.0168277445936103,-0.00063174744101128,0.034631243937116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,41913,0.0101171237865313,0.00479948329466921,0.000710136528979666,0.019524111044083,0.0350530010596946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,39560,0.010024540168216,0.00476664016494502,0.000681925444923718,0.0193671548915082,0.035483082119321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.0141698761784271,0.00673785595348826,-0.0273760738472641,-0.000963678509590097,0.0354855700906643
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0117645297447607,0.00559969313047185,-0.0227399282804855,-0.000789131209035865,0.0356703636026751
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.00705025741492809,0.00335686806163758,-0.0136297188157378,-0.000470796014118432,0.0357297410328248
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.0114833404657547,0.00547172615694341,0.000758757198145584,0.0222079237333637,0.0358685637500887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.0170181269955812,0.00813282159227509,0.00107779667472206,0.0329584573164404,0.0364145801627816
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_A,,39934,-0.00700329657082453,0.00334733901112713,-0.0135640810326337,-0.000442512109015357,0.0364429825180318
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0205746355978167,0.00983757427576308,-0.0398562811783123,-0.00129299001732106,0.0365114055324797
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.0111792665775818,0.00534965786918073,-0.0216645960011761,-0.000693937153987604,0.0366655399992432
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,39657,-0.00890567468963768,0.0042664834170908,-0.0172679821871356,-0.000543367192139703,0.0368787004434171
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0156158827661393,0.00748453465306285,-0.0302855706861425,-0.000946194846136112,0.0369634908963924
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0077526760385945,0.00374330928494116,-0.0150895622370792,-0.000415789840109817,0.0383705866179321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,39929,0.00803381889231056,0.003888863457243,0.000411646516114281,0.0156559912685068,0.0388650780054709
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.0176522655046281,0.00854812339403897,-0.0344065873569445,-0.000897943652311731,0.0389413000023427
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00631919018320187,0.00306551430326923,-0.0123275982176096,-0.000310782148794181,0.0392894977259659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00827034643852949,0.00401341585100786,-0.0161366415065049,-0.000404051370554083,0.039357550349358
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0111153355618883,0.00539823338165485,-0.0216958729899318,-0.000534798133844799,0.0395071286250498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,-0.00764612421294139,0.00371340434936702,-0.0149243967377007,-0.000367851688182038,0.0395075544603062
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00461425531133637,0.00224099433647567,-0.00900660421082868,-0.000221906411844054,0.0395155553808958
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0157983033644546,0.00768890113549674,-0.0308685495900282,-0.000728057138881019,0.0399326167297138
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,39657,-0.0133490047163969,0.00651060302994055,-0.0261097866550803,-0.000588222777713379,0.0403539678261019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00811773486456923,0.00396031833356953,0.000355510930772944,0.0158799587983655,0.0404107619466844
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,39475,-0.00827515775637346,0.00404144406679881,-0.0161963881272991,-0.000353927385447797,0.0406256828529703
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.0058417524092214,0.00285306915355154,-0.0114337679501824,-0.000249736868260392,0.0406293863645974
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.00522581169407679,0.00255618030089692,0.000215698304318821,0.0102359250838348,0.0409350130544157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0225697637023287,0.011051335017901,-0.0442303803374147,-0.000909147067242669,0.0411445873645923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,39757,0.0345734259329814,0.0169528873000764,0.00134576682483169,0.067801085041131,0.0414353547788306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.0131406890421527,0.00645144918482196,-0.0257855294444037,-0.000495848639901621,0.0416835176614552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.0116273126044438,0.0057121111096418,-0.0228230503793417,-0.000431574829545891,0.041818609382788
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,41839,-0.014193946819682,0.00697900096313101,-0.0278727887074188,-0.000515104931945266,0.0419908724634413
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0124319323004475,0.00611503561304467,-0.0244174021020151,-0.000446462498879953,0.042075467922696
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,39586,-0.0218838182224322,0.0108104084574222,-0.0430722187989796,-0.000695417645884686,0.0429605086162993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRTN,Neurturin,41913,-0.010144681055946,0.00501365826631874,-0.0199714512579307,-0.000317910853961224,0.0430509418682022
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIT,Vitrin,39958,-0.00792151616289096,0.0039151879896286,-0.015595284622563,-0.000247747703218898,0.0430678049476595
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0302362341988146,0.0149522146361521,-0.0595425748856726,-0.000929893511956478,0.0431808649630656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0159105940657223,0.00787631412700345,-0.031348169754649,-0.0004730183767955,0.043401709317169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,-0.00693618184601923,0.00344707577438546,-0.0136924503638147,-0.000179913328223722,0.0442197163698339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00539358439601943,0.00268376611333535,0.000133402813882136,0.0106537659781567,0.0444866385603824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.00618042951989741,0.00308500553609587,-0.0122270403706453,-0.000133818669149497,0.0451611829635759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.0140450930623681,0.00701133356362491,0.000302879277663324,0.027787306847073,0.0451803625388291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFB,Complement factor B,39794,-0.00664678173900322,0.00333546799759139,-0.0131842990142823,-0.0001092644637241,0.0463121519843024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0160284823876123,0.0080680539487571,0.000215096648048398,0.0318418681271762,0.046984476035637
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.00859942401439594,0.00433634112364966,-0.0170986526167493,-0.000100195412042606,0.0473804783144881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.0112437105269881,0.00567020741560787,-0.0223573170615795,-0.000130103992396647,0.0473940693348712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00531820513064089,0.00269128184830155,4.32927079698532e-05,0.0105931175533119,0.0481700090372386
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00564254588869259,0.00285820681916193,-0.01124463125425,-4.046052313522e-05,0.0483882698669885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,42119,0.015699824335263,0.00795935668263525,9.94852372979173e-05,0.0313001634332281,0.0485729984239081
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,39575,0.00920441188232763,0.00466890983021381,5.33486151085526e-05,0.0183554751495467,0.0487002089598298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.00699437651873461,0.00355616058581585,-0.0139644512669337,-2.43017705355451e-05,0.0492231425393292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.00893335165950575,0.0045428964429246,-0.017837428687638,-2.92746313735326e-05,0.0492675718285271
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.00769013131724048,0.00392389596446635,-0.0153809674075945,7.04773113575571e-07,0.0500372618111988
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0129080859063676,0.00658642775817628,-0.0258174843123931,1.31249965794507e-06,0.0500399179666354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.00682939324717668,0.00348805231136673,-0.0136659757774555,7.18928310211933e-06,0.050257695926706
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.019942046438197,0.0102268552316276,-0.039986682692187,0.00010258981579301,0.0512045177159
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00487428947068359,0.00250460899635744,-3.4744162176999e-05,0.00978332310354417,0.051664098863351
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.0100218003264167,0.00515069598811611,-7.35638102908366e-05,0.0201171644631243,0.0517137879903701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00684507243669891,0.00352050369856108,-5.51148124808025e-05,0.0137452596858786,0.0518793974669236
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FN1,Fibronectin,39979,-0.00538941420238136,0.00277381910008938,-0.0108260996385565,4.72712337938191e-05,0.0520458559492342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,41839,-0.00763853825101925,0.00393235980271938,-0.0153459634643492,6.88869623107482e-05,0.052099950044402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00618836775762878,0.00319144112813743,-6.68568535205846e-05,0.0124435923687781,0.0525207026373514
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,39649,0.0132449468605044,0.00684475056820365,-0.000170764253174733,0.0266606579741836,0.0530094294002134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.00716133810387604,0.00370301167520208,-0.0144192409872721,9.65647795200383e-05,0.0531481283859887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.00697090465424142,0.00360919066586601,-0.0140449183593388,0.000103109050855966,0.0534550061804321
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0146234649592382,0.00758565551202697,-0.000244419844334683,0.029491349762811,0.0539076171020605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNLY,Granulysin,42137,-0.0105051914496556,0.00546024167596913,-0.0212072651345551,0.000196882235243841,0.0543827234237065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.00886414619961039,0.00460946543476313,-0.0178986984517461,0.000170406052525345,0.0545015450619222
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.0116712333612644,0.00607317143519654,-0.000232182651720864,0.0235746493742496,0.0546605052221415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,-0.00418864413442521,0.00218975864929025,-0.0084805710870341,0.000103282818183673,0.0557903479563339
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00554972650748657,0.00290625256361977,-0.0112459815321813,0.000146528517208175,0.056212268868118
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0104881813685836,0.00549939413634819,-0.0212669938758261,0.000290631138658803,0.0565267931531622
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.00805761165925828,0.00422620943756893,-0.0163409821568934,0.000225758838376821,0.0565959866137364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,41839,-0.0127470094695626,0.00668772933039558,-0.0258549589571379,0.000360940018012767,0.0566680108381592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,41913,-0.00928922576511782,0.00487511028637409,-0.018844441926411,0.000265990396175404,0.0567445372816767
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00666574632735929,0.00350110707723673,-0.000196423544024707,0.0135279161987433,0.0569495687681319
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.00700636502263705,0.00370354033214085,-0.000252574028359012,0.0142653040736331,0.0585386893845273
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.0110236507606722,0.00584160342138438,-0.000425891945241154,0.0224731934665856,0.0591741428979422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00570504519400706,0.00303033999817466,-0.000234421202415282,0.0116445115904294,0.0597714241006564
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00713177216013476,0.00379256416743697,-0.0003016536080417,0.0145651979283112,0.0600711908940748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,42137,0.00446479431612454,0.00237859562636734,-0.000197253111555447,0.00912684174380454,0.0605297690785116
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.010970967317676,0.00585389207976537,-0.0224445957940162,0.000502661158664094,0.0609336684882315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALLD,Palladin,39657,0.00727952662339797,0.00388693435132083,-0.000338864705190857,0.0148979179519868,0.0611196740867178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00792146586216066,0.00424208804486781,-0.000393026705780251,0.0162359584301016,0.0618792463543939
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,39757,-0.00762137163393361,0.00408273831654841,-0.0156235387343685,0.000380795466501263,0.0619654593836192
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.0106089708094665,0.00569883382939297,-0.0217786851150768,0.000560743496143679,0.0626848323029423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0110347733944782,0.00594981810092877,-0.0226964168722986,0.000626870083342166,0.0636690776713146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,41913,-0.00546420315383853,0.00294875441417581,-0.0112437618056231,0.000315355497946061,0.0638966345825848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.0117168448525862,0.00633678441383401,-0.0241369423037009,0.000703252598528466,0.0644815339653793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEO1,Neogenin,39934,-0.0042425276795256,0.00230418182775039,-0.00875872406191636,0.00027366870286516,0.0656140435741137
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00698580070442179,0.00379520384635804,-0.0144244002432836,0.00045279883443998,0.0656932705842527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00484100730567672,0.00263074230267799,-0.000315247607572142,0.00999726221892557,0.0657655906691012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,39586,0.00877319108867876,0.00476795819840114,-0.000572006980187471,0.018118389157545,0.0657906397695648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0114553114700511,0.00623596797973787,-0.0236778087103373,0.00076718577023514,0.0662356202663546
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.0059796115633373,0.00326135654101691,-0.0123718703837304,0.000412647257055848,0.0667539659751685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0170453615900367,0.00929850821072525,-0.0352704376830582,0.0011797145029848,0.0668103344450603
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.0116604347263993,0.00636119046751087,-0.0241283680427206,0.00080749858992198,0.0668201098877307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00514706048304585,0.00281389844928451,-0.0106623014436435,0.000368180477551803,0.0673986562789501
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,41814,-0.0112743112490138,0.00616598795997317,-0.0233596476505612,0.000811025152533599,0.0675018847559521
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.00548972238249339,0.00300719209672507,-0.0113838188920745,0.000404374127087752,0.0679430803236728
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.0054741260232307,0.0029999115042148,-0.000405700525030309,0.0113539525714917,0.0680640203465792
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.00444618051626396,0.00243722034228289,-0.000330771354610497,0.00922313238713841,0.0681312776938583
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.0103653118862084,0.0056878812241827,-0.0215135590856065,0.000782935313189712,0.0684242994348864
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00808052815700857,0.00444655645488907,-0.0167957788085911,0.000634722494574009,0.0692053309126437
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00634226657565233,0.00350157949620043,-0.0132053623882052,0.000520829236900509,0.0701227790247875
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00800522515895247,0.00442265036733841,-0.000663169561030822,0.0166736198789358,0.0703098805788228
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00617639564283899,0.00341609823731546,-0.0128719481879773,0.000519156902299318,0.0706288390330954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,42296,-0.0144688172860409,0.00802367979200345,-0.0301952296783677,0.00125759510628587,0.0713686468655529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.0116492875881043,0.00646543958534354,-0.00102297399916903,0.0243215491753776,0.0716029355700451
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,41839,-0.00701210908333222,0.00389655382359385,-0.0146493545775762,0.000625136410911722,0.071951820282057
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,42119,-0.0100805980195697,0.00560323502135085,-0.0210629386614174,0.000901742622277919,0.0720302975198535
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00481705231582331,0.00267863672218952,-0.000433075659668144,0.0100671802913148,0.0721534074155021
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,39757,0.00613176193207467,0.00341087944524756,-0.000553561780610549,0.0128170856447599,0.0722504756841584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,39586,0.016952926695359,0.009449391479696,-0.00156788060484521,0.0354737339955631,0.0728285225071192
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.0120088186835667,0.00672225072246108,-0.00116679273245703,0.0251844300995904,0.0740575376202035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,41839,-0.00811057779364233,0.00455072494455592,-0.0170299986849719,0.000808843097687277,0.0747296549670718
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.0066131231467735,0.00371340005598192,-0.000665140962951067,0.0138913872564981,0.0749595648257412
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,39575,0.00730135035051095,0.00410128030105789,-0.00073715903956252,0.0153398597405844,0.0750608751587519
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.0107764580125667,0.00606371832030721,-0.0226613459203689,0.00110842989523542,0.0755625825666285
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,-0.00652435317780978,0.00367175721521511,-0.0137209973196314,0.000672290964011837,0.0756111598860155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.0146088658362637,0.00824949452063884,-0.0307778750967158,0.00156014342418841,0.0766082037913552
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,41538,-0.00507279275697161,0.00287260565810016,-0.0107030998468479,0.000557514332904699,0.0774327949995085
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,39560,0.00550446822525203,0.00312411992178623,-0.000618806821448975,0.011627743271953,0.0781096691857378
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,39560,-0.0127814218706929,0.00725488697629305,-0.0270010003442273,0.00143815660284144,0.0781365150933902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.00620674839029962,0.00353261995704607,-0.0131306835061099,0.000717186725510667,0.078947973629479
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0159739805250042,0.00909840788743002,-0.0338068599843671,0.00185889893435862,0.079168905721457
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,42262,-0.00563410946084426,0.00321490908243289,-0.0119353312624127,0.000667112340724206,0.0797113000078685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,42165,-0.00950397558202354,0.00542563418580434,-0.0201382185862,0.00113026742215297,0.0798514226613994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.0113533136031895,0.00648241280433494,-0.00135221549330695,0.024058842699686,0.0798996395511981
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.00946041816334712,0.00541290743170054,-0.0200697167294802,0.00114888040278594,0.0805298167474831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.0200954553462726,0.0115150033178165,-0.0426648618491929,0.00247395115664762,0.0809856292994013
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00463803445024386,0.0026576655891648,-0.00057099010451914,0.00984705900500687,0.0809861750966158
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00679517732453904,0.00389382861178539,-0.0144270814036384,0.000836726754560329,0.080992902466528
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0104566124709382,0.00599977546635157,-0.0222161723849873,0.00130294744311091,0.0813906001019553
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.0119332695338104,0.00684972377661299,-0.0253587281359719,0.00149218906835102,0.0815041343665708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00618400058855969,0.00355192718225007,-0.000777776688650445,0.0131457778657698,0.0817064374887936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.005605285088751,0.00322146125332036,-0.000708778967756902,0.0119193491452589,0.0818853821368414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.00707493573643195,0.00406741913054259,-0.0150470772322954,0.000897205759431518,0.0819847715076449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00691790519507403,0.00398261822040654,-0.000888026516922782,0.0147238369070708,0.0824107598117254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.00711222053314541,0.00409871902575443,-0.0151457098236241,0.000921268757333273,0.0827279714606007
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,39822,0.00554494530739637,0.00319993883474229,-0.00072693480869851,0.0118168254234912,0.0831536223572888
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0154254190350586,0.00891360136300149,-0.0328960777065415,0.00204523963642435,0.0835551585336985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.00902185486122608,0.00521797442803651,-0.0192490847401776,0.00120537501772549,0.0838378142721231
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.00777482089747508,0.00450671581603207,-0.00105834210194777,0.0166079838968979,0.0845205944634489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.00804890073096148,0.00466572936362345,-0.0171937302836634,0.00109592882174048,0.0845347429929372
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00977860380172557,0.00569258544931412,-0.0013788636789301,0.0209360712823813,0.0858651111568866
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00533780320485893,0.00310793197773605,-0.0114293498812216,0.000753743471503727,0.0859197144183149
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS2,Podocin,39657,0.0178401745825877,0.0103876640890398,-0.00251964703193038,0.0381999961971058,0.0859270774786127
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.0107529930204816,0.00628144480917429,-0.0230646248464632,0.00155863880549998,0.0869496201775183
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.00672694560402905,0.00393963224452941,-0.000994733595248599,0.0144486248033067,0.0877558693164192
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,42027,-0.0079781036111384,0.00469333671051198,-0.0171770435637419,0.00122083634146508,0.0891768848284932
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.00828726645273796,0.00487808595499226,-0.00127378201904687,0.0178483149245228,0.0893659107777872
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,39638,-0.00315700846736359,0.00185907584391008,-0.00680079712142734,0.000486780186700173,0.0895057293389605
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.00700057188016778,0.00412877331670586,-0.0010918238205757,0.0150929675809113,0.0899930162599753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00596186924523414,0.00351870801513133,-0.000934798464423276,0.0128585369548915,0.0902300381157899
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.00855709005817841,0.00506353388329629,-0.0184816164694391,0.00136743635308233,0.0910668070492291
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.00980282741771748,0.00580461377918434,-0.0211798704249188,0.00157421558948383,0.0912854874182224
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,39560,0.00523899689871728,0.00310258729271507,-0.000842074195004256,0.0113200679924388,0.0913265362683899
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00591131107725577,0.00351581797090137,-0.000979692145710907,0.0128023143002224,0.0927182506866991
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00690322692142995,0.00410870309568244,-0.0149562849889675,0.00114983114610763,0.0929566312021463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.00968418458482853,0.00578408627519626,-0.0210209936842132,0.00165262451455614,0.0940989158144417
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0144115699285223,0.00861292373528814,-0.00246976059264248,0.031292900449687,0.0943018240413253
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.0127547804137382,0.00762441024498225,-0.00218906366642698,0.0276986244939035,0.0943779221109157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0142495744165118,0.00853395211044825,-0.0309761205529904,0.00247697171996673,0.094997211053496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,39966,0.00809474126637521,0.0048754758149561,-0.00146119133093874,0.0176506738636892,0.0968821632407748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.00955965468918679,0.00576936452056129,-0.0208676091494869,0.00174829977111333,0.0975494280462204
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.0120244785454388,0.00728858054243143,-0.0263100964086044,0.00226113931772678,0.0990135138064034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00852700692197039,0.00517467424754839,-0.00161535460322445,0.0186693684471652,0.0994152560956155
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.00829537809586868,0.00504033388912859,-0.00158367632682336,0.0181744325185607,0.0998328094311445
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.0166037485129362,0.0100907091381255,-0.0363815384236621,0.0031740413977897,0.0999049648632923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,42015,-0.00841683145501298,0.00511831724260475,-0.0184487332505183,0.00161507034049234,0.100106123834714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.00903347723492712,0.0055008998931773,-0.0198152410255546,0.00174828655570039,0.100580129386852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.00802856876540982,0.00489784336087538,-0.0176283417527256,0.00157120422190592,0.101194391289749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.00712588474420347,0.00435498711935333,-0.015661659498136,0.00140989000972907,0.101809133025532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0129256144958866,0.00791793320865745,-0.0284447635848552,0.00259353459308203,0.102613633092295
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.00606260215054568,0.00372794837195318,-0.0133693809595739,0.00124417665848255,0.103923704095808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.0144598165345694,0.0088954433294007,-0.0318948854601948,0.00297525239105594,0.10407823274858
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.0053717408386303,0.00330686235275427,-0.00110970937276806,0.0118531910500287,0.104314405372954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0138563308704894,0.00853737080278483,-0.00287691590296888,0.0305895776439477,0.104613667208017
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,39919,0.0173354242279405,0.0106846113987217,-0.0036064141135539,0.038277262569435,0.104731346634901
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.00558823510666157,0.00344956459740717,-0.0123493817175796,0.00117291150425647,0.105259669594985
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00668499508054843,0.00413063208665154,-0.0147810339703854,0.00141104380928859,0.105606194300861
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,39586,-0.00643940431492964,0.00398217048243455,-0.0142444584605014,0.00136564983064208,0.105894272901682
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,0.00323898631215114,0.00200678700584302,-0.000694316219301188,0.00717228884360346,0.106551737210847
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00734695716899679,0.00455675033506211,-0.0162781878257185,0.00158427348772494,0.106920029285624
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.0126703032559165,0.00786014905137543,-0.0280761953966123,0.00273558888477936,0.106997616695094
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,39966,0.00526504295244361,0.00327053754785349,-0.00114521064134922,0.0116752965462364,0.107460508140659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.0100746067361258,0.00626118200150123,-0.0223465234590682,0.00219730998681661,0.107626917220202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00667879546837472,0.00415699795482408,-0.00146892052308046,0.0148265114598299,0.108162134514272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,39966,-0.0138769849592585,0.00865498841207068,-0.030840762246917,0.00308679232840003,0.108884952499554
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.0119358863185722,0.00745412707411232,-0.0265459753838323,0.00267420274668796,0.109345650799238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.00556976857995349,0.00348428441830225,-0.00125942887991893,0.0123989660398259,0.109950610956994
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.0137912732153602,0.00862812428651476,-0.0307023968169291,0.00311985038620876,0.109975393934721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00416080803085879,0.00260336893562504,-0.00926341114468387,0.000941795082966291,0.110017407881435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.0111038350555642,0.00695426506199535,-0.0247341945770751,0.00252652446594666,0.110357744483841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0113288431070295,0.00715764794605356,-0.0253578330812944,0.0027001468672355,0.113504662987311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00537491132415466,0.00340967409853389,-0.0120578725572811,0.00130804990897176,0.114963950934546
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0148263752734056,0.00940831709989078,-0.0332666767891915,0.00361392624238029,0.115082368775892
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,42119,-0.0102808764329649,0.00653704179510402,-0.0230934783513688,0.00253172548543894,0.115809192123308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.00940871623623645,0.00598486148256013,-0.0211390447420543,0.0023216122695814,0.115954006117357
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.0183535416681611,0.0116941534304433,-0.04127408239183,0.00456699905550789,0.116568008620165
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00858977672083616,0.00547916288131311,-0.00214938252653754,0.0193289359682099,0.116976120078955
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.00456912845258902,0.00291786877570231,-0.0102881512529655,0.00114989434778751,0.117392586797401
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0120707556516177,0.00771080224476225,-0.00304241674811628,0.0271839280513518,0.117509025296376
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.00981707595940698,0.00627544629952724,-0.00248279878766641,0.0221169507064804,0.117761148872812
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOC,Myocilin,42137,0.00707217512933508,0.00452640925081682,-0.00179958700226588,0.015943937260936,0.118211269039092
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00721133984341237,0.00462139094673336,-0.0162692660990098,0.00184658641218502,0.118687984811035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00495590515060553,0.00317616313439922,-0.011181184894028,0.00126937459281694,0.118702650232064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00541448581032526,0.00347032651892982,-0.0122163257874277,0.00138735416677719,0.118730510669824
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00838768334622682,0.00537891215414841,-0.00215498447590406,0.0189303511683577,0.118939064331276
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,42119,-0.00941818671615114,0.00604243439862792,-0.0212613581374619,0.00242498470515959,0.119096914526896
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.00387421851516047,0.0024887391374964,-0.00100371019433247,0.00875214722465341,0.119565267896685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.00495480749200001,0.00321148707117355,-0.0112493221515002,0.00133970716750015,0.122893205965335
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,39970,0.00557808012652387,0.00361855236666523,-0.00151428251213998,0.0126704427651877,0.123217484343064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0131492238412289,0.0085525313343868,-0.029912185256627,0.00361373757416922,0.12420345042198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00603363865334106,0.00393218606852047,-0.00167344604095905,0.0137407233476412,0.124949399356308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.0106687793206981,0.00695548570920103,-0.00296397266933591,0.0243015313107321,0.125091617757014
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.0104738254020803,0.00683888971273646,-0.00293039843488316,0.0238780492390437,0.125672351828255
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0121204257278849,0.00791666487689379,-0.0276370888865967,0.00339623743082697,0.125796970046364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.00565738058566746,0.00370078170100544,-0.0129109127196381,0.00159615154830321,0.126367732608684
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,39586,0.00817170257175857,0.00535917733897916,-0.00233228501264057,0.0186756901561577,0.12733642663062
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,41800,-0.00742432814786273,0.00486924384926205,-0.0169680460924164,0.0021193897966909,0.127348057022606
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.0046031115768976,0.00301977227484257,-0.00131564208179383,0.010521865235589,0.127456375916312
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.00666017766595966,0.00439027570722483,-0.001944762720201,0.0152651180521203,0.129287829788141
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.0094996409673054,0.00626648499879213,-0.00278266963032718,0.021781951564938,0.129561412240255
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.00542789068375419,0.00359044215701199,-0.00160937594398931,0.0124651573114977,0.130617998660313
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.0106623224755342,0.00706753719393191,-0.0245146953756408,0.0031900504245723,0.131420816465243
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.00869961417333947,0.00578972610058534,-0.0200474773304867,0.00264824898380779,0.132972293778404
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.00870740347143174,0.00581225485902992,-0.0200994229951304,0.00268461605226691,0.134133120842753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.00608948311882738,0.00408098679380662,-0.0140882172346884,0.0019092509970336,0.13568085627058
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,39929,0.00607753854404593,0.00407881272501903,-0.00191693439699138,0.0140720114850832,0.136245139480896
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0174331592282475,0.0117189709172889,-0.0404023422261338,0.00553602376963869,0.136879689875455
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,42249,-0.00978387530512884,0.0065876833557019,-0.0226957346823046,0.00312798407204689,0.137520057502484
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.015840408162077,0.0106684166749904,-0.0367505048450581,0.0050696885209041,0.137626732566518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,39510,0.00516494659546948,0.00350163161989661,-0.00169825137952788,0.0120281445704668,0.140238331796505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NENF,Neudesin,39919,-0.0168194132705417,0.0114647977029541,-0.0392904167683317,0.00565159022724835,0.14239066879949
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.00777965620678953,0.00530409896871691,-0.0181756901854747,0.00261637777189562,0.142478576159422
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.0108744655464526,0.00742525871808723,-0.0254279726339036,0.00367904154099838,0.143079593652855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00856599116371358,0.00585649393836581,-0.00291273695548341,0.0200447192829106,0.143592049836775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.00741809689602683,0.00507384054784856,-0.01736282436981,0.00252663057775635,0.14375726856787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.00750869810362562,0.00514658434271746,-0.0175960034153518,0.0025786072081006,0.144602543226337
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,39979,-0.00383170888240037,0.00262859955133886,-0.00898376400302454,0.0013203462382238,0.144950920338407
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0115483104307029,0.0079350203422735,-0.0271009503015589,0.00400432944015319,0.145593354379685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.00550020479087445,0.0037980334495421,-0.012944350351977,0.00194394077022808,0.147592072662527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.00499656204099085,0.00345776693872902,-0.0117737852408997,0.00178066115891803,0.14847385731451
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.00863223166067707,0.00597447099271898,-0.0203421948064063,0.00307773148505214,0.148527549716863
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00854408567000735,0.0059265254118836,-0.0030719041372845,0.0201600754772992,0.149424385930672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.00470808157279813,0.00326838174753183,-0.00169794665236425,0.0111141097979605,0.149751035600402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.00677482931400235,0.00470749559995582,-0.0160015206899158,0.00245186206191104,0.150133452513124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.00892260624363662,0.00620723514563979,-0.00324357464181737,0.0210887871290906,0.150612579011602
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,42070,0.00405582924442669,0.00282282465484068,-0.00147690707906105,0.00958856556791443,0.150798581651708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.0060540139641554,0.00421779420689473,-0.00221286268135827,0.0143208906096691,0.151215649335967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00650394043627178,0.0045378878586374,-0.0153982006392011,0.00239031976665752,0.151814064998928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.00896543207215866,0.0062766009894524,-0.0212675700114854,0.00333670586716805,0.153207994320715
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,39657,-0.00249445435096729,0.00174725223407062,-0.0059190687297457,0.000930160027811132,0.153422563345614
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,42137,-0.00492535413239033,0.00345335475146876,-0.0116939294452691,0.00184322118048844,0.15381867414531
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.00671992450905622,0.00471769112948706,-0.00252675010473842,0.0159665991228509,0.154356370791896
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.00411879769716133,0.00289305918356876,-0.00155159830263343,0.00978919369695609,0.154561378238802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.011274215109707,0.00792097817095327,-0.00425090210536141,0.0267993323247754,0.154667177224003
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.00486097142126005,0.00342290326487376,-0.0115698618204126,0.00184791897789251,0.15559772922223
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0100689082198004,0.00709974408417111,-0.00384659018517498,0.0239844066247758,0.156153109291737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,39657,0.00802169703809796,0.00566801752127892,-0.00308761730360873,0.0191310113798046,0.15702155010923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,39649,0.004927430864934,0.0034921673619454,-0.00191721716447897,0.011772078894347,0.158274228338342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.00903990421141265,0.00641461812482337,-0.0216125557360665,0.00353274731324115,0.158783841334523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.0100140036686951,0.0072152277211299,-0.00412784266471951,0.0241558500021097,0.165196103492973
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.00878380660421444,0.00636003199162669,-0.0212494693078027,0.00368185609937386,0.167277996630044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.00797878005920191,0.00578245343367877,-0.00335482867080847,0.0193123887892123,0.167668148828201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.00661881926294566,0.00480536393041425,-0.0160373325665576,0.00279969404066627,0.168417615055752
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0140045947787676,0.0101689486819988,-0.0339357341954853,0.00592654463795005,0.168480981271423
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,39757,-0.00987963479674389,0.00717793708042508,-0.023948391474377,0.00418912188088926,0.168728803916592
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0116637891065601,0.00849040232540141,-0.00497739945122671,0.0283049776643468,0.169543720187064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0108006983722026,0.00789096559934294,-0.0262669909469148,0.00466559420250957,0.171107670531804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.00742329576590669,0.0054346710316621,-0.0180752509879644,0.00322865945615102,0.17199285769847
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.0096131983502107,0.00705067619955162,-0.00420612700091049,0.0234325237013319,0.172770551578529
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,39979,0.00260315609691293,0.00191390050580336,-0.00114808889446166,0.00635440108828752,0.173815303591356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.00382264062126842,0.00281411213091697,-0.00169301915532885,0.00933830039786568,0.17436491284956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00717436352600836,0.00528478530853097,-0.0175325427307291,0.00318381567871235,0.174634857522439
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00494243546031895,0.0036439144686599,-0.00219963689825445,0.0120845078188924,0.175014681743238
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.00634621947647006,0.00468501591128294,-0.0155288506625846,0.0028364117096445,0.175575156340083
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.00529634644884378,0.00393048395084133,-0.00240740209480522,0.0130000949924928,0.177844642197048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00768780249862356,0.00572487366945958,-0.0189085548907643,0.00353294989351721,0.179339315213803
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00576517250982405,0.00430159882611459,-0.00266596118936055,0.0141963062090086,0.180194406011106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,39757,-0.0118069566426059,0.00882608592828694,-0.0291060850620483,0.0054921717768365,0.181010377991889
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.00383917377447396,0.00287169699637777,-0.00946769988737439,0.00178935233842647,0.181277499334028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00527475449311614,0.00395057738845396,-0.0130178861744859,0.00246837718825362,0.181843263795288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0031786427366784,0.00238075069641146,-0.00148762862828807,0.00784491410164486,0.181852007667261
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,39649,-0.00488093653246373,0.00366475470265553,-0.0120638557496686,0.00230198268474111,0.182933998778855
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00426871026539743,0.00320586516407688,-0.0105522059869881,0.00201478545619326,0.183041675618772
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.00636830894168903,0.0047844459292414,-0.00300920507962412,0.0157458229630022,0.183197131339353
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.00688753002578912,0.00518525045164205,-0.0032755608594293,0.0170506209110075,0.184104044236486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00490225536545665,0.00369589218935239,-0.00234169332567404,0.0121462040565873,0.184731817995792
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,39657,-0.00534733346914698,0.00405531047744622,-0.0132957420049416,0.00260107506664762,0.187330096055972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.0100706266511451,0.00765817302825971,-0.0250806457865342,0.0049393924842439,0.188531748671698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,41714,-0.00351361447158513,0.00267684966980857,-0.00876023982440993,0.00173301088123967,0.189343058434306
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.00462486973683179,0.00352428390385918,-0.00228272671473221,0.0115324661883958,0.189450945328421
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.00550795630235064,0.00421744845767134,-0.00275824267468518,0.0137741552793865,0.191582256878199
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.0108851084391976,0.00836856404747433,-0.0272874939722473,0.00551727709385203,0.193383494244264
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0159923195158884,0.0123021755980077,-0.0401045836879836,0.00811994465620669,0.193641588923174
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.00569353181475475,0.00438507730428267,-0.0142882833311488,0.0029012197016393,0.19418131755893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.00759085698510364,0.00585188826548782,-0.0190605579854598,0.00387884401525249,0.194602175224245
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.00925941634739756,0.00716046694973276,-0.0232939315688738,0.00477509887407864,0.195992427674638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00561572722769555,0.00434305761804498,-0.0028966657036726,0.0141281201590637,0.196026071747261
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,42137,0.00260625542004586,0.00201723344465592,-0.00134752213147974,0.00656003297157146,0.19638095001545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,41843,0.0116275778594826,0.00900523209768064,-0.00602267705197144,0.0292778327709367,0.196656019032707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,42145,0.0150046638667875,0.0116226392077343,-0.0077757089803717,0.0377850367139467,0.196730583966362
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,41900,-0.00635305501119769,0.00492538973997083,-0.0160068189015405,0.00330070887914514,0.197122276500587
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,41839,0.004215614881536,0.00326892131017375,-0.00219147088640456,0.0106227006494766,0.197210620288162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00702523201208467,0.00544942107366986,-0.00365563329230825,0.0177060973164776,0.197361272768405
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.00932091425838438,0.0072459461598612,-0.0235229687317123,0.00488114021494357,0.198339026815882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00435366204267299,0.00339152973996688,-0.00229373624766209,0.0110010603330081,0.199278630485139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.00874542371054694,0.00681895876768351,-0.0221105828952066,0.00461973547411273,0.199683643862192
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.00605084408847421,0.00473422189110325,-0.0153299189950366,0.00322823081808816,0.201238586318559
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00548021618183432,0.00428812915398492,-0.00292451695997613,0.0138849493236448,0.201277073179804
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00630476599401344,0.00494698717110722,-0.0160008608493836,0.00339132886135671,0.202525339791874
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,-0.00485209797811782,0.00381212802586692,-0.012323868908817,0.00261967295258135,0.203108994004953
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00567515885486685,0.00446787142455828,-0.0144321868470011,0.00308186913726738,0.204034660229251
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00933654975315779,0.00738430716561541,-0.00513669229144842,0.023809791797764,0.20612107799574
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00584059423132557,0.00462969956452157,-0.0149148053777879,0.00323361691513671,0.207137643089527
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00501462328700568,0.00398800702616382,-0.00280187048427541,0.0128311170582868,0.208621259011109
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.00851422295592596,0.00677200850625423,-0.0217873596281842,0.00475891371633233,0.208679140601275
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00782441090577409,0.00624834236849777,-0.00442234013648154,0.0200711619480297,0.210509451419532
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.00657629017773546,0.00525265274294091,-0.00371890919842872,0.0168714895538996,0.210594129992212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,39736,0.0122988667714265,0.00988953632344893,-0.0070846244225334,0.0316823579653864,0.213664081411446
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.0034048828736454,0.00273976396581733,-0.00196505449935657,0.00877482024664737,0.21397568301286
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0111137857135273,0.00896690807321307,-0.028688925537025,0.00646135410997029,0.215215503234736
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00672794015575442,0.00543810558879919,-0.003930746798292,0.0173866271098008,0.216044245789573
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00304507873903919,0.00246368748157232,-0.00787390620292093,0.00178374872484255,0.216490060905487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00587258284901219,0.00475165262598454,-0.00344065629791751,0.0151858219959419,0.216520959646309
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00781564969405832,0.00632665955702739,-0.020215902425832,0.00458460303771537,0.216721855541852
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-0.00285443482431725,0.00231502046721524,-0.00739187494005911,0.00168300529142462,0.217594789415526
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.00579434090437299,0.00469973160268758,-0.00341713303689467,0.0150058148456407,0.217631647628857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.0056138874661761,0.00455651373302286,-0.0033168794505487,0.0145446543829009,0.217953955990568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,39649,-0.00503068667608422,0.004091914604587,-0.0130508393010748,0.0029894659489063,0.218940095041239
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,42145,-0.00946708358818195,0.00773575031263977,-0.0246291542009559,0.005694987024592,0.221045442538111
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,42249,-0.00370438495234581,0.00304371843000414,-0.00967007307515392,0.00226130317046229,0.223602806041699
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00314538123699745,0.00258980510684572,-0.00193063677242016,0.00822139924641506,0.224573742402777
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.0058798485651747,0.00485024927955008,-0.0153863371530929,0.00362664002274345,0.225432230672119
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00517045493890423,0.0042739725121505,-0.00320653118491075,0.0135474410627192,0.226399201835856
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.0075514856396922,0.0062718911110914,-0.00474142093804694,0.0198443922174313,0.228607611416483
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00588632303740239,0.00490043748978746,-0.00371853444258102,0.0154911805173858,0.229706077966162
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.00618955952682225,0.00515944533083265,-0.00392295332160973,0.0163020723752542,0.230294438164275
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,42132,-0.0232465827248975,0.019439747920477,-0.0613484886490325,0.0148553231992374,0.231784884666064
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.0115380975311508,0.00965499522653024,-0.0304618881751501,0.00738569311284847,0.23209267274015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00368756908623579,0.00309178737107786,-0.0097474723335484,0.00237233416107681,0.233008978452576
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00477128765920612,0.00402413887010189,-0.00311602452619358,0.0126585998446058,0.235779599727196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00506414876159185,0.00428176409801576,-0.00332810887051903,0.0134564063937027,0.236943665331438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,39757,0.00499712219328488,0.0042330992972964,-0.00329975242941606,0.0132939968159858,0.237831415303478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESPL1,Separin,39560,0.00641415153331422,0.00543945556102171,-0.00424718136628834,0.0170754844329168,0.238348129206564
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,39657,-0.00562754259503522,0.0047823575573795,-0.015000963407499,0.00374587821742859,0.239328705805281
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.00378119317094932,0.00321551251046171,-0.00252121134955563,0.0100835976914543,0.23965137049458
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,39958,-0.0118348042668562,0.0100684279128688,-0.0315689229760792,0.00789931444236673,0.239844504845125
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,41864,-0.00591792991673839,0.00503614582957674,-0.0157887757427088,0.00395291590923203,0.239979382589818
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.0288581108193986,0.0245689599526444,-0.0770132723265817,0.0192970506877844,0.240189075896829
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.00832743850321248,0.00709122350507608,-0.0222262365731616,0.00557135956673663,0.240283155445699
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.00982021558198172,0.00836447084933956,-0.00657414728272382,0.0262145784466873,0.240404436105202
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00638758598198409,0.00547818459661502,-0.00434965582738135,0.0171248277913495,0.243633771989198
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.00883815752140042,0.00761477680112068,-0.00608680500879612,0.023763120051597,0.245805938027629
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.00861977938856181,0.0074775853293915,-0.0232758466341692,0.00603628785704553,0.249037593898382
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.00564197165635212,0.00491070259263735,-0.0152669487379213,0.00398300542521709,0.250616734782783
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,39757,0.00621920841160872,0.00543544798859459,-0.00443426964603668,0.0168726864692541,0.252567628146474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00546395642917889,0.00478049807441755,-0.0148337326550373,0.0039058197966795,0.253076010302905
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.00562218271819855,0.00493835669566643,-0.0153013618417048,0.00405699640530766,0.254943370657692
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00419802042578475,0.00368904178689628,-0.00303250147653196,0.0114285423281015,0.255157509689755
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00494253707236457,0.00435002433502452,-0.00358351062428348,0.0134685847690126,0.255893887701108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.00718821288354545,0.00632683385596033,-0.0195888072412277,0.00521238147413679,0.255919917385009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00647352263404145,0.00569810491776769,-0.00469476300478322,0.0176418082728661,0.255946427159404
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,41843,0.00625165163977328,0.00550381844573826,-0.0045358325138737,0.0170391357934203,0.256029296266169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00600918539910133,0.00532202280641882,-0.0164403500996822,0.00442197930147956,0.258873274749938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.00555152738526868,0.00493090249247101,-0.0152160962705119,0.0041130414999745,0.260246806779068
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,0.00320224572005914,0.00285006720388681,-0.00238388599955901,0.00878837743967728,0.261219874642597
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,41913,0.00309956859246884,0.00276819924022809,-0.00232610191837821,0.00852523910331589,0.262859376352008
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.00979606066721706,0.00880993163537239,-0.0270635266725469,0.00747140533811282,0.266190795063659
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPGN,Epigen,39919,0.00523914454207181,0.00472382036651531,-0.00401954337629821,0.0144978324604418,0.267414683461621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,39649,0.00540601650816831,0.0048889392695346,-0.00417630446011951,0.0149883374764561,0.268852449748402
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,39759,-0.00275461277566663,0.00249259154481747,-0.00764009220350887,0.00213086665217562,0.269131420604381
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00751199059721462,0.00683904994798314,-0.0209165284952616,0.00589254730083233,0.27205535363309
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.00837953949618601,0.00763724458354019,-0.0233485388799248,0.00658945988755277,0.272580287581419
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,42079,0.00316915203693944,0.00290543905777369,-0.00252550851629698,0.00886381259017587,0.275395677154208
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,39757,-0.0048117409109501,0.00441924929452304,-0.0134734695282153,0.00384998770631506,0.276259393616591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.00562619198020607,0.00517978753387649,-0.00452619158619185,0.015778575546604,0.277417764920035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.00416151315143103,0.00385074762555895,-0.00338595219466451,0.0117089784975266,0.279852410060721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.00337389738570504,0.0031535504952414,-0.0028070615849681,0.00955485635637819,0.284699376266395
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,42144,0.00360375980845886,0.00336997324981515,-0.00300138776117884,0.0102089073780966,0.284920498469311
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.0053810123386116,0.00504303822173691,-0.00450334257599274,0.0152653672532159,0.285987198002865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.00266034531723749,0.00249551008236839,-0.00223085444420456,0.00755154507867954,0.286419055395689
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLPS,Colipase,42115,0.00793278284616328,0.00746372096248161,-0.00669611024030068,0.0225616759326272,0.287870975174634
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.00567534665228469,0.00534722291750775,-0.0161559035705999,0.00480521026603049,0.288547804330404
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.0028558292697442,0.00269260670416201,-0.00813333840990174,0.00242167987041334,0.288885668160553
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.00257552910195328,0.00243063885288774,-0.0021885230497067,0.00733958125361325,0.289341277811735
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00319098243521141,0.00301846895727305,-0.00910718159146659,0.00272521672104377,0.29046522909294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.00309597851141108,0.00293175446609029,-0.00884221726494806,0.00265026024212589,0.290979857411232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,39649,-0.00617708289318427,0.00589546585468443,-0.0177321959683658,0.00537803018199722,0.29476823840857
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00518800004017445,0.0049523075929241,-0.0148945229223057,0.00451852284195679,0.294845797128775
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.00802699192849715,0.0076649534166098,-0.0230503006250524,0.00699631676805807,0.295011261098665
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,39736,0.00552452620048894,0.00532496210695034,-0.00491239952913371,0.0159614519301116,0.299536093028279
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.0111974686453536,0.010797081869436,-0.00996481181874093,0.032359749109448,0.299720086687296
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,-0.00542784416089612,0.00523473694565238,-0.0156879285743748,0.00483224025258255,0.299809382154871
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.00395454883698553,0.00381986949152519,-0.00353239536640385,0.0114414930403749,0.30057142284353
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.00537803829446998,0.00519719024930494,-0.0048084545941677,0.0155645311831077,0.30078249244546
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.00419420936566926,0.00408138479515414,-0.0121937235641714,0.00380530483283285,0.304140139370419
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,39649,0.00614009020842297,0.00600256815055469,-0.00562494336666422,0.0179051237835102,0.306372542226698
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00365270918249211,0.00357719854902963,-0.00335859997360597,0.0106640183385902,0.307221511980942
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.00356275508332015,0.00349182503517392,-0.00328122198562073,0.010406732152261,0.307601689273749
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,39657,0.00344423361789104,0.00339533642388624,-0.00321062577292598,0.0100990930087081,0.310413509581774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.00377571341099127,0.00372569001439189,-0.00352663901721684,0.0110780658391994,0.310878804705232
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.00137558358857929,0.0013626949979537,-0.00129529860740995,0.00404646578456854,0.312776791339959
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00540324479283749,0.00535277461137869,-0.00508819344546475,0.0158946830311397,0.31278748578468
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,42166,-0.00834883078254807,0.00833755564271696,-0.0246904398422733,0.00799277827717717,0.316674361404135
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.00900450090745722,0.00901586286782715,-0.0266755921283984,0.00866659031348399,0.317942093525425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.00280350027262108,0.00282255924687362,-0.00833571639649336,0.00272871585125121,0.320611066339715
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,39586,-0.00495354972086021,0.00499485884736981,-0.014743473061705,0.00483637361998463,0.321351255097224
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.00576669289292582,0.00585414727645646,-0.0172408215547805,0.00570743576892885,0.324611663904748
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,42158,-0.00307498873341024,0.00312828482156215,-0.00920642698367206,0.00305644951685158,0.325643110640633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,39959,0.00224641380852442,0.00228802958399147,-0.00223812417609885,0.0067309517931477,0.326213621472865
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,41900,0.00270287665380095,0.00276131013619773,-0.0027092912131466,0.00811504452074851,0.327677590618178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,41900,0.00321473439009421,0.0032869721234413,-0.00322773097185073,0.00965719975203916,0.328080729608099
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,39929,-0.00301173268434435,0.00308118636410443,-0.00905085795798903,0.00302739258930033,0.328362943156468
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00486727882059088,0.00498299823274258,-0.00489939771558459,0.0146339553567663,0.328700997567813
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.00353588328768554,0.00362334857254636,-0.00356587991450534,0.0106376464898764,0.329154308473041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.00486838224317611,0.00502608558321361,-0.0147195099862748,0.00498274549992257,0.332753977549348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00393915728548092,0.00407336692045519,-0.00404464187861126,0.0119229564495731,0.333539419427505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.00356214313911068,0.00368970766233453,-0.003669683879065,0.0107939701572864,0.3343516443133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.00662359950624149,0.00687374056085913,-0.0200961310055254,0.0068489319930424,0.335262460874397
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,-0.0108769777325108,0.0112892611476581,-0.0330039295819207,0.0112499741168991,0.335328490456432
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.0058965639289721,0.0061258992943243,-0.0179033265458477,0.00611019868790352,0.335787441509993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,39560,0.0045931459384011,0.00477216860638949,-0.00476030453012231,0.0139465964069245,0.335826717613805
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,39929,-0.00954717585051217,0.00998384908662711,-0.0291155200603013,0.010021168359277,0.33896026987278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.00305151422455124,0.0031911372839393,-0.0032031148519698,0.00930614330107227,0.338968575698034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.00550740949858026,0.00576158202364048,-0.00578529126775508,0.0168001102649156,0.339147459670491
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,39560,0.00645998241431901,0.00676235323864853,-0.00679422993343211,0.0197141947620701,0.339454076982106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.00451320040719659,0.00474129717409196,-0.0138061428684168,0.00477974205402365,0.341172825449167
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.00252665341795121,0.00267408282790904,-0.00776785576065293,0.00271454892475052,0.344747128142153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.00626803523968494,0.00663988303176984,-0.0192822059819538,0.00674613550258394,0.345187883062025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,39757,0.00323494045922379,0.00342793405018592,-0.00348381027914062,0.0099536911975882,0.345343543361481
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00214863813198882,0.00227827209970111,-0.00661405144740299,0.00231677518342535,0.345650440275609
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.00388974593526448,0.00412550969848447,-0.00419625307376508,0.011975744944294,0.345773116022088
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00739994803406111,0.00786778039509266,-0.00802090154032052,0.0228207976084427,0.346962124804495
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.00320910256975548,0.00342274411601326,-0.00991768103714146,0.00349947589763051,0.348476166100721
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.0182401565387206,0.019468087576848,-0.0563976081893427,0.0199172951119014,0.348813426268482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.0119779420192067,0.0127932442819107,-0.0370527008117516,0.0130968167733382,0.349150812645512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.00598006210861048,0.00639613640025932,-0.0185164894531188,0.00655636523589778,0.349834973218772
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,42246,-0.00411543599181972,0.00443378524355519,-0.0128056550691879,0.00457478308554846,0.35332065771885
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00457150525729505,0.00492929317431253,-0.00508990936435751,0.0142329198789476,0.353730991469928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.00995781478775057,0.0107555836762197,-0.0310387587931412,0.01112312921764,0.354555871406451
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.00343115816522767,0.00371034942922096,-0.00384112671604541,0.0107034430465007,0.355114274108303
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,41774,0.00593202495805618,0.00643201653174039,-0.00667472744415498,0.0185387773602673,0.356407155333136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00257211892140508,0.002793809860996,-0.00290374840614708,0.00804798624895724,0.357253491664278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,39929,0.00884461024814664,0.00967290597159407,-0.0101142854561777,0.027803505952471,0.360542179691802
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.00370321051155026,0.00405454345504982,-0.00424369466034738,0.0116501156834479,0.361075446551916
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00325814904162981,0.00357316780729147,-0.0102615579439211,0.00374525986066146,0.361874179719915
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00179447348018664,0.00197110392054879,-0.00206889020408898,0.00565783716446227,0.362636104598513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.00795103404668119,0.00874524173715093,-0.00918963975813463,0.025091707851497,0.363269243848921
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,39750,-0.00919830034967601,0.010124004825597,-0.029041349807846,0.010644749108494,0.363600265162292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.00755035404519381,0.00831752320586837,-0.0087519914383082,0.0238526995286958,0.364022505363917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENG,Endoglin,42310,-0.00157829990237558,0.00174848435739677,-0.00500532924287324,0.00184872943812209,0.366718279411289
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSC1,Hamartin,39657,0.0068063419296859,0.00754450930240196,-0.00798089630302194,0.0215935801623937,0.366992417098113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00642171681688167,0.00712149834290424,-0.020379853568974,0.00753641993521063,0.367215892445136
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00457747252150248,0.00509350525977038,-0.00540579778764746,0.0145607428306524,0.368838564370763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0126617476209793,0.0141113993957459,-0.0403200904366413,0.0149965951946826,0.369593400961815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00553960645712172,0.00617936336964364,-0.0065719457473798,0.0176511586616232,0.370022080231396
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00374186967252835,0.0041795578915091,-0.00445006379482949,0.0119338031398862,0.370654243739742
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00519621021976726,0.00582873494223662,-0.00622811026701651,0.016620530706551,0.3726903578481
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.0025994234145691,0.00291955205068075,-0.00312289860476516,0.00832174543390337,0.37329743289031
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00543627556800802,0.00611730317958758,-0.00655363866398363,0.0174261897999997,0.374195571646712
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.00583901213485381,0.00657140289698178,-0.00704093754323047,0.0187189618129381,0.374265120040429
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,-0.00714121728572365,0.00804628770194031,-0.0229119411815267,0.00862950661007936,0.374816323639188
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,0.00313393601342794,0.00353700531797892,-0.00379859440981074,0.0100664664366666,0.375613579851087
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,0.00341850336304517,0.0038760815153583,-0.00417861640705709,0.0110156231331474,0.377823488767474
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.0036285629642991,0.00411443873466382,-0.00443573695564199,0.0116928628842402,0.377845016505465
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,41843,-0.00655155754683811,0.00743091235347962,-0.0211161457596582,0.00801303066598195,0.377975290209638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00265029214957728,0.0030125773497292,-0.00855494375504651,0.00325435945589196,0.37901797178482
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.00472173041107403,0.0053914302080874,-0.0152889336189253,0.00584547279677728,0.381162874853169
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00614851181117065,0.00704379343684737,-0.0199543469473915,0.0076573233250502,0.382737753496242
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.00340730661817494,0.0039113875353061,-0.0110736261873749,0.00425901295102503,0.383704482528036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00346713774397494,0.00398087024387704,-0.00433536793402406,0.0112696434219739,0.38380069443658
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,39560,0.00532630686056292,0.00611675860260911,-0.00666254000055094,0.0173151537216768,0.38389730531738
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00387800964695267,0.00445717977590816,-0.0126140820077327,0.00485806271382733,0.384287138840779
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.0060638055934479,0.00697212944103743,-0.00760156811098547,0.0197291792978813,0.384471744078005
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00461239118240499,0.00531217256100659,-0.0150242494019779,0.00579946703716792,0.385266468241298
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00676402146889138,0.00779052482102701,-0.00850540718032155,0.0220334501181043,0.385283307925904
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,39649,-0.00650256503191214,0.00751360534969686,-0.021229231517318,0.0082241014534937,0.38681682426331
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00323233409581282,0.00374020530774191,-0.010563136498987,0.00409846830736131,0.387489645994589
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,39652,-0.00624285320018049,0.00724383867442136,-0.0204407770020463,0.00795507060168537,0.388807694898449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,39649,-0.00523041375060865,0.00607895843077593,-0.0171451722749295,0.00668434477371217,0.389580192046763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00310308003507261,0.00362901007420771,-0.0102159397805197,0.00400977971037451,0.392527079265083
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,0.00933061048006743,0.010938217705481,-0.0121082962226753,0.0307695171828102,0.393661536414344
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.00313838688227873,0.00368232166917041,-0.00407896358929528,0.0103557373538527,0.394071357584245
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,39560,0.00529910897357403,0.00624198222651227,-0.00693517619039002,0.0175333941375381,0.395929603445255
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.00707183679424687,0.00839344017136542,-0.0235229795301231,0.00937930594162936,0.399502254212036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C5,Complement C5,39979,-0.00127749131513581,0.00152947973889813,-0.00427527160337615,0.00172028897310453,0.403596941879199
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.0108636165861863,0.0130069809997758,-0.0146300661733743,0.0363572993457469,0.403611676400038
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,41865,-0.00628865607542278,0.00755113492175155,-0.0210888805220558,0.00851156837121027,0.404967231216545
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.00280452970696368,0.00336803675487006,-0.00379682233258165,0.00940588174650899,0.40503427846756
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00264718099281186,0.00317991400392637,-0.00887981244050755,0.00358545045488383,0.40516220149981
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.00695598969056367,0.00840206832358614,-0.0234240436047925,0.00951206422366517,0.4077507440425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.00551709920372536,0.00666730904991681,-0.0185850249415623,0.00755082653411159,0.407980129368851
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00400531471653576,0.00484143507797592,-0.0134945274693686,0.00548389803629704,0.408085439813415
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00410550938741471,0.00496814576681109,-0.0138430750903644,0.00563205631553502,0.40861109486301
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.00381847076274283,0.00462227402135009,-0.012878127844589,0.00524118631910334,0.408763941298919
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00499716916198096,0.00604916410254347,-0.00685919247900423,0.0168535308029662,0.408769027397943
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.0144572965213605,0.0175529519340413,-0.0488610823120815,0.0199464892693605,0.410162021577895
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.00579344417471042,0.00704513929776303,-0.019601917198326,0.00801502884890513,0.410905487402578
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.00287711359400719,0.00349922614695086,-0.00973559684203089,0.00398136965401651,0.410969711008317
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.00237421901032184,0.00288974619067826,-0.00803812154405123,0.00328968352340756,0.411318352805463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00357456095361728,0.00435263286996253,-0.00495659947150928,0.0121057213787438,0.411526662908793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.00383193410866903,0.00467713472777771,-0.00533524995777528,0.0129991181751133,0.412638098784723
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.00414585084640693,0.00506926542976137,-0.0140816110887392,0.00578990939592536,0.413463581376794
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.00232362426559443,0.00284393642595552,-0.00325049112927839,0.00789773966046725,0.413920269941258
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.00368879923621779,0.00451850009149927,-0.0125450594155564,0.00516746094312079,0.414302174063517
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,41960,-0.00331363606253871,0.00409162890092472,-0.0113332287083512,0.00470595658327374,0.418036545205472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.0051459731148802,0.00638346766029125,-0.0176575697290511,0.00736562349929065,0.420179061023389
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00543032014330152,0.00675727077869241,-0.0078139305829356,0.0186745708695386,0.421629981861502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,42310,0.00196782655532739,0.00245477448926668,-0.0028435314436353,0.00677918455429007,0.422779572668669
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,-0.00314461868465247,0.0039259205438752,-0.0108394229506479,0.00455018558134292,0.423154840525923
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00440194174809345,0.00552009955028784,-0.0152213368666576,0.00641745337047072,0.425213337180101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,39657,-0.00268234689496641,0.00336483936175645,-0.00927743204400905,0.00391273825407623,0.425369786291848
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00390655194940219,0.00490209184578495,-0.0135146519671407,0.00570154806833631,0.425517187499028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEB,Nebulin,39575,-0.00323158470881111,0.00405621263182114,-0.0111817614671805,0.00471859204955832,0.425642502600234
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00207069349136759,0.00261051822892685,-0.00718730922006422,0.00304592223732904,0.427671566335967
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,42075,-0.00471852946364186,0.00596689172406097,-0.0164136372428014,0.00697657831551763,0.429083284917481
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00692931542138461,0.00876739526484544,-0.0241134101404817,0.0102547792977124,0.429340039499278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00308303510054975,0.00390793429854064,-0.00457651612458991,0.0107425863256894,0.430177184103613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,42249,-0.00179019079567397,0.00229046748973602,-0.00627950707555658,0.00269912548420863,0.434473149523917
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.00264306325376564,0.00338607173163962,-0.00927976384777929,0.00399363734024802,0.435069588074385
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,39657,0.00375124637371708,0.0048108032661681,-0.0056779280279724,0.0131804207754066,0.435551975206963
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,-0.00195261354431852,0.00250924055265557,-0.00687072502752344,0.00296549793888639,0.436485561147326
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00533869704433698,0.00686329546751304,-0.00811336207198857,0.0187907561606625,0.436667001633133
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.00537586082098157,0.00692604907464377,-0.00819919536532022,0.0189509170072834,0.437659435052515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.00357724823456446,0.00463305749935239,-0.0126580409332951,0.00550354446416624,0.440063111045063
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,42016,0.00815747164862937,0.0105876171769373,-0.0125942580181677,0.0289092013154265,0.4410330175002
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.00816234910148148,0.0106088860170506,-0.0126310674919377,0.0289557656949007,0.441679076794793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,42007,0.00384053009835013,0.0049957286339566,-0.00595109802420481,0.0136321582209051,0.442047705696309
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HLA_DRA,,42060,0.0028317720866221,0.00368436108001606,-0.00438957563020938,0.0100531198034536,0.44214877740656
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,39649,-0.00316495653234581,0.00412342194481874,-0.0112468635441905,0.00491695047949893,0.442767517231151
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,41913,0.00732917467901274,0.00955081094673951,-0.0113904147765967,0.0260487641346222,0.442864658881425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.00265697773432405,0.00346372867475555,-0.00413193046819684,0.00944588593684493,0.443046782230377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.00313394119597806,0.0040947673177182,-0.0111596851387057,0.00489180274674961,0.444078012215938
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,42310,0.00570729116581156,0.00749251611206829,-0.00897804041384229,0.0203926227454654,0.446232925256621
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.00558000836693256,0.00738068288579279,-0.00888613008922132,0.0200461468230864,0.449648176074123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00494146202731754,0.00654302646138352,-0.0177657938916292,0.00788286983699415,0.450129773191449
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,39929,0.00168111849452936,0.00222605521238019,-0.00268194972173581,0.00604418671079453,0.450144257562629
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00306469446216333,0.00408262931161287,-0.00493725898859789,0.0110666479129245,0.452869297103363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.00259857872383783,0.00346287741913414,-0.00938581846534075,0.00418866101766508,0.453020653521726
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,41843,-0.00752352714697306,0.0100266172858208,-0.0271756970271819,0.0121286427332357,0.453053972345493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.00402295683722195,0.00536440745391337,-0.0145371954468922,0.00649128177244825,0.453309674174664
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00384771931726493,0.00513479043017888,-0.00621646992588567,0.0139119085604155,0.453666573347711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.00581787715538099,0.00780234353892667,-0.00947471618091529,0.0211104704916773,0.455890125550591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,39624,-0.00508815756616439,0.00684816124616448,-0.0185105536086468,0.00833423847631799,0.457499832703466
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.00210107715006511,0.00282822830710495,-0.00344225033186059,0.00764440463199081,0.457557935506524
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,39929,-0.00201795004347087,0.00272500972789117,-0.00735896911013756,0.00332306902319581,0.458994125616322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARTN,Artemin,41913,-0.00338452450320357,0.00457417533426878,-0.0123499081583704,0.00558085915196324,0.459361493931472
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.00399658689511016,0.00540752645689971,-0.0145953387506336,0.00660216496041328,0.459874617383042
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.00305498346947605,0.00414197047093517,-0.00506327865355688,0.011173245592509,0.460792876341628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,39657,-0.00222842480432001,0.00302348592685456,-0.00815445722095495,0.00369760761231493,0.461114721805654
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,41881,0.00423405952144497,0.00574860116084978,-0.00703319875382061,0.0155013177967105,0.461416749589882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,39859,0.00228821369638597,0.00312218230036226,-0.00383126361232406,0.008407691005096,0.463641266702168
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.00210040764261689,0.00287480013006458,-0.00353420061230969,0.00773501589754347,0.465022284627377
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,42262,-0.00323547738212146,0.00445898913458741,-0.0119750960859128,0.00550414132166985,0.468091655069336
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00405083939233506,0.00561388465232648,-0.00695237452622485,0.015054053310895,0.470571107525877
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.00409968833029134,0.00570448444142863,-0.0152804778354915,0.00708110117490878,0.472354434966902
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.00444108335732255,0.00618033271924972,-0.00767236877240689,0.016554535487052,0.472410272448334
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,39560,-0.0052821400961108,0.00745017160727821,-0.0198844764463761,0.0093201962541545,0.47834218726385
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00262545371589529,0.00374094283721036,-0.0099577016768276,0.004706794245037,0.482808672118774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00419837707624358,0.00599145941797992,-0.00754488338299707,0.0159416375354842,0.483488310254672
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00334959101761376,0.00482822407040237,-0.0128129101956024,0.00611372816037489,0.487852313355065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00236330695189975,0.00340676023291063,-0.00431394310460508,0.00904055700840457,0.48787818554678
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,39398,-0.00498328006307339,0.00718454408805025,-0.0190649864756519,0.0090984263495051,0.487941003717993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,41913,-0.00969194604222561,0.0139788402398806,-0.0370904729123916,0.0177065808279404,0.488114722205153
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,39575,-0.00391601050256177,0.00568004457726947,-0.0150488978740099,0.00721687686888639,0.490565361872481
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,39586,0.00337129366854531,0.00489076838670279,-0.00621461236939216,0.0129571997064828,0.490637861839968
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,39934,-0.0109738584447912,0.0159321027569484,-0.04220077984841,0.0202530629588277,0.49097010549036
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.00382347961645756,0.00556804359877197,-0.0147368450700506,0.0070898858371355,0.492297066006628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,41967,-0.00733717842594126,0.0106993917491472,-0.0283079862542697,0.0136336294023872,0.492878506124567
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.00754992070978621,0.011058093518488,-0.0292237840060227,0.0141239425864503,0.494779020268496
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.00362903039610236,0.00532300544222186,-0.0140621210628572,0.00680406027065249,0.49540048057254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,39733,-0.00267037845520684,0.00392356316936495,-0.0103605622671621,0.00501980535674847,0.496138561070161
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.00271563099303767,0.00399097372661563,-0.00510667751112897,0.0105379394972043,0.496238219580498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00306088385493694,0.00449898421927037,-0.0118788929247069,0.00575712521483298,0.496296795797001
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.00163523273914687,0.00240647522001717,-0.00308145869208678,0.00635192417038052,0.496826716356241
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00226869517689701,0.00334266836738629,-0.00882032517697413,0.00428293482318012,0.49733731813987
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00521093353008021,0.00768708390020932,-0.00985575091433005,0.0202776179744905,0.49785849403252
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.00635691153035978,0.00938386876009004,-0.0247492943001362,0.0120354712394167,0.498147548721378
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.00389902556900422,0.00576356796844321,-0.00739756764914448,0.0151956187871529,0.498738162076542
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,42249,-0.00220199237478944,0.00325503853230913,-0.00858186789811534,0.00417788314853646,0.498742741295039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,42187,-0.00186382377258536,0.00276269037808599,-0.0072786969136339,0.00355104936846317,0.499915454561732
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,42262,-0.00314749636263149,0.00467364030252528,-0.012307831355581,0.00601283863031806,0.500667908836731
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00315817356417799,0.00469044148948118,-0.0123514388835611,0.00603509175520513,0.50075473569043
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,42070,-0.0129516182054188,0.019352980880356,-0.0508834607309165,0.0249802243200789,0.503359490084094
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.00473188945392076,0.00708140841204872,-0.00914767103369473,0.0186114499415363,0.504011664045403
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00406437817660221,0.00609224351237593,-0.016005175460859,0.00787641910765462,0.504694407657603
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,41913,0.00327756177439197,0.0049175714566055,-0.00636087828055481,0.0129160018293388,0.505103061592227
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.00205986574048883,0.00309136344988829,-0.00399920662129222,0.00811893810226988,0.505214696068831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.00277789802722628,0.00420365246549395,-0.0110170568595944,0.00546126080514186,0.508735381724038
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.00418080047887952,0.00635162535095242,-0.0166299861667463,0.00826838520898723,0.510407076533759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00516999451839579,0.00786429790581404,-0.0205840184137913,0.0102440293769997,0.510937141994881
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.0111119103604594,0.0169372027254097,-0.0220850069813436,0.0443088277022624,0.511795456290966
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.00607520968539406,0.00927113015097797,-0.0242466247813109,0.0120962054105228,0.512297011951413
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,41913,-0.00319822207893823,0.00488540218054383,-0.0127736103528041,0.00637716619492767,0.51270528504927
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00348534774510489,0.00532953129455749,-0.0139312290824376,0.0069605335922278,0.513145527483686
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.00121265406444109,0.00186797252017503,-0.00487388020398416,0.00244857207510197,0.516233872145398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00295431640453409,0.00455749826888836,-0.0118870130115553,0.00597838020248709,0.516848221403771
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00363557065141015,0.0056457500844879,-0.00743009951418613,0.0147012408170064,0.519622475688163
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00314886629466667,0.00492951406202592,-0.0128107138562375,0.00651298126690412,0.52298053880112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.00351026598722566,0.00551294482742587,-0.00729510587452904,0.0143156378489804,0.524312900380737
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,41843,0.0056691128778809,0.0089637644402692,-0.0118998654250467,0.0232380911808085,0.527105242982287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,39958,0.00192758784323899,0.00306389140505986,-0.00407763931067835,0.00793281499715632,0.52927621053835
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,-0.00586144689332527,0.00933991323964244,-0.0241676768430245,0.0124447830563739,0.530298798547015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00161700808045044,0.0025819899390683,-0.00667770836102431,0.00344369220012342,0.531154226347018
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00280967656502192,0.00449571652289041,-0.00600192781984329,0.0116212809498871,0.532005008940876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.00410841868689469,0.00658377254815642,-0.00879577550749188,0.0170126128812813,0.53262612959354
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,42196,-0.00221298418165187,0.00355642617743426,-0.00918357948942302,0.00475761112611927,0.533788299043123
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,42207,-0.00978282198287665,0.0158394152695827,-0.0408280759112587,0.0212624319455053,0.536832766661308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00192754373220659,0.00312751352629252,-0.00420238277932675,0.00805747024373994,0.537695019529993
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00413485017493488,0.00671249800996358,-0.0172913462744635,0.00902164592459374,0.537911864650425
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,42262,-0.00387042330801768,0.00634168215534586,-0.0163001203324956,0.0085592737164602,0.54166335964249
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00258749603873015,0.00424834084995123,-0.0109142441046346,0.00573925202717427,0.542496633507098
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.00303268675795831,0.00498260885334357,-0.00673322659459509,0.0127986001105117,0.542766158113293
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00210908584995561,0.00346709510661357,-0.00468642055900699,0.00890459225891822,0.542991183967888
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,41883,-0.00545740861271374,0.00898028759524937,-0.0230587722994025,0.012143955073975,0.543390363595475
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,41913,-0.00371265600021719,0.00613701235579573,-0.0157412002175768,0.00831588821714245,0.545214910727787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,42016,0.00781513440462519,0.0129563300073734,-0.0175792724098267,0.0332095412190771,0.546392203138005
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.000982326107385933,0.00163261546564878,-0.00221760020528568,0.00418225242005755,0.547391391496373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.00290840361861083,0.00483786791977475,-0.0123906247413693,0.00657381750414768,0.547733903456708
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00287528176671509,0.00480799077121471,-0.0122989436782959,0.00654838014486574,0.549837564108132
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,39560,0.0039736347539696,0.00666140896570871,-0.00908272681881947,0.0170299963267587,0.550843116955628
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00316380863317541,0.00531562154930663,-0.0135824268698164,0.00725480960346558,0.551726163745267
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00465725411489925,0.00786985290224148,-0.0107676575734941,0.0200821658032925,0.554007375967012
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,41839,0.00303622244813344,0.00513419230097979,-0.00702679446178694,0.0130992393580538,0.554280657219946
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,39575,0.00350496466764713,0.00594067825191547,-0.0081387647061072,0.0151486940414014,0.555206802361146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.00305165458221263,0.00517763727817462,-0.0131998236474349,0.00709651448300962,0.555610834043074
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.00195083829245414,0.00332606661010425,-0.00846992884825847,0.0045682522633502,0.557531381032957
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.00649460554491783,0.0110823869588101,-0.0282160839841857,0.01522687289435,0.557867738642288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.00425926152866458,0.00727507283934379,-0.00999988123644924,0.0185184042937784,0.558250665469871
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.00262550557879765,0.00448675218384085,-0.0114195398591257,0.00616852870153042,0.558444410812438
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,39919,-0.00254388276131525,0.00435461698346368,-0.0110789320489041,0.00599116652627356,0.559110454249195
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.00573293045760104,0.00982933166671255,-0.0135325596091555,0.0249984205243576,0.559738853858244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.00347986625616532,0.00596873299499542,-0.0151785829263563,0.0082188504140257,0.559892317220374
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,39657,-0.00181462343743467,0.00313932097273003,-0.00796769254398553,0.00433844566911618,0.563255263339432
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.00327030070883161,0.00566384047205355,-0.0143714280340566,0.00783082661639335,0.563681018243146
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.0038073730423794,0.00663010129396892,-0.00918762549379968,0.0168023715785585,0.565806582014653
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,42048,-0.00338024075568269,0.00589531578416687,-0.0149350596926498,0.00817457818128438,0.566398786058649
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,0.00159215543383758,0.00278459413166325,-0.0038656490642224,0.00704995993189756,0.567485219769315
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.00220573194042849,0.00386547611667399,-0.0097820651291095,0.00537060124825252,0.568264277762714
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.0024760772423964,0.00434958312365365,-0.0110012601647576,0.00604910567996476,0.56918603715894
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,F2,Prothrombin,39979,0.000860779838673488,0.00151368155243329,-0.00210603600409575,0.00382759568144273,0.569593776818157
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,-0.0027318379168036,0.00484026412833292,-0.0122187556083361,0.00675507977472893,0.572494478947039
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.00277947976471649,0.00492853821689597,-0.0124394146698326,0.00688045514039961,0.572795489191819
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCN,Decorin,41900,-0.00130932500155504,0.00232711739326963,-0.00587047509236351,0.00325182508925344,0.573690798476429
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,41900,0.00344856928828033,0.00616006660334615,-0.00862516125427813,0.0155222998308388,0.575607129973763
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.00184030429856587,0.0033024401731753,-0.00463247844085771,0.00831308703798945,0.577362016863356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00328010755962613,0.0059087643468437,-0.00830107056018753,0.0148612856794398,0.578819743139055
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.00291985297346295,0.00526725773314607,-0.00740397218350334,0.0132436781304292,0.579357303594359
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,41839,-0.00329298409040084,0.00596458854318779,-0.0149835776350489,0.00839760945424724,0.580896655303024
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,39736,-0.00194715662315935,0.00352958888420275,-0.00886515083619674,0.00497083758987803,0.581187803906512
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00367916255152156,0.00667284421732519,-0.0167579372174789,0.0093996121144358,0.581395577713549
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.0033062252900503,0.00599657574275003,-0.00844706316573976,0.0150595137458404,0.581403478592308
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,0.00147785918304438,0.00269655326716079,-0.00380738522059076,0.00676310358667952,0.583664959343626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00362075622499129,0.00660892062011204,-0.00933272819042831,0.0165742406404109,0.583799833477029
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,42145,-0.0019603610527314,0.00358304603057845,-0.00898313127266517,0.00506240916720237,0.584304365332143
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,39959,-0.000803114834374289,0.00147274179909044,-0.00368968876059156,0.00208345909184298,0.585544496096972
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.00214464395147513,0.00395638385391346,-0.0098991563051455,0.00560986840219525,0.587778193896322
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,41913,0.00167020081256164,0.00310900444887411,-0.00442344790723161,0.0077638495323549,0.591128758709981
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,41843,0.00205594472817394,0.00383638739138934,-0.00546337455894916,0.00957526401529704,0.592032210356343
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NRN1,Neuritin,39934,0.00190065347963784,0.00354749819099091,-0.00505244297470434,0.00885374993398001,0.592126010165216
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00311842163807159,0.00582178984595882,-0.0145291297361509,0.0082922864600077,0.592213625098759
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00253449467449553,0.00475066252208957,-0.0118457932177911,0.00677680386880003,0.593695952185124
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.00239015063213565,0.00448427107105391,-0.00639902066713002,0.0111793219314013,0.594039115394481
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.00231014140951264,0.00433689930094967,-0.0061901812203487,0.010810464039374,0.594271901343834
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CLSPN,Claspin,41820,0.00190621342887601,0.00359903591993113,-0.005147896974189,0.00896032383194102,0.596366587297098
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.00296305714111835,0.00562599446384968,-0.0139900062902637,0.00806389200802702,0.598431608998019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,39649,-0.00147949921637981,0.00281632159107626,-0.00699948953488929,0.00404049110212967,0.599364101706542
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,0.00197193210693765,0.00376150552973418,-0.00540061873134133,0.00934448294521664,0.600121741293561
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00269328818983505,0.00514814963171691,-0.00739708508833009,0.0127836614680002,0.600875878382647
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,39934,0.00183229714925229,0.00353908447532092,-0.0051043084223767,0.00876890272088129,0.60465539951711
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00206668670474141,0.0040256892685633,-0.00995703767112547,0.00582366426164266,0.60769945993287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00210589175632408,0.00410828164507845,-0.00594634026802967,0.0101581237806778,0.60824375373363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.00372370458889665,0.00728810920804863,-0.0105609894588787,0.018008398636672,0.60941114390235
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,39870,0.00168398951440792,0.00331662419585516,-0.00481659390946819,0.00818457293828404,0.611644202396348
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,39919,-0.00178065651078023,0.00350982523045789,-0.0086599139624777,0.00509860094091725,0.611929803237626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.00516598472330903,0.0103132861885377,-0.0253800256528429,0.0150480562062248,0.616447475724011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00286655900132807,0.00572364936378165,-0.0140849117543401,0.00835179375168396,0.616502833235445
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,-0.00236491307906116,0.00472553390909448,-0.0116269595408863,0.00689713338276401,0.616763398385185
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,0.0015720417039352,0.00315686198915127,-0.00461540779480128,0.00775949120267169,0.618510817944931
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,39657,-0.00144074411319622,0.00289439428592508,-0.00711375691360937,0.00423226868721694,0.61865570450286
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFP,Properdin,39979,0.00119872640283801,0.00241033922591198,-0.00352553847994947,0.00592299128562548,0.618968193155172
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,42119,-0.0031090586833469,0.00628316636260019,-0.0154240647540433,0.00920594738734947,0.620732720763893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,39586,0.00459871981026034,0.00930187152629149,-0.013632948381271,0.0228303880017917,0.621043123848246
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.0016118694511643,0.00326328354551586,-0.00800790520037539,0.00478416629804678,0.621356058746787
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.00259394950655999,0.00528905775527744,-0.0129605027069038,0.0077726036937838,0.623834532894034
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00240199096568389,0.00495781818633345,-0.00731533267952968,0.0121193146108975,0.628050964229294
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.00202982536936823,0.00419522877972668,-0.0102524737776325,0.00619282303889607,0.628507926707342
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,0.00216915410783152,0.00452473518602789,-0.00669932685678315,0.0110376350724462,0.631664265103506
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.00222336592921492,0.00471811729266518,-0.0114708758228387,0.00702414396440884,0.637477068765448
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,39966,0.00207512330582091,0.00441879623685019,-0.00658571731840546,0.0107359639300473,0.638640681613815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,39575,0.00226203287720992,0.00484929331761467,-0.00724258202531484,0.0117666477797347,0.640890880267478
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.00282379363580683,0.00607002837220777,-0.014721049245334,0.00907346197372039,0.641795520429839
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,-0.00285686479970971,0.00620189770871445,-0.01501258430879,0.0092988547093706,0.645061813364977
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00133407522585579,0.00290845202309805,-0.00703464119112796,0.00436649073941639,0.646466198305928
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.00416082517315956,0.0090972904885703,-0.0136698641844382,0.0219915145307574,0.647412651437487
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,41839,0.00339832653595737,0.00756833752973128,-0.0114356150223159,0.0182322680942307,0.653425377747307
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.00351563792086946,0.00797739744807456,-0.0191513369190956,0.0121200610773567,0.659438991491997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,42119,-0.00225513348570146,0.00515540626897044,-0.0123597297728835,0.00784946280148061,0.661805939311653
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,39586,0.0026064853272098,0.00597064974198674,-0.0090959881670842,0.0143089588215038,0.662446530481258
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,41913,-0.00140881186833618,0.00323610653204045,-0.00775158067113547,0.0049339569344631,0.663321534610586
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.00155523115546482,0.0035785274809696,-0.00856914501816525,0.0054586827072356,0.663859246909825
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.00176697756634082,0.00410115505283018,-0.00980524146988799,0.00627128633720634,0.66658527747122
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,41913,-0.00170666348135438,0.00399162777607098,-0.00953025392245349,0.00611692695974474,0.668977841368177
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,39736,0.00158611520787341,0.00373051426226947,-0.00572569274617475,0.00889792316192158,0.670718532831489
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.00155232952415332,0.00365268477473823,-0.00560693263433362,0.00871159168264025,0.670857225466584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,39560,0.00504745000342435,0.0119242171092504,-0.0183240155307064,0.0284189155375551,0.672089049768206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,41900,0.00459975030925916,0.0108786782910874,-0.0167224591412722,0.0259219597597905,0.672431582181035
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,39925,0.0020642571824825,0.00488615837861513,-0.00751261323960316,0.0116411276045682,0.672689737347565
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,39757,0.00240570773581824,0.00573648341181236,-0.00883779975133397,0.0136492152229705,0.67495398682288
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.00426915642989978,0.0102634074268972,-0.0243854349866183,0.0158471221268187,0.677448029103645
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00126742290542821,0.00307004402388435,-0.00728470919224153,0.00474986338138511,0.679735211404261
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00198612210761719,0.00488036795013081,-0.0115516432898736,0.0075793990746392,0.68404416446351
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00267055438219311,0.0065654230654114,-0.0155387835903995,0.0101976748260132,0.684191822626206
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,39934,-0.0018387510658613,0.0045207916757505,-0.0106995027503323,0.00702200061860969,0.684212445796933
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00190737100735099,0.00472393715597217,-0.00735154581835446,0.0111662878330564,0.686391764891275
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,41843,-0.00545505899340258,0.0135157206874278,-0.031945871540761,0.0210357535539559,0.686507192051048
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,41913,0.00248594239200353,0.00616475650230744,-0.00959698035251906,0.0145688651365261,0.686770279272502
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.00178114558283973,0.00444895807240068,-0.00693881223906561,0.0105011034047451,0.68890543078638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.00147812187198238,0.00373023747943232,-0.00583314358770496,0.00878938733166972,0.691923939809273
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,-0.00208463523943668,0.0052671623741734,-0.0124082734928165,0.00823900301394318,0.692275220107254
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,39638,-0.0035173360814745,0.00898765091323768,-0.0211331318714204,0.0140984597084714,0.695544545439327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00140750553302562,0.00369087693653303,-0.00582661326257911,0.00864162432863035,0.702952977519589
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.00104675341997305,0.00274971651575303,-0.0043426909509029,0.00643619779084899,0.703450163478572
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.00116014815035757,0.00305952910037077,-0.00715682518708428,0.00483652888636914,0.704551569375264
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,42262,-0.0011342608341045,0.00299399378103314,-0.00700248864492946,0.00473396697672045,0.704808543153722
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00205045089593952,0.00541799990906349,-0.012669730717704,0.00856882892582492,0.705102320686823
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.00251653119419311,0.00666150056625371,-0.0105400099156642,0.0155730723040504,0.705605719417179
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00153363180022087,0.00406485361080551,-0.00643348127695794,0.00950074487739968,0.705964826432154
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BSND,Barttin,39560,-0.00128970454400256,0.00342005029917287,-0.00799300313038138,0.00541359404237626,0.706105815220518
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,42310,-0.00158666028423947,0.00422667442457771,-0.00987094215641177,0.00669762158793284,0.707374669799272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00253865390862105,0.00680538631806703,-0.0158772110920324,0.0107999032747903,0.709128867434753
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.00249149538555024,0.00668704469068281,-0.0155981029792886,0.0106151122081881,0.709462787707335
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NCLN,Nicalin,41913,0.00192484952414898,0.00518210239832321,-0.00823207117656451,0.0120817702248625,0.710314396219373
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,0.00277892193471204,0.00752842501755688,-0.0119767910996994,0.0175346349691235,0.712042456180278
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,0.00297616657516307,0.00817944253598791,-0.0130555407953732,0.0190078739456994,0.715969941864409
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,41825,0.00207566203044149,0.00570823357236301,-0.00911247577139,0.013263799832273,0.716143135683175
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,0.00157779783136891,0.00434244183008377,-0.00693338815559527,0.0100889838183331,0.716355331425194
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.00124517462487785,0.00345228299868461,-0.00552130005254399,0.00801164930229968,0.718344442926398
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00259902417096507,0.00723204010315297,-0.0167738227731449,0.0115757744312148,0.719320472078067
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,39560,0.00153087507786979,0.0042687070451269,-0.00683579073057892,0.00989754088631851,0.719880794344831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,42310,-0.00110889218235305,0.00312692497261895,-0.00723766512868618,0.00501988076398009,0.722874462133065
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00302416168093845,0.00853513807360901,-0.0197530323052121,0.0137047089433352,0.723105463366075
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.00127096219052276,0.00360541572126632,-0.00579565262315923,0.00833757700420476,0.724459034214843
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00197749172194661,0.00560978944393155,-0.0129726790320524,0.00901769558815922,0.724464624141435
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,39575,0.00151091796721618,0.00436459451464793,-0.00704368728149376,0.0100655232159261,0.729217069455144
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,42119,0.00237382831729861,0.00686752115901665,-0.011086513154374,0.0158341697889712,0.72960352266891
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,41900,0.00245546660925979,0.0071101829412485,-0.0114804919555873,0.0163914251741068,0.729840430676996
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.00218374265654899,0.00633221337134338,-0.010227395551284,0.014594880864382,0.73020429297399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.00203282040290653,0.00590063815354853,-0.00953243037804859,0.0135980711838617,0.730469300363648
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.000931559187803274,0.0027161810644128,-0.00625527407405236,0.00439215569844581,0.731630161683956
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00319879839038479,0.00932902164093617,-0.0214836808066197,0.0150860840258501,0.731690197468101
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.00202296966629055,0.0059602466129129,-0.0137050530275998,0.00965911369501874,0.734306976011626
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,39657,-0.000888636095823542,0.00263121638153452,-0.00604582020363119,0.00426854801198411,0.735574397533886
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.00402247583545272,0.0119860689829886,-0.0275151710421104,0.0194702193712049,0.737182010199936
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.000992976822180954,0.00296471303934847,-0.00481786073494205,0.00680381437930396,0.737682849148335
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,0.00189921486271073,0.00570668156377355,-0.00928588100228543,0.0130843107277069,0.739286286412171
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,-0.00141098937011359,0.00434768691992637,-0.00993245573316927,0.00711047699294209,0.745535878960664
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00133134551570318,0.00410875731470033,-0.00672181882110947,0.00938450985251583,0.745924275681646
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.0011883250964199,0.00367885028863178,-0.00602222146929838,0.00839887166213818,0.746689794592568
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,39930,-0.00854766247068269,0.0265002114511739,-0.0604880769149835,0.0433927519736181,0.74704146636113
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,39575,0.00104238535600087,0.00326063996078386,-0.00534846896713551,0.00743323967913724,0.749211433461284
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.0013428562751147,0.00422290740728636,-0.00693404224316656,0.00961975479339596,0.750495032326214
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00131642378445546,0.00415889437788302,-0.00946785676510618,0.00683500919619525,0.751604600889522
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.000959383399726879,0.00303858730839279,-0.00691501452417674,0.00499624772472298,0.752209704505798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00109083412554478,0.00350503755316309,-0.00577903947865487,0.00796070772974444,0.755640084754862
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-0.00231582791394662,0.00748081855644499,-0.0169782322845788,0.0123465764566856,0.756894677826633
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,39979,0.00104479150913177,0.00337814547457289,-0.0055763736210311,0.00766595663929464,0.757114504021884
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,-0.00150171915849499,0.00485694683577506,-0.0110213349566141,0.00801789663962412,0.757181875493651
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,39560,0.00289819104992847,0.00944361537394255,-0.0156112950829989,0.0214076771828559,0.758929712898816
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,41839,0.00170920046063069,0.00559027328428682,-0.00924773517657147,0.0126661360978329,0.759803294226513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00154503890697376,0.00506311791193435,-0.00837867220041756,0.0114687500143651,0.760253414972246
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,-0.00119582753976772,0.00394531072612292,-0.00892863656296864,0.00653698148343319,0.761818620890011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,39919,0.0017649032890306,0.00583696844035216,-0.00967555485405964,0.0132053614321208,0.762378301137201
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.00259908053921122,0.00870069939075654,-0.019652451345094,0.0144542902666716,0.765157716065104
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,41913,0.00219171303797842,0.00742649137414705,-0.0123642100553498,0.0167476361313066,0.767906103983399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,39638,0.00123382744615248,0.00418091459043648,-0.00696076515110302,0.00942842004340797,0.767915813885134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,0.0016073710156146,0.00549617181085576,-0.00916512573366269,0.0123798677648919,0.769945954061009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.00183439758834025,0.0063088376054618,-0.0141997192950454,0.0105309241183649,0.771235522914345
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00146459608881182,0.00509863016022084,-0.00852871902522103,0.0114579112028447,0.773924133219477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,39657,-0.00179615416100799,0.00628968544859528,-0.0141239376402547,0.0105316293182388,0.775211774709486
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.00227766030702003,0.00798905142241419,-0.0133808804809118,0.0179362010949518,0.775574489702973
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,39657,0.00113394112683653,0.00398380995972869,-0.0066743263942317,0.00894220864790475,0.775927320450591
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.000773570856170796,0.00271833870331759,-0.00610151471467327,0.00455437300233168,0.775975250379392
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.00770563531427451,0.0271686190301387,-0.0455448579847973,0.0609561286133463,0.776704908394798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,0.0021858610926596,0.00774294482609221,-0.0129903107664811,0.0173620329518003,0.777716053913776
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.000689072590426536,0.00250353481280071,-0.00559600082351593,0.00421785564266286,0.783137102375798
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.0010377824223402,0.00381731942772414,-0.00851972850067951,0.0064441636559991,0.785733419225744
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,39657,-0.00166837534906281,0.0061387510237489,-0.0137003273556107,0.010363576657485,0.785798062691454
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,39919,-0.00108030354632479,0.00397973002564703,-0.00888057439659296,0.00671996730394339,0.786048774232416
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,39575,0.00227443966850566,0.0084097634624228,-0.014208696717843,0.0187575760548543,0.78681741305599
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,41976,0.00176138932823382,0.00659002881198802,-0.0111550671432627,0.0146778457997303,0.789256954305418
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,0.00148922986285049,0.00562865069234455,-0.00954292549414482,0.0125213852198458,0.791336947414112
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.00113443800446468,0.00430917221918846,-0.00958041555407406,0.00731153954514471,0.792354096773663
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.000836581879499627,0.00319760212000777,-0.00710388203471486,0.0054307182757156,0.793613220265213
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PTTG1,Securin,39757,-0.0011098026427418,0.00425157452997306,-0.00944288872148899,0.00722328343600539,0.794071624919925
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,42070,-0.00146074416311207,0.00564236624999489,-0.012519782013102,0.00959829368687791,0.795725168753477
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.00225186327517658,0.00873353612327462,-0.0148658675264417,0.0193695940767948,0.796534498024009
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,39919,-0.000696769492740599,0.0027086155560155,-0.00600565598253099,0.00461211699704979,0.796996693416244
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000791803399172123,0.00308034994374185,-0.00682928928890615,0.00524568249056191,0.797144966771636
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.00140389140777984,0.00552384234959893,-0.00942283959743406,0.0122306224129937,0.799383441231887
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,39757,0.000709348782272583,0.00281614911569838,-0.00481030348449625,0.00622900104904141,0.80113375308781
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.00228734796180868,0.00909787878953297,-0.0201191903892933,0.0155444944656759,0.80149743085431
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,39586,0.00118197173253162,0.00474517768513984,-0.00811857653034247,0.0104825199954057,0.80329656717685
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.000555025511958751,0.00223696911764224,-0.00382943395862004,0.00493948498253754,0.804050065529569
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.00160527908284059,0.00651611509558949,-0.014376864670196,0.0111663065045148,0.805411794375952
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.000849536639213217,0.00346586901129159,-0.00594356662291831,0.00764263990134474,0.806371791523939
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.000911186103192352,0.00372636780108885,-0.0063924947869418,0.0082148669933265,0.806829610676727
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.000979442545252589,0.00403304254365937,-0.00888420593082496,0.00692532084031978,0.808122649673539
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00152153249340003,0.0062719794834085,-0.0138146122808807,0.0107715472940806,0.808325883262363
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.00113482347962326,0.00468363533404938,-0.01031474873436,0.00804510177511351,0.808554951227979
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,39586,0.00185162865821662,0.00765835659321857,-0.0131587502644918,0.016862007580925,0.808956039860265
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,42070,-0.000704768726872281,0.00291520603970194,-0.00641857256468809,0.00500903511094352,0.808972868033916
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,39657,0.000899421837962628,0.00374943200666055,-0.00644946489509205,0.00824830857101731,0.810426060270868
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.000860685422214849,0.00372848229219281,-0.00644713987048305,0.00816851071491275,0.817442017353668
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,0.000979741635612607,0.0042860438999611,-0.00742090440831114,0.00938038767953635,0.819192794471356
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.000988170492778807,0.00440044542757166,-0.00763670254526164,0.00961304353081925,0.822324591429098
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,-0.000713022643560784,0.00318568290742517,-0.00695696114211411,0.00553091585499255,0.822900048691193
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,39990,0.000493096116817971,0.00232632094812455,-0.00406649294150614,0.00505268517514208,0.832138971885134
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,41913,-0.00102513478929446,0.00487962800821432,-0.0105892056853945,0.00853893610680562,0.833604845032364
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,39806,-0.000763046067821479,0.00363447814052253,-0.00788662322324563,0.00636053108760267,0.833713223812434
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.0014781339284215,0.00707031285704018,-0.0123796792713773,0.0153359471282203,0.834403694844019
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.00219983852547895,0.0105717228326971,-0.0229204152775653,0.0185207382266074,0.835164840601644
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,39518,0.00092741170128049,0.004489424510675,-0.00787186033964251,0.00972668374220349,0.836344101610841
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.00142170997669225,0.00695364230819255,-0.0122074289473652,0.0150508489007497,0.838001403741095
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.00145169952158806,0.00712044418012632,-0.0154077701146357,0.0125043710714595,0.83845285528189
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.000530037589105132,0.00265099510494802,-0.004665912816593,0.00572598799480326,0.841531783273414
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,41843,0.00326279072765506,0.0164226104121498,-0.0289255256801585,0.0354511071354686,0.842518668568303
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,42119,0.00178377001876656,0.00909043568016327,-0.0160334839143535,0.0196010239518866,0.844437072852044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00125635286514582,0.00647229982775442,-0.0139420605275445,0.0114293547972528,0.846091565302746
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,41913,0.000836277255188323,0.00432803124754484,-0.00764666398999956,0.0093192185003762,0.846786899193945
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,39649,0.00119522229961614,0.00618595403100993,-0.0109292476011633,0.0133196922003956,0.846793739185701
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,42103,-0.00135440696901583,0.00706670023301165,-0.0152051394257187,0.012496325487687,0.848011067259814
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00122232674369211,0.0064059323072792,-0.0137779540659593,0.0113333005785751,0.848676662229379
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.000793112879460325,0.00415727979850514,-0.00735515552560975,0.0089413812845304,0.848703808489693
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,39908,-0.00118042901328338,0.00623010868547872,-0.0133914420368217,0.0110305840102549,0.849726568110989
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.000555308839768438,0.00294168609747655,-0.00632101359082248,0.0052103959112856,0.850274179269774
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.00132013755472783,0.00704062983560653,-0.012479496923061,0.0151197720325166,0.851269292254287
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.000621483126305291,0.00334848715721287,-0.00594155170183194,0.00718451795444252,0.85276036811463
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,0.00135125570162137,0.00734102780400801,-0.0130371587942343,0.0157396701974771,0.85396209027246
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.000934008822264558,0.00510701137862359,-0.0109437511243668,0.00907573347983769,0.854889622980476
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.00156954015904601,0.00880311472419927,-0.0188236450184766,0.0156845647003846,0.858495539794074
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.00113395988015075,0.00639800863052709,-0.0136740567959838,0.0114061370356824,0.859325997081688
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,42181,-0.000673574169152319,0.00389135407686205,-0.00830062815980193,0.00695347982149729,0.862579287090624
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00110277775858041,0.00646920826649925,-0.0137824259609189,0.0115768704437581,0.864647041336504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.00159196285521816,0.00937623281918768,-0.0167854534703897,0.019969379180826,0.865180742537145
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,39586,-0.00105759881207961,0.00627211029636661,-0.0133509349929582,0.0112357373687989,0.866099207364263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,39575,0.00106982764324233,0.00665758196210737,-0.0119790330024881,0.0141186882889728,0.872338062924156
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,39757,0.000372069896379315,0.00236464359619737,-0.00426263155216753,0.00500677134492616,0.874974121400995
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,41843,-0.00124598936641565,0.00793382443337693,-0.0167962852558344,0.0143043065230031,0.875209601084584
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,-0.00079139736912757,0.00518041628843098,-0.0109450132944523,0.00936221855619716,0.878584722061815
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.000422180308935664,0.00276775109665697,-0.005002611840512,0.00584697245838333,0.878767304968913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.000689339611270477,0.00460474975818114,-0.00971464913730552,0.00833596991476456,0.881002569728007
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.000746236975240483,0.00499346153707285,-0.0105334215879033,0.0090409476374223,0.881206971268399
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,39586,0.00145301929739986,0.00995116287190203,-0.0180512599315281,0.0209572985263278,0.883912206122041
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,39657,0.000846093152810998,0.00582742669769353,-0.0105756631746683,0.0122678494802903,0.884562278644196
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.000692952622241648,0.00479835063837708,-0.0100977198734607,0.00871181462897743,0.885175165920575
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,41913,0.00083885718106695,0.00585586479886587,-0.0106386378247102,0.0123163521868441,0.88609429726139
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,39900,-0.000739811067634014,0.00536371561283379,-0.0112526936687883,0.00977307153352022,0.890299115513432
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,0.0007467798455483,0.00549059431879379,-0.0100147850192875,0.0115083447103841,0.891815275513269
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MB,Myoglobin,42310,-0.00074750968240208,0.00567644854073467,-0.011873348822242,0.0103783294574379,0.895234469173004
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.000654518162745879,0.00497697272666991,-0.00910034838152715,0.0104093847070189,0.89537484652106
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.000259549073844963,0.00206301679165046,-0.00378396383778994,0.00430306198547986,0.899883830206108
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.000598732766529294,0.00491357866330455,-0.00903188141354761,0.0102293469466062,0.903017919992458
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,39930,0.00140429388449807,0.0118029767646626,-0.0217295405742406,0.0245381283432367,0.905294940717272
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.00028948370792698,0.00255235325375818,-0.00471312866943906,0.00529209608529302,0.909700557929882
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.000773994228903301,0.00694017175634887,-0.0143767308713471,0.0128287424135405,0.91120264772983
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.000460670500515574,0.00413661900841871,-0.0076471027559851,0.00856844375701625,0.911329667365391
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,39657,-0.00113290509993228,0.0102180543017863,-0.0211602915314335,0.0188944813315689,0.911719164601551
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SCIN,Adseverin,39586,0.000823915664442328,0.00752660541395224,-0.0139282309469041,0.0155760622757887,0.912834014995028
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.000563790356318246,0.00516961862444691,-0.0106962428602342,0.0095686621475977,0.913158147309667
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.00135443582418048,0.0125397171183908,-0.0232234097278655,0.0259322813762265,0.913988069020229
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.000804809581698961,0.0076224630458535,-0.0141352179881739,0.0157448371515718,0.915914405511651
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,42123,0.00132832830811423,0.0130312385028215,-0.024212899157416,0.0268695557736444,0.91881044931614
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,39757,-0.000533472149191997,0.0052760741439798,-0.0108745774713924,0.0098076331730084,0.919463709102893
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00037800315660292,0.00373903784594176,-0.00695051102144293,0.00770651733464877,0.91947579330913
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.000250005538367565,0.00248475206459289,-0.0046201085082345,0.00512011958496963,0.919856873011504
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,-0.000668408286757936,0.00673647441801546,-0.0138718981460682,0.0125350815725524,0.920963591547613
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,-0.00114884689117149,0.0116305644831081,-0.0239447532780633,0.0216470594957203,0.921316072283493
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,42016,0.000557496169612817,0.00569449026942409,-0.0106037047584584,0.011718697097684,0.922012385484505
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.000710175449110921,0.00736291269124527,-0.0151414843239517,0.0137211334257298,0.923162168612096
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CFD,Complement factor D,39979,0.000198761951248652,0.00206077428432165,-0.00384035564602177,0.00423787954851908,0.923164776828015
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.000533399634618435,0.00565106891783177,-0.0105426954443318,0.0116094947135687,0.924801739903384
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.000681483086393201,0.00772474101179807,-0.0158219754695174,0.014459009296731,0.929702767563375
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.000478230594727553,0.00549371872956403,-0.011245919304673,0.0102894581152179,0.930632986588412
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.000286881114968828,0.00338416675927591,-0.0069198479631496,0.00634608573321195,0.932444534134945
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,41976,0.000478540699563715,0.00564954777682573,-0.0105945729430147,0.0115516543421421,0.932497785844361
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.00037802884501132,0.00454607408906805,-0.00928833405958469,0.00853227636956205,0.933729541277263
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.000523488546818212,0.00629815875879985,-0.0128678797140659,0.0118209026204295,0.933759191951011
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.000278992041657747,0.00337675877285745,-0.00633945515314285,0.00689743923645835,0.934153924795669
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.000770183426205845,0.00945214725474147,-0.0177560251930874,0.0192963920454991,0.935059778135754
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.000277504339547592,0.0034198041075178,-0.00698032039028248,0.0064253117111873,0.935327112365654
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,-0.000322181704157231,0.00402725075796341,-0.00821559318976551,0.00757122978145105,0.936238115189707
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.000435704858374053,0.0057501638400464,-0.0108346162681169,0.011706025984865,0.939601354148515
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.000403367800958364,0.00552151068667137,-0.0104187931449175,0.0112255287468343,0.941764571917292
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.000435398005501959,0.00607413828914144,-0.0123407090522192,0.0114699130412153,0.942857343316178
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.000347698482663428,0.00515958361238953,-0.0104604823629469,0.00976508539762005,0.946273151243794
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,-0.000184492185952201,0.00276111526868824,-0.00559627811258115,0.00522729374067674,0.946727779979212
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,-0.000198026553000124,0.00300118172737946,-0.00608034273866386,0.00568428963266361,0.947392664568523
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.000348966331769944,0.00535133734299454,-0.0101396548604994,0.0108375875240393,0.94800711018808
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,42208,-0.000729037120398694,0.0113235309476018,-0.0229231577776983,0.0214650835369009,0.94866661756872
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.000233190694983442,0.00380618456341789,-0.00722693104931561,0.0076933124392825,0.951148259984025
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00029961859328001,0.00507318745492628,-0.0102430660049355,0.0096438288183755,0.952905999313026
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.000282378019029898,0.00495456026763242,-0.00999331614358944,0.00942856010552964,0.954551329145044
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00038168608625018,0.00699149287547458,-0.0140850121221804,0.01332163994968,0.956463748304954
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.000226053289221959,0.00432467937834358,-0.00825031829233146,0.00870242487077538,0.958314085049955
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,42070,-9.77637935894208e-05,0.00193842493282011,-0.00389707666191683,0.00370154907473799,0.959776768270876
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.0002125982187168,0.00425935952785171,-0.00856094289330616,0.00813574645587256,0.960192469015128
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,39560,-0.000213292638799479,0.004371580787696,-0.00878159098268364,0.00835500570508469,0.961086954985741
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.000262948148202929,0.00547248192616237,-0.0109890127234812,0.0104631164270753,0.961677938895997
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.000260128439832435,0.00547957602763028,-0.0110000974539878,0.0104798405743229,0.962137591592687
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.00014438401086402,0.00319227715368703,-0.00611247921036256,0.0064012472320906,0.963925330890886
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.000155452441133591,0.00374910077254538,-0.00719278507305536,0.00750368995532254,0.966926793453327
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,39586,-0.000142257796962255,0.00344951159723835,-0.00690330052754943,0.00661878493362491,0.967105328977953
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.000283683384303652,0.00713991054224827,-0.013710541278503,0.0142779080471103,0.96830743809126
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.000160440809932879,0.00412291483652925,-0.00824135388953021,0.00792047226966446,0.96895932856953
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,39575,0.000195486088586658,0.00512513080292499,-0.00984977028514631,0.0102407424623196,0.969574637166908
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,-0.000179665675126608,0.00576401698243908,-0.0114771389607072,0.011117807610454,0.975134382678513
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,39919,9.97540838068564e-05,0.0035929987973318,-0.00694252355896348,0.00714203172657719,0.977851297663831
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-6.40741448720104e-05,0.00266851144842922,-0.00529435658379329,0.00516620829404927,0.980844102970151
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-4.28287021689379e-05,0.00186854650188715,-0.00370517984586776,0.00361952244152989,0.981713798779428
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,0.000135747018718835,0.00599848621693911,-0.0116212859664818,0.0118927800039195,0.981945652133224
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,42224,0.000116091038796328,0.0061912449750058,-0.012018749112215,0.0122509311898077,0.985040146156498
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,39657,4.94314311987206e-05,0.00267147879472919,-0.0051866670064705,0.00528552986886794,0.985237601928724
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,39757,-6.1252432468637e-05,0.00362478603658858,-0.00716583306418224,0.00704332819924497,0.986518114829728
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,SAG,S-arrestin,39586,7.70293813314836e-05,0.00533331641957202,-0.0103762708010297,0.0105303295636926,0.988476772464542
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,42088,-8.85562623692645e-05,0.00734450880278319,-0.0144837935158243,0.0143066809910858,0.990379934907793
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.00010218566501172,0.00852394428059104,-0.0166047451249467,0.0168091164549702,0.990435345606615
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,-0.000105980726155011,0.00904016907121765,-0.0178247121057416,0.0176127506534316,0.990646575794638
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,6.02864758263817e-05,0.00599254910949782,-0.0116851097787894,0.0118056827304421,0.991973408747548
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,41839,2.80811803960368e-05,0.004601675541442,-0.00899120288083029,0.00904736524162236,0.99513112605947
NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,1.71105260295445e-05,0.00453652558593994,-0.00887447962241274,0.00890870067447183,0.99699067358752
